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A maker of Bonnets and Hoods-
A Barrister, brought to arrange their disputes-
And a Broker, to value their goods. 
From -The Hunting of the snark·, by Lewis Carroll 
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1 . GENERAL INTRODUCTION AND OBJECTIVES OF THE STUDY 
The ~irst example o~ a well documented epidemiological study that 
demonstrated a relationship between environmental conditions and 
cancer was the study o~ Doll and Hill [40], who found a ten-fold 
increase in the ~umber of deaths attributable to cancer, in 
relation to the use of tobacco. First in the U.S., and later in 
other countries as well, this discovery led to the recommendation 
to avoid the habit of smoking tobacco [163]. 
After these first epidemiologic studies, an avalanche of articles 
appeared, in which many environmental factors were mentioned that 
might increase tumor risk [4,36,41 ,44,65,121 ,129,152,172,173]. Of 
the numerous factors mentioned, dietary factors, occupational 
factors, and stress were the most prominent. 
Higginson [65] stated that environmental factors may contribute 
to 90% of total tumor incidence; implicating that a tremendous 
preventive potential might be achieved by changing personal life 
styles. 
Although experimental animals are not always adequate substitutes 
for men, a basic principle in cancer research should be that 
suggestive evidence ~rom retrospective epidemiological studies 
has to be confirmed in animal studies before a "suspected" 
carcinogenic ~actor is declared "guilty" [66]. That one will 
encounter problems when a potentially carcinogenic factor is 
investigated in animal studies is no reason to avoid such 
experiments. To facilitate extrapolation to the human situation 
one has to design the experiments very carefully. For instance, 
the carcinogenic regimen (how much, how often?) and the choice of 
the tumor model in which the carcinogenic factor is studied 
should be very well considered [66]. 
1.1. The Frame of the Study 
In the present study, it was our aim to study some potentially 
carcinogenic factors like stress, and dietary lipids within the 
following framework: 
-the carcinogenic factors studied have to be administered in such 
a way that the animals are kept in a condition of "wellbeing" as 
much as possible. Particularly, acute injurious effects have to 
be prevented. 
-the factors have to be present chronically (lifelong), or at 
least subchronically {period of at least one month). 
-the tumor , model has to be comparable with a human tumor, in 
·histo-pathological appearance, as well as in biological behavior. 
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-the "control" of the suspected carcinogenic factor shall be in 
such a way that the above mentioned considerations with regard to 
noxiousness, etc, are identical for the control non-carcinogenic 
factor. 
-the biological variability of the tumor models as well as the 
methodological variability of the parameters have to be small. 
Furthermore, it is our assumption that when a certain 
environmental factor causes an altered tumor risk, this factor 
will trigger some biochemical processes, which will result in 
measurable changes in the homeostasis of the individual. It will 
be clear that a choice had to be made, which of the many 
biochemical processes should be monitored. With our choice we do 
not suggest that, the biochemical processes not studied, do not 
play a role in the relationship between environmental factors and 
increased cancer risk. 
1.2. The Hypothetical Pathways 
1 .2.1. the immune-endocrine pathway 
How environmental factors might elicit their effect on 
carcinogenesis remains unclear. Alterations in hormone levels 
[14,55,61 ,83], immunological inadequacies [133,169], infectious 
diseases [41 ,155], and geophysical factors [85,142], were 
mentioned. To restrict ourselves in our quest for those 
mechanisms that might be responsible for the observed cancer risk 
from environmental factors, we have chosen the "immune-endocrine 
pathway" as a main track for our studies. We prefer to use this 
terminology because variations in hormone levels and immune 
capacity are very closely related [169]. For instance, when 
adrenocortical hormone secretion is increased, murine mammary 
tumor growth is decreased [169]. As corticosteroids are also very 
potent immunosuppressive agents, in such situations as the given 
example, it is impossible to differentiate between hormonal and 
immunological alterations. 
To summarise our hypothesis; we assume that certain environmental 
factors may lead to a decreased capability of the individual to 
recognise and/or to eliminate malignant cells, which are caused 
by alterations in cell-cell interactions. We may illustrate this 
with an example: as a result of stress, plasma corticosteroid 
levels increase, the high corticosteroid levels lead to a 
depressed cellular immune response, with subsequently a depressed 
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cellular immune system, resulting in an altered pattern of tumor 
growth and incidence. 
·1 . 2. 2. the prostaglandin pathway [ 17,90, 91 , 153] 
As it has been shown that the quantity of polyunsaturated fatty 
acids (PUFA; in particular, linoleic acid) in the diet is 
important to prostaglandin synthesis capacity [49,125], some 
investigators postulated that the increased growth of mammary 
tumors in rats on high PUFA diets might be caused by an increased 
prostaglandin synthesis capacity [68,80]. 
Some evidence for the potential role of prostaglandins in 
relation to diet and cancer has been obtained so far: 
-dietary factors could induce changes in prostaglandin (PG)-
synthesis [49,125] 
-increased tumorigenesis in rats, 
abrogated when in these animals 
indomethacin therapy [24] 
fed high fat diets, could be 
PG-synthesis was blocked by 
-tumor bearing individuals showed increased plasma PG values 
[1,94,124,162] 
-PG-synthesis by malignant tumor cells in vitro was different 
from PG-synthesis by cells from normal or hyperplastic tissue 
[10,12,88,92] 
-PG's could play an important role in certain immune processes 
[59] 
-PG's and Thromboxane-A2 (TXA2 ) played an important role in 
hemostasis, which seemed, on its turn, to play an important role 
in tumor spread [71] 
-in some cases tumor associated complications, such as diarrhoea 
[6], or bone decalcification [136], could be decreased with 
therapy that blocks PG-synthesis. 
-tumor cells were found to be able to synthesize -pro-coagulant 
factors- (TXA2?) which stimulate a platelet aggregation 
[50,51,57]. 
In summary; the hypothesis that prostaglandins are involved in 
carcinogenesis is based on the finding that changes in 
arachidonic acid availability (e.g. induced by changes in the 
dietary fatty acid composition) lead to changes in prostaglandin 
synthesis; which changes may then be responsible for an altered 
immune response, which links this hypothesis with the -immuno-
endocrine pathway-. 
N.B. although 5-lipoxygenase products may also play a role in 
tumorigenesis, in the context of this thesis the discussion of 
this pathway has been intentionally omitted. 
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As has been mentioned, the capacity ~or synthesis o~ in 
particular PGI 2 and TXA2 seems to play an important role in 
hemostasis as well [60], there~ore alterations in the synthesis 
o~ these PG's may a~~ect metastasis in the ~ollowing hypothetical 
way: malignant tumor cells entering the circulation (lymph, or 
blood), will eventually arrive in the capillary system. At this 
site they cause a local platelet aggregation by means o~ the 
tumor cell's capacity to synthesize aggregating ~actors, as a 
result o~ which the tumor cells are surrounded by platelets and 
are shielded ~rom cells with phagocytic capacities, the tumor 
cells survive and new tumors are born [167]. 
For many aspects o~ the hypothesis, experimental evidence was 
~ound [71]. It is one o~ the purposes o~ the present study to 
bring in new in~ormation on this subject in order to ~ind proo~ 
pro or contra the hypothesis that prostaglandins play an 
important role in tumor metastasis. 
1 .3. The Choice of the Environmental Factors 
In the earlier mentioned epidemiological studies in man the 
strongest correlation between increased tumor risk and 
environmental ~actors was obtained ~or "nutrition" [128,172]. 
This latter could be ~urther di~~erentiated into a great number 
o~ di~~erent dietary ~actors, ~rom which dietary ~at seemed to be 
the constituent that correlated most signi~icantly with certain 
types o~ cancer, in particular colon and mammary tumors [41,129]. 
There~ore, this speci~ic environmental ~actor was studied in 
I particular. The aim o~ an important part o~ the study was to 
investigate the relationship between diets with. a constant ~at 
content but "high'' or "low" in the two . main types o~ 
polyunsaturated ~atty acids, and tumor growth or incidence. 
Another environmental ~actor that raised special interest in 
relation to increased cancer risk in man was stress [36,62]. 
There~ore, in our rat tumor models, as a second environmental 
~actor, stress was studied. Rats were exposed to weekly 
alterations in night/dark rhythm. This type o~ stress induces, 
~or instance a chronic adaptation o~ dietary hapits, and can be 
regarded as mild chronic stress [175]. 
In summary; tumor incidence 
receiving mild chronic stress 
with regard to polyunsaturated 
and growth was studied in rats 
or diets in which the composition 
~atty acids was al,tered. 
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2. GENERAL METHODOLOGY 
2.1. The Choice of the Tumor Models 
In general, 3 types of tumor models can be distinguished: 
physico-chemically induced, virally induced, and "spontaneous" 
tumors [132]. In syngeneic rat strains it often is possible to 
transplant such obtained tumors. After some passages in syngeneic 
rat strains one may speak of a "transplantable tumor line". 
Biological and histopathogical features of such transplantable 
tumor lines may vary. For instance, transplantable tumor lines 
can be further differentiated into: immunogenic vs non-
immunogenic; carcinoma vs sarcoma; metastasizing vs non-
metastasizing; hormone responsive vs non-hormone responsive, 
ones. 
Within the frame of the study as was mentioned in Chapter 1.1 ., 
we considered "spontaneous tumor models" as the most proper ones 
for studying environmental factors and carcinogenesis. The 
obvious disadvantages of these models, however, are the long 
study period and the tremendous amount of work needed to process 
the histology to obtain the microscopic data. Nevertheless, this 
should not be taken as a too serious handicap. The second best 
model of tumor growth that resembles the "ideal tumor model" as 
was for instance formulated by Clifton [33], is a "transplantable 
tumor model", preferably one that originated "spontaneously". In 
our studies such models were used as well. The tumors used have a 
number of biological characteristics in common, but important 
differences in behavior exist as well. This gave us the 
opportunity to correlate differences in tumor characteristics 
with differences in either one of the aspects studied. 
2.2. The Parameters Chosen 
2.2.1. Tumor size was chosen as it was our experience that this 
parameter reflects tumor growth rather well. In our studies, 
tumor size was sometimes converted to "tumor growth rate", which 
expresses a tg~. representing the slope of the tumor growth rate 
[Appendix, Publication IV]. 
2.2.2. Number of metastatic foci in the lungs was taken as 
parameter of tumor metastasis. The transplantable tumors selected 
are capable to metastasize from their inoculation site to the 
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lungs; at termination of the study the lungs were taken out, and 
fixated; after histologically processing, the tumor foci easily 
can be distinguished. In those studies where the tumor was 
inoculated intravenously it was the method of choice to determine 
"tumor take" 
2.2.3. Serum corticosterone concentrations were determined in 
most of the Light-Dark shift experiments as a function test of 
the adrenal glands. It serves as a parameter to establish 
"stress" [159]. 
2.2.4. Plasma free fatty acids were determined to confirm the 
composition of the food with regard to its fatty acid 
distribution, and whether this was effectively ingested. 
2.2.5. Body weight was measured as 
very useful to obtain a general 
the animals. Moreover, differences 
this parameter is simple and 
impression of the condition of 
in body weight themselves may 
have important consequences on tumor growth rates_. 
2.2.6. Food consumption was measured to establish whether the 
experimental diets were well taken. Substantial differences in 
food consumption cannot be accepted, as such differences may in 
itself be responsible for differences -in tumor growth. 
2.2.7. The measurement of Plasma arachidonic acid bioconversion 
products (PGE2 , 6-keto-PGF1a, and TXB2 ) formed the backbone of 
that part of the study in which tumor growth was correlated with 
prostaglandin synthesis capacity. 
2.2.8. In vitro platelet aggre~ation was measured 
blood aggregometer". The parameter was chosen because 
in prostaglandin synthesis, particularly of PGI2 and 
reflected in the platelet function, from which 
capacity is an important characteristic [21]. 
in a "whole 
alterations 
TXA2 may be 
aggregation 
2.2.9. Cellular immune response (concanavalin-A induced 
stimulation of lymphocytes, phytohemagglutinin induced 
stimulation of lymphocytes, popliteal lymph node assay, natural 
killer cell activity) were other important parameters in this 
study, since it was our working hypothesis that during stress as 
well as in the dietary studies the evoked immunological changes 
were in some way responsible for differences in tumor growth. 
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3. REVIEW OF THE EXPERIMENTAL RESULTS 
3.1. The Bac~ound of the Study 
In earlier studies it was our rinding [99] that untreated 
allogenic kidney transplantations perrormed between inbred rats 
could show a large variation in grart survival time. This 
phenomenon among others initiated the present study. 
In the rererred transplantation experiments conditions were 
optimally standardized. Still approximately 10~ or the kidney 
grarted rats could be considered as "long survivors". The mean 
survival time or animals with allogenic kidney transplantations 
without immunosuppressive treatment was 13 days, whereas the one 
out or ten "long surviving" allograrted rat at least lived ror 
more than 50 days. 
Although experimental conditions, (i.e. degree or histo-
compatibility, age, body weight, housing conditions, etc.) were 
controlled, post operative stress could have varied. This 
environmental ractor was taken as a subject or a next study in 
which it was investigated, whether a certain amount or stress, 
given post operatively, could be held responsible ror the 
observed prolongation or grart survival time [100]. The results 
were striking, not more than one day or restraint stress could 
alter the mean grart survival time signiricantly. Our conclusion 
was that, stress could induce a suppression or the immunological 
response. 
At the same time, dietary inrluences on kidney grart survival 
were studied [100]. Our starting point ror the study on the role 
or nutrition on kidney grart survival was slightly dirrerent rrom 
that related to the role or stress. It was hard to believe that 
variations in the rat's daily rood uptake could have been 
responsible ror the observed variation in kidney grart survival 
times. However, in a slightly dirrerent context the consumption 
or certain diets, in particular or diets high in unsaturated rat, 
were shown to have immunosuppressive potentials, which eventually 
led to prolongation or grart survival [113,114]. 
In our studies [100] we could partly conrirm the results obtained 
by Mertin and associates [113,114]. In rats receiving the semi-
synthetic diets, which were "high" in rat (35 en~). kidney grart 
survival times were prolonged, compared with those rats on 
standard chow, which is "low" in rat (16 en% rat; N.B. standard 
rat chow is also dirrerent in other constituents, such as crude 
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fiber). However, no significant differences between the 35 eni 
fat diets high or low in linoleic acid were seen. This latter was 
not in accordance with data obtained by others [19,97,113-116], 
where linoleic acid high diets were relatively more 
immunosuppressive compared to diets high in saturated fat. The 
results of these latter animal studies tempted some groups to 
-treat- kidney transplantation patients with diets rich in 
linoleic acid with promising results [110]. 
Actually, nowadays there is consensus about the role played by 
long chain fatty acids on the immune response: diets deficient in 
essential fatty acids (linoleic acid) induce a relatively high 
immune response. When the dietary linoleic acid concentration 
increases, the cellular immune response decreases [113,166]. 
However, whether an immunopotentiating effect can be obtained 
with low dietary quantities of linoleic acid, without attaining 
conditions that are the result of linoleic acid deficiency is 
still a subject of debate [76,77]. 
The fact that stress as well as certain dietary compositions 
could induce immunoinhibitory actions, expressed as prolonged 
kidney graft survival, may have its implications to 
carcinogenesis as well. However, so far only little evidence for 
a correlation between immunosuppression and increased tumor risk 
in man could be obtained [113,133,170]. From epidemiological 
studies in man, there is substantial evidence that environmental 
factors contribute to cancer occurrence [41,172,173]. And in the 
context of environmental factors and cancer, nutrition and stress 
(psychological stress), were often mentioned as factors of great 
significance in increasing cancer risk [41,65,122,135]. 
3.2. Stress and Cancer 
With regard to stress, in particular the pioneering animal 
studies of Rasmussen [139], and of Solomon [156], produced 
evidence for a relation between stress and decreased 
immunocompetence. These findings led others to investigate also 
the role of stress induced depression of immunity and cancer 
[8,30,140,160]. Several comprehensive articles on this subject 
have been published [4,36,62,122,152]. 
The role of stress in carcinogenesis in man has been suspected 
since long. Galen living in the second century, believed that 
melancholic women were more likely to develop cancer than those 
who were more confident and vital. In modern science, the role of 
emotional stress and carcinogenesis risk is still being 
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considered seriously [36,62]. In this relation, the concept 
"cancer prone personality" was given for individuals with an 
inhibited life-style, melancholic and easily giving up, and the 
propensity to withdraw from unacceptable realities [4,62,122]. 
In experimental animals as well as in studies in men, the 
mechanism responsible for the increased tumor risk, was supposed 
to be stress induced changes in the neuroendocrine system 
[141 ,157]. For instance, in murine studies, severe acute stress 
resulted in significantly increased corticosteroid levels 
accompanied with a decreased cellular immune response 
[87,141 ,156]. In humans, such effects on the immune system as a 
result of emotional stress could also be established [8,36,62]. 
Depressed lymphocyte function [8,36,37,120], increased 
corticosteroid levels [36,152], and a higher susceptibility to 
Epstein-Barr virus infections were noted [95]. 
In our first animal experiments on the influence of stress on 
kidney graft survival [99,100], stress was induced by means of 
physical restraint; this stress can be considered as a form of 
acute severe stress [112]. In our later studies on the relation 
between stress and cancer, mild chronic stress was preferred as 
we considered such stress better comparable to the stress that 
humans endure as a result of their personal life style. For this 
purpose, light-dark (L-D) shift stress was chosen. 
In a first experiment L-D shift stress was given during 35 weeks, 
while its capacity to induce neuroendocrine changes and 
alterations in the cellular immune response were tested 
[Appendix, Publication I]. Rats receiving L-D shift stress showed 
a significantly depressed cellular immune capacity in the Con A 
test and in the popliteal lymph node assay. However adrenal 
cortical activity, as measured by serum corticosterone levels, 
was not significantly increased. Rather unexpectedly, the weights 
of the adrenal glands were significantly decreased in those rats 
undergoing L-D shift stress. On the basis of these latter results 
one might conclude that L-D shifts do not cause stress, as stress 
is often defined as a condition accompanied with increased 
adrenal gland weight, and a cortical activity leading to 
increased levels of plasma corticosteroids [141,159]. However one 
has to keep in mind that the correlation between stress and 
increased cortical activity has always been found in studies on 
acute stress [141 ,159]. In studies on chronic stress, by others 
as well [8,120], such a correlation could not be demonstrated. 
Despite this lack of increased adrenal cortical activity, like in 
our study, the immune capacity was found to be decreased [8,120]. 
Therefore we concluded that L-D shift stress is significantly 
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different from acute or from repeated acute stress, but still has 
to be regarded as a condition with chronic alterations of the 
homeostasis (e.g. showing in the altered immune capacity), and as 
such has to be considered as -stress- (see also definition of 
stress as given in -glossary of terms-). Therefore, the model of 
L-D shift stress seems to us a proper model to study the relation 
between chronic stress and cancer. 
With this background information the actual experiments could be 
planned and the influence of mild chronic stress on tumor growth 
and incidence was studied. The study falls in two parts, one in 
which the role of chronic stress on ttimor incide.nce of 
spontaneous tumors in BN female rats is studied [Appendix, 
Publication II]; and another part, in which the role of stress on 
the growth of transplantable tumors is investigated [Appendix, 
Publication III]. 
3.2.1. stress and spontaneous tumor incidence 
[Appendix, Publication II] 
100 BN female rats underwent light-dark shift stress during their 
whole life span (from weaning to maximally 150 weeks). A control 
group received standard lighting regimen (7 a.m.-7 p.m., light; 7 
p.m.-7 a.m., dark). The differences in tumor incidence between 
experimental and control group were not statistically significant 
3.2.2. stress and transplantable tumor growth 
[Appendix, Publication III] 
6 weeks old BN female rats underwent L-D shift stress from 7 
weeks prior to tumor inoculation until the animals were 
sacrificed. The rats received one of the following types of tumor 
inoculae: 
-leiomyosarcoma 
-squamous cell carcinoma 
-basal cell carcinoma 
-fibrosarcoma 
-myeloid leukemia 
The biological characteristics of these tumors with regard to 
hormonal responsiveness, metastatic behavior, etc., · are 
summarised in Table I of Appendix Publication VI. 
The fibrosacoma and the myeloid leukemia showed a retardation of 
tumor growth in those rats receiving L-D shift stress, compared 
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with the control rats. No significant differences in tumor growth 
by L-D shift stress were observed in the other tumor models. Both 
stress responsive tumors were distinguished from the other ones 
by the fact that these two tumors had proved to be -hormone 
responsive- (hormone responsiveness was established in parallel 
experiments, by determining differences in tumor growth between 
control rats and rats that were either adrenalectomized or 
ovariectomized). It seems logical to consider that this fact in 
particular may have contributed to the different growth 
characteristics of the myeloid leukemia and the fibrosarcoma. 
3.3. Dietary PUFA (n-6) and Cancer 
Pearce and Dayton [131] caused a lot of alarm with their rather 
careless statements based on the data of an epidemiological study 
entitled -Incidence of cancer in men on a diet high in 
polyunsaturated fat-. In this study they found -evidence-
(p=0.06) for a greater incidence of carcinomas in the group of 
men on diets high in unsaturated fat. Carroll et al. [25-29], 
studied this phenomenon in experimental animals using chemically 
induced tumor models. Although there was some criticism on their 
tumor models and experimental design, their experiments, and 
those carried out later by others as well [19,20,31 ,32,34,68, 
79,80], demonstrably influenced food recommendation to men 
[35,164]. Diets high in polyunsaturated fat (PUFA), possibly able 
to prevent coronary heart disease were suspected to increase 
cancer risk, in particular with regard to mammary adenocarcinomas 
[63,121]. As mentioned earlier in this chapter, the studies, the 
epidemiological ones as well as the animal studies, were not 
always designed with the necessary care: For instance in 
experimental animal studies essential fatty acid deficient diets 
were often taken as controls (animals under such a restricted 
dietary regimen are actually ill [76,77]), and as soon as a small 
amount of linoleic acid was added to the diet the -favorable-
inhibiting effect on tumor incidence, seen in rats receiving 
diets deficient in linoleic acid, could not be demonstrated 
anymore [68]. 
Epidemiological studies further revealed that total fat intake 
correlated with mammary and colon cancer risk [41 ,44,117,129, 
172], however there was no proof that specifically the dietary 
PUFA content was primarily responsible. On the contrary, in 
particular, animal fat seemed to be correlated with a high cancer 
incidence on colon and breast cancer, while a vegetarian life 
style was correlated with a low risk in that respect [98,135]. 
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Because we felt that additional data on this subject were needed 
to obtain a better fundamented opinion on PUFA and cancer risk, 
we designed a study in which semi-synthetic diets, containing the 
same amount of fat but with either 3.3 en~ of linoleic acid 
("low"") or 17.7 en~ of linoleic acid ("high"), were supplied to 
rats. Both diets were identical in all other constituents and 
contained those elements, in quantity and quality necessary for 
adequate development of rats [143]. 
As sequential bleeding (e.g. for determinations of immune 
response) was shown to be stressful as such [23,56], blood 
sampling for determinations ,of cellular immune response and 
hormone levels were carried out in a parallel study. In this 
study identical diets were given to groups of rats that were 
sacrificed for the assays after 7 weeks on diet. This implies 
that the data gathered in the parallet study, were from rats in 
which no tumors were inoculated and had not undergone earlier a 
possible stressful event, such as bleeding. 
Con A stimulation of peripheral lymphocytes, and the popliteal 
lymph node assay (PLNA), which is a local graft-versus-host assay 
[105], were taken as a measure of cellular immune response. 
Furthermore, the earlier mentioned kidney transplantation 
experiments [100] can also be regarded as a first attempt to 
establish differences in immune capacity of rats fed diets either 
high or low in linoleic acid. These studies [100-102, Appendix, 
Publication IV] showed that cellular immune response was 
depressed in those animals receiving the 35 en~ fat diets, when 
compared with rats receiving the standard rat chow, which was 16 
en~ of fat. No statistically significant differences were 
observed between diets high or low in linoleic acid. By which it 
was demonstrated that diets rich in fat could effectively alter 
the immune system; the quantity of fat appeared to be more 
important in that respect than the quality. 
3.3.1. dietary PUFA (n-6) and spontaneous tumor growth 
[Appendix, Publication V] 
Total spontaneous tumor incidence in BN female rats receiving a 
35 en~ fat diet "low" (3.3 en~) or "high" (17.7 en~) in linoleic 
acid, was not statistically significantly different. However 
statistically differences in th~ incidence of adrenocortical 
carcinomas and reticulo-endothelial tumors were seen: Rats 
receiving the diets low in linoleic acid had a higher number of 
these tumors. With regard to the age of the animals in which the 
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tumors were assessed, differences were established too; mammary 
gland-, and pancreatic island tumors were seen earlier in rats 
receiving the diets low in linoleic acid. Only multiple mammary 
tumors (i.e. >1 tumor ih the same rat), predominantly benign 
mammary fibroadenomas, occurred statistically significantly more 
often in those rats on the diet rich in linoleic acid. 
3.3.2. dietary PUFA (n-6) and transplantable tumor growth 
[Appendix, Publications IV and VI] 
Groups of BN female rats received 35 en~ fat containing diets 
high (17.7 en~) or low (3.3 en~) in linoleic acid at 6 weeks of 
age. In these animals, 7 weeks thereafter, one out of the 
following tumors was inoculated: A mammary adenocarcinoma, a soft 
tissue fibrosarcoma, a skin basal cell carcinoma, a ureter 
squamous cell carcinoma, an adrenal cortical carcinoma, a 
cervix/uterus leiomyosarcoma, or a myeloid leukemia. All these 
tumors were obtained from longevity studies, in which they 
occurred spontaneously. 
Statistically significant differences -in tumor growth were seen 
in those rats in which either the cortical carcinoma or the 
myeloid leukemia were inoculated. In rats given the diet low in 
linoleic acid growth of the cortical carcinoma was significantly 
increased, whereas the opposite effect was seen in rats with 
myeloid leukemia. 
Note, that the adrenal cortical carcinoma and myeloid leukemia 
were the 2 tumors that showed differences in spontaneous tumor 
incidence as well (summarized in 3.3.1.). 
3. 4. Dietary- PUFA (n-3) and Cancer 
The reason for this part of the study was predominantly because 
data from epidemiological studies, from which certainly those of 
Dyerberg [46,47] should be mentioned, showed a low incidence of 
coronary heart disease among Greenland Eskimos, although ~hey 
consumed a high fat, high protein diet. The high consumption~of 
marine lipids by these people was considered responsible for this 
[7]. Fish and its predators living in cold sea waters contain 
many polyunsaturated fatty acids of the n-3 type (docosahexaenoic 
acid, DHA; and eicosapentaenoic acid, EPA), which explains also 
the observed tendency in Eskimos to have prolonged bleeding times 
[47,106], due to altered platelet function caused by a disturbed 
ability to synthesize certain types of PG's [53,81] 
24 
Apart from the claimed favorable effects on coronary heart 
disease DHA/EPA rich diets may influence tumorigenesis as well. 
Epidemiologically there is no evidence for such an assumption, 
although the low incidence of mammary tumors among Greenland 
Eskimo-, and Japanese women [123,173] is sometimes attributed to 
their dietary regimen, in which fish is an important constituent 
[7,126]. In experimental animal studies there is more evidence 
for a role of diets rich in n-3 fatty acids on carcinogenesis. 
Karmali, et al. [93], showed that growth of transplantable rat 
mammary adenocarcinomas was significantly retarded in those rats 
receiving an EPA/DHA mixture, as an oral supplementation to their 
diet, compared with rats that had the standard rat chow alone. 
This finding was confirmed by Carroll and Braden [29], and by 
Jurkowski and Cave [89]. Although others [161] could not confirm 
this tumor growth inhibitory action, they did find a decreased 
PG-synthesis by tumor tissue of rats on diets high (17~ of total 
fatty acids) in EPA, compared with rats low in EPA (0.1 ~ of 
total fatty acids). 
Our study was undertaken to shed more light on this subject. 
Moreover, as tumor metastasis has not been particularly well 
investigated, this aspect was studied separately. The studies 
with diets enriched with n-3 fatty acids are subdivided into 3 
parts: a part in which tumor prostaglandin synthesis was studied 
[Appendix, Publication VII]; a part in which tumor dissemination 
was studied exclusively [Appendix, Publication VIII]; and a part 
in which a n-3 PUFA enriched diet was given at tumor inoculation. 
Finally we studied a possible alteration of tumor growth and 
metastasis by a diet given for -therapeutical- purposes 
[Appendix, Publication IX]. In all studies the transplantable 
mammary tumor model (BN472) was chosen as in this model, tumor 
take, growth, and spread can be studied. 
3.4.1. dietary PUFA (n-3) and tumor growth 
[Appendix, Publication VII] 
In this study the transplantable mammary adenocarcinoma BN472 was 
inoculated in rats that received 30 en~ fat diets low or high in 
linoleic acid (group I and II; 3 and 10 en~ of linoleic acid 
respectively); and diets isocaloric in fat, rich and low in fish 
oil (group III and IV; 7 or 2 en~ of EPA/DHA, respectively). The 
diets were given from weaning till death of the animals, while 
tumors were inoculated when the animals were 9 weeks on diet. In 
a number of rats, plasma concentration of 6-keto PGF 1 ~, PGE2, 
TXB2 , and platelet aggregation in vitro were measured, before and 
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after tumor inoculation. Cellular immune response was determined 
exclusively before tumor inoculation. 
The results showed that tumor growth was significantly inhibited 
in those groups of rats receiving the diets containing fish oil. 
There was no statistically significant difference in tumor growth 
between rats rece1v1ng the diets high (7%) or low (2%) in 
EPA/DHA. Plasma PGE2 and TXB2 values were significantly decreased 
in rats fed diets containing fish oil; no differences between the 
high and low n-3 diets were observed. As such the observed 
differences in tumor growth correlated with inhibited PG 
synthesis and with the presence of n-3 fatty acids in the diet 
(but not with the concentration of dietary n-3 fatty acids). 
Cellular immune response capacity in all dietary groups was the 
same, therefore the observed differences in mammary tumor growth 
could not be ascribed to differences in the cellular immune 
response. 
Tumor metastasis, which could be established in this tumor model 
as well, did not show any significant difference in either one of 
the experimental groups. 
3.4.2. dietary PUFA (n-3) and tumor dissemination 
[Appendix, Publication VIII] 
The same experimental design was chosen as was described under 
3.4.1. However in stead of inoculation of a solid piece of 
mammary tumor in the flank, intravenous inoculation of in vitro 
cultured tumor cells of the same tumor line (BN472, mammary 
adenocarcinoma) was carried out. To determine tumor cell PG 
synthesis-capacity, 6-keto-PGF1a, PGE2 and TXB2 were measured in 
the culture medium of the tumor cells. Moreover the capacity of 
the tumor cell to induce platelet aggregation in vitro was tested 
as well. 
The results of this part of the study showed that no significant 
differences in the number of metastatic foci in the lungs, which 
was taken as a measure of tumor dissemination capacity, could be 
shown in neither experimental group. PG measurements in the 
supernatant of BN472 tumor cells showed that they could produce 
significant quantities of TXB2 , however, this latter activity was 
also seen by cultured fibroblasts, which were used as a non-tumor 
control cell line. When the same concentration of cells was 
compared, synthesis of TXB2 was even significantly higher in 
fibroblast culture medium. But the fibroblasts produced also 
large quantities of PGI 2 (measured as 6-keto-PGF1a> which is a 
--------------------
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strong anti-aggregatory agent. PGE2 and 6-keto-PGF1a could not be 
detected in the supernatant of the tumor cell cultures. Although 
it is far from sure that PGI 2 and TXA2 play a role in tumor 
metastasis, the results of the cell cultures indicate that TXA2-
synthesis alone cannot be regarded as a characteristic of 
malignant tumor cell behavior. A balance between cellular PGI 2 
and TXA2 synthesis, strongly in favor of TXA2 , could possibly be 
more specific for malignant tumor behavior. 
Our results with tumor cell aggregation studies were in 
accordance with the idea that malignant tumor cells could produce 
-pro-coagulant- activities [57,73]. 1x105 tumor cells added to 
whole blood in a -whole blood aggregometer-, induced a strong 
irreversible aggregation. However, when such an experiment was 
carried out with cultured fibroblasts in stead of tumor cells, no 
such an aggregation could be demonstrated. 
3.4.3. dietary PUFA (n-3) as a tumor therapy 
[Appendix, Publication IX] 
In this experiment a slightly different experimental design was 
used. Only two dietary groups were studied, and in one group of 
rats a conversion of diets from a diet low in linoleic acid and 
high in saturated fat (diet group I, as used in 3.4.1. and 
3.4.2.) to a diet high in fish oil (diet group III, as was used 
in 3.4.1. and 3.4.2.). Mammary adenocarcinomas were inoculated 
subcutaneously as was discussed previously (experiments 3.4.1.). 
The change from diet I to diet III took place at the time of 
tumor inoculation and was as such meant as a -therapeutical 
approach- to inhibit tumor growth or tumor cell spread. The 
rationale of this approach was that studies in men suggested that 
cancer growth could be inhibited and survival prolonged, when 
e.g. vegetarian diets were given therapeutically [151]. The 
theoretical background for this was that tumor metabolism might 
be influenced by the dietary composition possibly resulting in a 
reduced tumor cell turnover [151]. This hypothesis is more or 
less the same one as was used in our studies (see Chapter 
1 . 2. 2.). 
The results of this study, however, did not show any therapeutic 
effect whatsoever of the fish oil diet. Exclusively, those rats 
that had received the diet from weaning onwards, had a 
significantly reduced growth of the inoculated primary tumor. 
Differences in the number of lung metastases between the 
experimental groups were small and not statistically significant. 
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3.5. Prostaglandins and Cancer 
In Chapter 1.2.2 .• the reasons for this part of the study were 
explained briefly. In particular the connection between dietary 
PUFA and prostaglandin synthesis were mentioned. In the study, 
reviewed under 3.4. this relation between plasma PG levels and 
dietary fat is further shown. Apart from dietary modifications, a 
more frequently used approach to influence PG synthesis is the 
pharmacological approach, using drugs that can alter PG 
synthesis. 
Clinically a small number of studies have been carried out in 
which by means of non steroid anti inflammatory agents (NSAIA), 
such asp1r1n or indomethacin, one attempted to inhibit tumor 
growth or to overcome tumor associated complications such as 
hypercalcemia or diarrhoea [6,136]. In studies with experimental 
animals more knowledge on this subject was gathered 
[11,13,16,54,108,109]. In vivo, as well as in vitro studies, 
demonstrated that tumor growth could be significant reduced by 
tnerapy with NSAIA [13,54,108,109]. However, in some in vitro 
studies, no effect of indomethacin on tumor cell growth could be 
shown [127]. 
Not only tumor growth, but also tumor metastasis could be reduced 
by therapy with NSAIA [42]. The anti platelet activity,of these 
drugs was considered to be responsible for this. A number of 
pharmacological approaches were investigated, most of which were 
based on the theory that therapy should correct -favorable-
conditions for tumor cells to metastasize (i.e. to decrease TXA2 
or increase PGI 2 levels [5,39,118,165]). 
The results of these studies on the control of tumor metastasis 
varied [69,72,73,109,148]. One possible explanation for this 
variability in the results obtained was considered particularly, 
viz., the amount of aspirin used. For, in experimental animals 
the effect of asp1r1n on platelet aggregation is related in an 
inverse way to the amount of the drug given; i.e. low doses of 
aspirin were most effective [48,119]. Also in humans in which 
prolongation of the bleeding time was wanted in patients that 
underwent coronary bypass surgery only low doses of aspirin 
proved to be effective in the control of patency of the bypass 
[168]. 
In our study on the effect of platelet anti-aggregatory therapy 
on tumor metastasis, aspirin in a high, 200 mg/kg/day or a low 
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dose, 20 mg/kg/day was used. Furthermore, in another group of 
rats, theophyllin (a phosphodiesterase inhibitor, which acts 
anti-aggregatory too) 75 mg/kg/day, was given. Combinations of 
theophyllin with aspirin either in high or low doses were given 
as well. 
The malignant fibrosarcoma (BN175), that metastasizes from its 
inoculation site to the lungs was used as a tumor model. In the 
discussed studies the tumor was inoculated subcutaneously. 
3.5.1. tumor growth and prostaglandin synthesis 
[Appendix, Publication X] 
In this study tumor size of a malignant fibrosarcoma (BN175) and 
plasma-PGE2 , 6-keto-PGF1a and TXB2 values were determined. 
Moreover, platelet aggregation in vitro was measured as well. 
Tumor growth correlated with increased (10-fold) plasma TXB2 and 
PGE2 levels. Animals with small tumors (<20 mm in diameter) did 
not show any significant increase in plasma PG values. At the 
same time that due to tumor progression significant alterations 
in plasma PG values were observed, ADP-induced platelet 
aggregation was shown to be reduced. 
With this study we confirmed that tumor growth could he 
correlated with increased plasma PG levels. However control 
(irradiated) tumor cells also showed elevated plasma PG levels. 
It remains therefore unclear whether the observed changes were 
due to tumor PG synthesis or due to a tumor initiated host 
response. 
3.5.2. tumor growth and NSAIA treatment 
[Appendix, Publication XI,103] 
Like others before [9,13,109,148], we observed a reduction in 
tumor growth in our tumor model in those rats receiving the high 
dose asp1r1n treatment. Not only tumor growth itself was 
significantly inhibited, but also the number of metastatic foci 
in the lungs was shown to be reduced. Treatment with low dose of 
aspirin, theophyllin (this latter used as a drug to increase 
endogenous prostacyclin, by inhibiting its bioconversion [118]), 
or their combinations, did not show any favorable effect on tumor 
growth or metastatic spread, in comparison to the non treated 
rats. 
The favorable effect seen on tumor metastasis in the groups of 
rats receiving therapy with high dose of aspirin might have been 
mediated by an inhibitory effect on the growth of primary tumor 
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itself, since it seems logical to presume a correlation between 
tumor mass and the number of metastasis. To exclude such an 
influence on tumor metastasis, in a next study the tumor was 
inoculated in the dorsum of the foot and therapy was given after 
tumor removal only, according to the same therapeutical regime. 
This experimental design should show the effect of treatment on 
metastasis more accurate as the previous model, as treatment was 
started at a time that all primary tumors were removed while 
being approximately the same size. 
This experiment also showed a reduced number of metastatic foci 
in the lungs of those rats receiving 200 mg/kg aspirin [103]. All 
other treatment groups did not differ from the control untreated 
group. We therefore concluded that in order to obtain a reductive 
effect on tumor growth and metastasis, apparently the synthesis 
of more arachidonate metabolic products have to be inhibited. A 
more selectively blocking of TXA2-synthesis, which may be 
achieved when low dose of aspirin is given, does not seem to be 
effective in the control of tumor growth and metastasis. 
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4. GENERAL DISCUSSION AND CONCLUSIONS 
At cursory reading, the results of the studies on the relation 
between stress or dietary factors on tumorigenesis may seem to be 
disappointing, since light-dark shift stress as well as the 
dietary lipids studied apparently were not that important to 
tumor growth and metastasis. One might wonder if the experimental 
designs used indeed were proper ones, as other investigators on 
the subject of environmental factors and cancer were rather 
confident in their condemnation of stress and dietary fat as 
tumor promoting factors [4,28,31,80,152]. As an explanation for 
our contradictory results, we can advance the following 
arguments. 
4.1. L-D Shift Stress 
In those experiments by others in which in experimental animals a 
correlation between stress and enhancement of carcinogenesis was 
noticed, stress was always in the form of an acute or repeated 
acute stress [4,141,152]. Such forms of stress are very harmful 
to the individual, with acute, and long lasting (for more than 24 
hours) effects on the neuro-endocrine system [22,134,141 ,157]. A 
direct result of acute stress is a depression of the immune 
system, which correlated with increased plasma corticosteroid 
levels [45,67,140,141]. Chronic stress, however, is different 
from acute stress, in particular with regard to the synthesis of 
corticosteroids [120,159]. Despite the fact that enhanced 
corticosteroid production in chronic stress could not be 
demonstrated, like in acute stress, a depression of the immune 
system was observed too [8,120]. 
L-D shift stress as used in our study proved to be a stressful 
procedure even after 35 weeks of L-D shifts. This could be 
demonstrated by significantly decreased body weights, and 
diminished adrenal gland weights. The results also showed that 
this model of chronic stress did not lead to adaptation, which is 
commonly observed in most types of stress that are repeatedly 
given [18,149]. In our studies, glucose levels were altered as 
well, although these alterations could also have been due to the 
time of blood sampling, as many hormones and other biochemical 
end products are subject to a circadian rhythm [58,130,175]. When 
the night-day pattern is changed, metabolites subject to such a 
rhythm will show different levels despite measuring at the same 
time of the day. In our experiments, to eliminate such a 
disturbing effect, blood samples were taken exactly a week after 
shifting from dark to light, when, according to other 
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investigators, adaptation to the new light-dark rhythm should 
have taken place [175]. Yet, circadian rhythms may have 
complicated the interpretation of hormone determinations. 
L-D shift stress has its human equal; the stress that rats are 
subject to by L-D shifts will certainly be related to that one of 
human shift work [96,154,171], and therefore we considered it 
superior to other methods and more relevant to the human 
situation. 
Despite the demonstrable inhibiting effect of L-D shift stress on 
the immune capacity, not all tumor models demonstrate a 
difference in tumor growth [Appendix, Publication II and III]. 
This is not so surprising, since 3 out of 5 tumor transplantable 
tumor models used in our studies, were non-immunogenic, according 
to the criteria as formulated by Prehn and Main [137]. The as 
such classified non-immunogenic tumors should consequently be 
insensible to induced immunological alterations. 
In humans, most tumors are non-immunogenic as well [170], so it 
should be expected that immunosuppression only leads to. 
enhancement of certain types of lymphoblastic tumors [133]. It 
might have been coincidence, but in our experiments, one of the 
two tumors that showed reduced tumor growth after stress induced 
immunosuppression, was an (immunogenic!) myeloid leukemia. 
However, the cortical carcinoma that was also stress-responsive 
although its is a non-immunogenic tumor. For this reason, it 
seems more likely that the hormonal alterations that were caused 
by chronic L-D shift stress are to be hold responsible for the 
observed inhibition on tumor growth by L-D shift stress. This 
would explain why only the adrenal cortical carcinoma, and the 
myeloid leukemia, which were the hormonal responsive tumor models 
used, showed differences in tumor growth after L-D shift stress. 
4.2. Diets Rich in Linoleic Acid 
On comparison of carcinogenesis in rats on semi-synthetic 
experimental diets to that in rats on commercial chow, important 
differences in the immune response and tumor growth could be 
observed. However, differences between diets, identical in fat 
concentration, but high or low in linoleic acid were not that 
significant. Despite the fact that many authors have recorded 
such differences [28,32,80] as mentioned in Chapter 3.3., this 
discrepancy might be explained by the fact that the control 
groups in those studies received too low quantities of linoleic 
acid, and have to be considered (partially) essential fatty acid 
deficient. Also a deficiency in dietary essential amino acids, or 
total protein have been shown to offer a kind of "protection" 
against tumor development [144,145]. Moreover most results were 
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obtained in animal models in which tumors were induced by 
administration of chemical carcinogens. Such tumors are 
immunogenic [138], and may better respond to the dietary induced 
immunosuppressive differences. But because spontaneous human 
tumors are seldom immunogenic [170], we preferred to use non-
immunogenic tumor models. Such animal models probably give a more 
realistic picture of the possible effect of dietary factors, and 
are more relevant to the cancer risk situation in man [2,144]. 
Despite the fact that actually no important differences in immune 
response could be shown between those groups of rats either on a 
diet high or low in linoleic acid, differences in tumor incidence 
and growth were observed. At the same anatomical site tumors that 
proved to be "stress-responsive", were "dietary fat-responsive" 
as well. Incidence and growth of tumors of the reticulo-
endothelial system and adrenal cortical tumors differed in the 
experiments on linoleic acid, high or low, both in the model of 
spontaneous tumor incidence and in the models of transplantable 
tumor growth. However, in general the diet high in linoleic acid 
was not tumor promoting, contrary to the diet low in linoleic 
acid. This is the opposite to what was found by the earlier 
quoted investigators [~8,32,80]. The differences in tumor growth 
and incidence observed in our experiments do not seem to be 
dependent of the immune response, since only non-statistically 
significant differences in the immune response were observed 
between diets high or low in linoleic acid. As a mechanism for 
the relation between dietary fat and enhanced carcinogenesis, 
others have mentioned also: alterations in membrane fluidity (due 
to differences in phospholipid. composition) and alterations in 
prostaglandin synthesis capacity [26,78,166,169]. As an 
explanation for the differences in tumor growth by dietary fat 
hormonal alterations were mentioned too [86], which is then the 
same explanation as was discussed earlier in this chapter for the 
relation between stress and tumorigenesis. 
When enhancement of tumorigenesis is found after feeding high 
levels of dietary fat, many indications exist that hormones play 
an important role in this. In the first place, in longevity 
studies, pituitary gland tumors incidence is very high [Appendix, 
Publications II,V]; the presence of these tumors correlated 
strongly with mammary gland hyperplasia. This observation and the 
finding that pituitary gland tumors were diagnosed as 
prolactinomas, made it likely that increased prolactin synthesis 
might have occurred. Increased prolactin levels are sometimes 
mentioned to be tumor promoting [82,86]. Rats receiving diets 
high in saturated fat have also prolonged increased insulin 
levels, in comparison to rats on diets high in unsaturated fat, 
probably due to a longer intestinal resorption period of the 
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first mentioned diet [84]. So one may conclude that sufficient 
data is present to support the importance of a hormonal pathway. 
In future research on the relationship between dietary fat 
compositions and carcinogenesis this pathway justifies more 
research. Certainly, prostaglandins, being local hormones as 
well, should then be included in these studies. 
As an important side issue of the investigations on stress or 
linoleic acid and cancer in the spontaneous tumor incidence 
model, a strong correlation could be shown between body weight at 
a certain age of the rat and tumors at some particular anatomical 
sites [Appendix, Publications II and V]. This was especially the 
case in animals with a relative overweight and the incidence of 
mammary- and Langerhans' islet tumors. In the studies of Ross et 
al. [147] such a correlation was found as well. 
4.3. Diets Rich in Fish Oil 
The supposition that prostaglandins could play an important role 
in the relation between stress or dietary linoleic acid and 
altered tumor risk may seem to be farfetched, still, this pathway 
is often proposed as an explanation of the favorable (inhibiting) 
effect of diets high in fish oil on cancer growth [38,106,161]. 
In our studies we further confirmed this hypothesis. Not only a 
difference in tumor growth could be demonstrated in those rats 
rece1v1ng the fish oil (Menhaden oil) enriched diets compared 
with rats fed diets high in saturated or unsaturated fat of the 
n-6 fatty acid, also a correlation with decreased eicosanoid 
synthesis could be shown, although this was not the case for 
PGI 2 , since 6-keto-PGF1a levels in rats receiving the fish oil 
rich diets did not show any alterations. 
4.4. Metastasis 
Although we considered the possibility that tumor metastasis 
might as well be influenced by stress [160,174], or by the 
quantity or quality of PUFA in the diet, this was not shown in 
our experiments. Many investigators could influence metastatic 
spread of malignant tumors by means of a therapy that altered the 
PGI 2 /TXA2 balance. Despite the fact that we could significantly 
reduce TXA2 synthesis by means of fish oil [Appendix, Publication 
VII, VIII, IX], we could not find any favorable effect of this 
reduction of the eicosanoid synthesis on "spontaneous metastasis" 
(from subcutaneously implanted tumors) nor on "artificial 
metastasis" (from intravenously inoculated tumor cells). 
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Still, in our experiments, in which the tumor growth rate could 
significantly be reduced by NSAIA therapy, spontaneous metastasis 
was also significantly decreased. However, when the same therapy 
was given to rats in which tumor cells were inoculated 
intravenously, the favorable effect on metastasis disappeared. 
This proved that the originally acquired decreased tumor spread 
was not obtained by an effect on tumor take, e.g. the number of 
metastasis, but by an inhibition of successful tumor metastasis 
growth. 
Despite the favorable effect on tumor metastasis that could be 
demonstrated by some investigators [42,43,69-75], our results 
suggest that treatment which interferes with platelet function, 
by blocking PG synthesis, plays only a minor role in the 
prevention of metastasis. Also other anti-aggregatory or anti-
coagulant therapies using different types of drugs were not very 
successful in this respect [104]. Without derogating the 
importance of the experiments mentioned above - in particular the 
excellent work of Honn and others [69-75] - we think that so far 
the prospectives of therapies directed to obtain a "favorable" 
hemostatic conditions by altering the PGI2/TXA2 balance (i.e. 
compensate for tumor TXA2 production or for decreased vessel PGI 2 
synthesis), are so far not very promising with regard to the 
prevention of tumor metastasis. 
4.5. Diet Cancer Therapy 
In groups of rats a change of diets was given at tumor induction 
from a diet with "tumor promoting" (diet group I in Publication 
VII; 30 en% fat, high in saturated fatty acids) to a diet with 
"tumor inhibiting" capacities (diet group III in Publication VII; 
30 en% fat, with unsaturated fatty acids of the n-3 type). This 
experiment was for an important part inspired by the hypothesis 
that the inhibiting effect on arachidonate metabolism of the 
latter diet may decrease tumor growth and metastasis as well, 
when supplied after tumor inoculation only. 
However, for such a cancerostatic effect no evidence could be 
found. We therefore conclude that the favorable effect on tumor 
growth is primarily initiated by a retardation of the "tumor lag 
time", which we define as the time between inoculation of the 
transplantable tumor and first detectable tumor growth. It was 
our experience that when a tumor starts to grow, not many 
differences in growth can be obtained anymore. Most is reached in 
this first phase after tumor inoculation. If this is true it 
should not be surprising that not much can be gained by a "tumor 
inhipiting" therapy, when supplied exclusively after tumor 
inoculation. Also in humans, one may wonder in which phase of 
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life a change of environmental conditions may still merit 
preventive measures. It seems most unlikely, that a change of 
life style just before or after tumor detection will give an 
alteration in the patient's prospects. Therefore, on the basis of 
the above reasoning, it does not seem sensible to propose a 
certain diet as a cancerostatic therapy {apart from diets to cope 
with cancer cachexia) [64,150]. 
4.6. Aspirin Therapy 
In the experiments in which by pharmacological means the 
prostaglandin system was affected, only high doses of aspirin 
showed an inhibiting effect on tumor growth. This suggests that 
the cyclooxygenase pathway had to be blocked to a major extent in 
order to obtain that favorable effect, since low dose of aspirin 
nor theophyllin showed any favorable effect. Like in later 
experiments [Appendix, Publication X], in particular increased 
plasma PGE2 levels were associated with tumor growth, a finding 
that could be confirmed by many other investigators 
[15,52,111 ,158]. If so, it is not surprising that treatment with 
aspirin 200 mg/kg/day, which blocks all synthesis of cyclo-
oxygenase products, was in our hands the only treatment that 
inhibited tumor growth. 
4.7. Tumor Prostaglandin Synthesis 
It is far from sure that the high PGE2 levels sometimes 
accompanying tumor growth are synthesized by the tumor itself, 
since we demonstrated that irradiated dead tumor tissue could 
initially also induce elevated PGE2 levels [Appendix, Publication 
X]. Because isogeneic irradiated spleen cells did not show 
increased plasma PGE2 levels, we presume that a host 
immunological reaction, specific to tumor tissue, could also have 
been responsible for the increased plasma PGE2 levels in tumor 
bearing rats. Other investigators found that monocytic cells, 
attracted by the tumor, could produce substantial amounts of PGE2 [15,59], a process which could have been involved in our study as 
well. Compared with normal control values, 13 days after 
inoculation of viable tumor or non-viable irradiated tumor 
tissue, still differences in PG synthesis could be observed 
[Appendix, Publication X]. However, thereafter plasma PG values 
of rats with irradiated tumor tissue returned to basal levels, 
while plasma PG values of tumor bearing rats further increased. 
This does not imply that the increased PG activity originated 
from the tumor itself. After 2 weeks, an immunological reaction 
to the tumor inoculum in those rats with irradiated tumor tissue 
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could have faded away, whereas in animals with vital tumor 
tissue, this reaction may still continue and could actually be 
augmented by the increasing tumor mass. 
4.8. Conclusions 
Our main conclusion from the work presented in this thesis is 
that the hypothesis that both mild chronic stress and diets rich 
in linoleic acid may increase the incidence, growth and 
metastatic behavior of some, or most cancer types could not be 
confirmed. In fact, the opposite seems to be more true: a 
decreased cancer incidence correlated with the diet high in 
linoleic acid, and with the stress given. 
Enrichment of the human diet with fish oil (rich in EPA and DHA) 
may have advantages; not only with regard to a possible 
preventive effect on coronary heart disease, but also to 
(mammary) tumor incidence these dietary constituents are claimed 
to be favorable. However one also has to take into consideration 
that tumors at other sites may increase. The Japanese and 
Greenland Eskimos have a low incidence of mammary tumors but for 
example the incidence of stomach tumors is high [123,126]. As it 
seems likely that both ·tumor types are influenced by dietary 
habits, it may be possible that what is gained at one side is 
lost at the other. More research related to this problem is 
urgently recommended. 
The amount of fish that is necessary to obtain a favorable effect 
on tumorigenesis is hard to realize in human diet. From 
epidemiological studies one may get the impression that much fish 
of a certain kind (only a few types of fish contain useful 
quantities of EPA/DHA) is needed. 
Although our results are not yet conclusive in that matter, it 
does not seem necessary to consume very high quantities of fish 
oil in order to obtain a reductive effect on tumor growth, since 
no significant differences were seen between those groups of rats 
receiving either 7 en% or 2 en% of EPA/DHA. 
With regard to stress, more or less the same conclusion may be 
drawn as we did for dietary PUFA: promotion of cancer incidence 
by mild chronic stress does not seem likely. This may not be true 
for acute stress, as in animal studies as well as in 
retrospective epidemiological studies in men a strong correlation 
appeared to exist between acute stress and increased tumor risk 
[4,141 ,152]. It is yet unclear which forms of stress in human 
have to be considered acute stress, and which as chronic ones. 
Hospitalization, surgery or bereavement could be acute stress, 
whereas persons with certain psychological characteristics might 
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considered to suffer from chronic stress. Therefore the often 
observed negative effect of surgery on cancer patients could have 
been the results of acute stress, caused by anesthesia, tissue 
damage, blood loss, blood transfusions, etc., [107,160]. 
Although mild chronic stress may be relatively insignificant in 
respect to cancer risk, its importance to other diseases will 
have to be regarded carefully. After all, it seems that chronic 
stress does increase the susceptibility to coronary heart 
disease, bacterial or virus diseases [3,96,154]. 
Some more evidence was gathered by us with r.egard to the relation 
between tumor growth and eicosanoid-synthesis. But it will need 
further exploration to learn whether increased plasma PGE2 and 
TXB2 synthesis is either from tumor, or from tumor bearer origin. 
Treatment with aspirin-like-drugs as adjuvant to anti-cancer 
therapy seems promising, but more fundamental research is needed 
before this can be applied in cancer patients. 
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6. SUMMARY 
This thesis is a compilation of eleven publications on the 
relation between environmental factors and tumorigenesis. 
Two environmental factors were chosen, i.e. stress and diet, and 
studied in relation to their impact on tumor growth and 
incidence. Epidemiological studies in man have been shown that 
these factors in particular, are suspected to be responsible for 
the increase of colon- and mammary tumor incidence, observed in 
Western countries. For instance a positive correlation between 
animal fat consumption and the occurrence of colon- and mammary 
tumors has been found. Stress as a tumor promoting factor is most 
certainly less important than nutrition, nevertheless also stress 
received much attention in cancer research. Investigators found 
that certain stressful events could decrease the "threshold of 
resistance" to cancer. 
The form of stress studied in this thesis is considered to be a 
mild chronic stress (weekly alterations of the night/day 
pattern); diets were either high or low in the quantity of 
dietary polyunsaturated fatty acids. 
It was our hypothesis that if tumor incidence and growth could be 
altered by environmental factors this might have been caused by 
changes in the individual's immune capacity. Therefore the 
cellular immune capacity was in our study an important parameter. 
In order not to run the risk that the results obtained are valid 
for only one particular tumor model, we decided to carry out our 
experiments with several models, "spontaneous tumor incidence" as 
well as with various transplantable tumors which have different 
biological characteristics, and which allowed studies both with 
regard to tumor growth and to formation of lung metastases. 
The cellular immune capacity of the rats subject to the 
experimental diets or stress could indeed be altered. In 
particular in the animals receiving stre13s, the cellular immune 
capacity was significantly decreased. 
However, in next experiments in which animals received a 
transplantable tumor no correlation between immunosuppression and 
promotion of tumor growth was seen. With 3 types of tumors no 
differences in tumor growth were seen, in 2 ones even an inverse 
relationship between immunosuppression and tumor growth could be 
demonstrated. This implies that the hypothesis that mild chronic 
stress or diets rich in polyunsaturated fat could show tumor 
promoting capacities, via an immunosuppressive effect could not 
be confirmed: viz.,. although there was a relation between stress, 
diet and immunosuppression, this did not result in the expected 
increased tumor incidence and growth. 
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In those transplantable tumor models in which a relation between 
stress or diets rich in fat, and altered tumor growth were seen, 
e.g. a myeloid leukemia, a fibrosarcoma and an adrenal cortex 
carcinoma, it appeared that hormonal sensitivity of these 
particular tumors may have played a more important role in the 
obser~ed di~~erences in tumor growth than the depression in 
cellular immune capacity. 
Apart ~rom alterations in either hormone levels or cellular 
immune capacity, an other explanation for changes in 
tumorigenesis has been discussed also. Several investigators 
demonstrated that diets rich in polyunsaturated fatty acids alter 
the capacity o~ cells to synthesise prostaglandins (PG's). 
Furthermore it has been suggested that PG's can play an important 
role in cancer. There~ore, the relations between the quality o~ 
dietary fat, plasma levels o~ some eicosanoids and tumor growth 
were investigated also. 
Tumor development of rats on 
measuring some plasma PG 
that inhibit PG synthesis 
growth, was investigated. 
standard rat chow was monitored by 
metabolites, and the effect of drugs 
(in our study, aspirin) on tumor 
Rats rece1v1ng diets with a ~ish oil relatively rich in 
polyunsaturated fatty acids o~ the n-3 type showed a 
signi~icantly decreased mammary tumor growth in comparison with 
rats that had received a diet with the same en% of fat, the fat 
being either rich in saturated fatty acids or rich in linoleic 
acid. Thromboxane-B2 (TXB2 ) and PGE2 levels in plasma of the rats 
on the fish oil diets (Menhaden oil) were decreased in comparison 
to rats on the two other diets studied, which might be an 
explanation for the observed tumor inhibiting activity of the 
fish oil rich diet. 
Growth of a malignant fibrosarcoma in animals on standard rat 
chow was shown to be positively correlated with increased levels 
of plasma TXB2 and PGE2 . However, it appeared that the increased 
plasma arachidonate levels were not necessarily a contribution of 
tumor PG synthesis capacity, as rats implanted with lethally 
irradiated tumor tissue also showed increased PG levels. 
Therefore it seems plausible that the increased plasma 
arachidonate levels might have been the result of some "host" 
reaction against the tumor, probably by the invading white blood 
cells attracted by the implanted tissue. 
Rats receiving a daily dose of 200 mg/kg of aspirin intra-
peritoneally, showed a significant reduced tumor growth, which 
supports the above discussed results. 
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Another aspect in our studies that received particular attention 
was metastatic spread. 
As some investigators presume a correlation between "pro-
coagulant activity" of tumor cells (most probably by TXA2 
biosynthesis). and the capacity of such a tumor to metastasise. 
we have also selectively altered platelet TXA2 synthesis. in 
order to influence tumor metastatic behavior. Not only by low 
dose of non steroid antiinflammatory agents. such as aspirin, the 
balance between vessel wall PGI 2 synthesis. and platelet TXA2 
synthesis capacity is altered (and consequently conditions will 
be achieved that prevent circulating tumor cells from sticking to 
the vascular endothelium and to develop to a new tumor). but the 
same can be expected by diets rich in polyunsaturated fatty 
acids. 
However. despite conditions could be achieved that might be 
considered to be potentially beneficial to prevent or decrease 
tumor metastasis (decreased TXA2-synthesis. prolonged bleeding 
time in vivo and in vitro). the number of metastatic foci in the 
lungs of animals bearing malignant tumors were the same in all 
experimental groups. 
The conclus.ions based on our experiments were: 
-eicosanoids seem to play an important role in tumor growth 
(based on the tumor growth reduction by aspirin). 
-rats receiving diets enriched with polyunsaturated fatty acids 
of the n-3 type have a decreased TXA2 and PGE2 synthesis 
capacity. 
-so far there is no proof for the supposition that. by a 
decreased hemostasis •. due to induced changes in PGI 2 and TXA2 
synthesis, tumor metastatic behavior can be decreased. 
-growth of the tumors studied are associated with an increase of 
plasma PGE2 and TXB2 levels. due to increased host arachidonic 
acid synthesis activity. 
-in some but not all rat tumor models used in this series of 
experiments a correlation between dietary fat intake and 
increased tumor incidence can be shown. When such a correlation 
existed, the diets rich in saturated fat were more "tumor 
promoting" than the diets rich in unsaturated fat. 
-no evidence could be obtained for the supposition that mild 
stress correlates with increased tumor risk, an inverse relation 
seems more likely. 
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7. SAMENVATTING 
Deze studie is een compilatie van een 11-tal publicaties metals 
onderwerp de relatie tussen bepaalde milieufactoren en het 
onstaan van kanker. Milieu wordt hier opgevat als het samenspel 
van factoren, die door onze leefstijl en/of door onze 
wooonomgeving wordt bepaald, waaronder eet- en drinkgewoonten, 
roken, stress, etc. 
In dit proefschrift wordt beschreven op welke W1JZe, in ratten, 
de invloed van twee milieufactoren: "stress, en voeding", worden 
onderzocht op het onstaan en de groei van tumoren. Uit 
epidemiologische onderzoeken was gebleken dat de toenemende 
incidentie van met name mamma- en colontumoren voor een 
belangrijk deel toegeschreven kon worden aan deze twee 
milieufactoren. Zo vond men een positieve correlatie tussen de 
consumptie van dierlijk vet en het optreden van mamma- en colon 
tumoren. Voor wat betreft stress, bleek bijvoorbeeld dat vrouwen 
onder sterke emotionele stress een verhoogd risico hadden tot het 
krijgen van een maligne mammatumor. 
Als te onderzoeken potentieel tumorbevorderende factoren, werd in 
het onderhavige onderzoek gekozen voor: een milde vorm van 
chronische stress (een wekelijks herhaalde verschuiving van het 
dag-nacht ritme); en voor wat betreft voeding, voor de kwaliteit 
en kwantiteit van meervoudig onverzadigde vetzuren. 
Het spreekt vanzelf, dat wanneer een bepaalde relatie wordt 
verondersteld, tussen milieufactoren en verhoogd kankerrisico, 
hier een bepaalde mechanistische veronderstelling aan ten 
tengrondslag ligt. Bij zowel stress als voedingsvetten werd 
verondersteld dat een verandering van de immuunrespons de reden 
zou kunnen zijn voor de veranderingen in tumorincidentie. 
De cellulaire. immuunrespons van de dieren 
beinvloed te kunnen worden door voeding en 
stress gaf een zeer duidelijke verlaging 
immuuncapaciteit. 
bleek 
stress. 
te zien 
inderdaad 
Met name 
van de 
In de experimenten, waarbij de ratten een tumor kregen, bleek 
echter in het geheel niet dat deze verlaging van de immuunrespons 
een tumorbevorderende rol speelde. Integendeel, juist in die 
ratten, waarbij een relatieve immunosuppressie, als gevolg van 
stress of voeding, was geinduceerd, bleek de groei van bepaalde 
tumoren geremd te zijn ten opzichte van dieren, met een hogere 
immuunrespons. Overigens werd de tumorgroei niet in al de 
gebruikte tumormodellen beinvloed door de aangetoonde verschillen 
in immuunrespons. 
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Dat betekent dus dat onze hypothese dat de gekozen vorm van 
stress of vetrijke voeding een tumorgroei bevorderende werking 
had, die veroorzaakt zou worden door een verlaging van de 
immuunrespons slechts ten dele bevestigd kon worden: namelijk 
slechts voor de relatie tussen stress, voeding en 
immunosuppressie. 
In die gevallen, dat er een relatie kon worden aangetoond tussen 
stress en vetrijke voeding en een verandering van de tumorgroei, 
zoals bij de myeloide leukemie, de fibrosarcoma en de 
bijnierschorstumor, leek eerder de gevoeligheid van deze tumoren 
voor hormonale veranderingen verantwoordelijk te zijn voor de 
gevonden verschillen in tumorgroei. 
Behalve hormonale en immunologische veranderingen als verklaring 
voor een verandering in het ontstaanspatroon van kanker, worden 
nog enkele verklaringen gegeven. Zo toonden onderzoekers aan, 
dat voeding rijk aan linolzuur het vermogen van de eel om 
prostaglandines (PG's) te synthetiseren, kon veranderen. 
Bovendien stelden weer andere onderzoekers vast dat deze PG's een 
belangrijke rol speelden in het verloop van het ziekte van de 
kankerpatient. Daarom werd in een vervolgstudie (publicaties VII-
XI), met name de relatie tussen voedingsvetten, prostaglandine-
synthese en tumorgroei onderzocht. 
In deze studie werd dus getracht antwoord te geven op de vragen: 
in hoeverre is de vetzuursamenstelling in de voeding van invloed 
op de synthese van arachidonzuur-metabolieten, en in hoeverre 
speelt dit een rol in tumorgroei? In een later experiment werd 
bovendien de vraag opgeworpen of tumorgroei gepaard gaat met 
verhoogde spiegels van PG's in het plasma, en of tumorgroei kon 
worden beinvloed door therapie met aspirine, een PG-synthese 
remmer. 
Voeding verrijkt met een visolie, relatief rijk aan onverzadigde 
vetzuren van het n-3 type, remde significant de tumorgroei in 
ratten, die een transplantabel mamma adenocarcinoom hadden 
gekregen, t.o.v. de dieren, die een voeding hadden, dat slechts 
bestond uit voedingsvetten van het n-6 type (zoals linolzuur). 
Bovendien kon worden aangetoond, dat thromboxaan-A2 en PGE2 
synthese was gereduceerd in dieren op het visolie (Menhaden oil) 
dieet. 
Tumorgroei van een maligne fibrosarcoom in dieren op standaard 
rattekorrels bleek gepaard te gaan met verhoging van thromboxaan-
B2 en PGE2 plasmaspiegels. Het lijkt echter onwaarschijnlijk, 
zoals veelal wordt gedacht, dat de synthese-capaciteit van de 
tumor hiervoor verantwoordelijk gesteld kan worden, want toen 
letaal bestraald tumorweefsel in plaats van vitaal tumorweeefsel 
werd geinoculeerd, werden ook sterk verhoogde plasma PG waardes 
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gevonden. Het lijkt dus meer waarschijnlijk dat de drager van de 
tumor, en niet de tumor zelf, verantwoordelijk is voor de 
gevonden verhoogde PG waardes. 
De vraag of asp1r1ne tumorgroei kon beinvloeden kon met "ja" 
worden beantwoord. Wanneer ratten dagelijks een intraperitoneale 
injectie van 200 mg/kg aspirine ontvingen, was de tumorgroei 
significant geremd. 
Een ander aspect, dat in onze studies extra aandacht heeft 
gekregen, was de mogelijkheid te onderzoeken of het aantal 
metastases van een tumor kon worden beinvloed, door het remmen 
van bepaalde arachidonzuur metabolieten. 
Er wordt door een aantal onderzoekers verondersteld, dat er een 
correlatie zou bestaan tussen de aggregatoire activiteit van een 
tumorcel (TXA2-synthese?) en de capaciteit van zo'n tumorcel om 
te metastaseren. Wanneer dit zo zou Z1Jn, dan kan door 
manipulatie van de prostacycline/thromboxaan balans (prostacyline 
van epitheelcellen van de bloedvatwand, TXA2 van thrombocyten en 
tumorcellen), omstandigheden worden gecreeerd, die voorkomen dat 
circulerende tumorcellen aan het vaatendotheel blijven plakken en 
zich verder kunnen ontwikkelen tot een tumor. 
Dit werd enerzijds gedaan 
voeding en anderzijds door 
is namelijk bekend dat zij 
door de eerder genoemde visolie-rijke 
behandeling met aspirine. Van beiden 
de bloedingstijd in vitro en in vivo, 
via remming van de arachidonzuur-synthese, kunnen verlengen. 
Hoewel in onze studies kon worden aangetoond, dat potentieel 
gunstige omstandigheden aanwezig waren om het aantal metastases 
te verminderen (een verminderde synthese van thromboxaan-A2 , 
verlengde bloedingstijd in vitro en in vivo), bleek dit geen 
effect te hebben op het aantal metastases, dat in de longen werd 
waargenomen. 
De eindconclusies 
zijn: 
gebaseerd op het onderzoek in dit proefschrift 
-prostaglandines lijken een belangrijke 
van tumoren (vooral gebaseerd op 
eigenschap van aspirine). 
rol te spelen bij groei 
de tumorgroei remmende 
-ratten, die een voeding krijgen, rijk aan omega-3 vetzuren, 
hebben een verminderde capaciteit van TXA2 en PGE2 synthese. 
-vooralsnog is er geen aanW1JZ1ng dat door een verminderde 
plaatjesaggregatie, geinduceerd door veranderingen in de synthese 
van PGI 2 en TXA2 , tumor metastase gedrag kan worden beinvloed. 
-tumorgroei van 
van plasma PGE2 
verhoging van 
tumor drager. 
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bepaalde rattetumoren gaat gepaard met verhoging 
en TXB2 spiegels, die wordt veroorzaakt door een 
synthese van arachidonzuur metabolieten door de 
-in enkele van de gehanteerde tumormodellen kan een correlatie 
worden aangetoond tussen vetrijke voeding en een verhoogde tumor 
incidentie. Wanneer dit het geval is, is, op een enkele 
uitzondering na, de voeding rijk ~an verzadigd vet meer tumor 
bevorderend dan de voeding rijk aan onverzadigd vet. 
-geen bewijs kan worden geleverd voor de veronderstelling dat 
milde chronische stress tumorgroei en incidentie verhoogt, eerder 
het tegenovergestelde lijkt het geval te zijn. 
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8. CURRICULUM VITAE 
Wil Kort werd geboren 12 september 1943 te 's-Gravenhage. Hij 
volgde het middelbaar onderwijs aan de Zuiderpark HBS te 's-
Gravenhage en voltooide dat in 1960 aan de Willem Ruys MULO in 
dezelfde stad (diploma MULO-B). Tot aan zijn militaire dienst-
plicht werkte hij in het electro-technisch bedrijf van zijn 
vader. De militaire dienstplicht (mei 1963 september 1964) 
vervulde hij als korporaal schrijver in de legerplaats de 
Harskamp. Hierna werkte hij bij de Gist & Spiritus fabriek te 
Delft, waar hij tegelijkertijd in de avonduren de opleiding van 
leerling analist en later van analist (Zo5logie) volgde. In 1967 
haalde hij hiervoor het diploma. Hij was op de Gistfabriek 
werkzaam op het Farmacologische Laboratorium (Hoofd Dr. J. 
Wieriks), waar hij betrokken was bij het screenen van nieuwe 
farmaca in diermodellen. In november 1967, startte hij zijn werk 
aan de Erasmus Universiteit (toen nog Medische Faculteit 
Rotterdam). Hij begon op de afdeling Pathologische Anatomie II 
(hoofd Prof. Dr. M.J. de Vries), waar hij o.a. betrokken was bij 
de promotieonderzoeken van Dr. R.W. de Bruin (The effect of 
immunosuppression on function of kidney allografts in the rat, 
1970), Dr. v. Vuzevski (Ultra structural basis of acute renal 
allograft rejection, 1976), en Dr. E.D. Wolff (Liver transplan-
tation in the rat, 1976). De voor deze onderzoekslijn benodigde 
microchirugische handva~rdigheid paste in feite beter bij een 
meer chirurgische geori~nteerde afdeling, waardoor hij sollici-
teerde bij het Laboratorium voor Chirurgie (Hoofd Prof Dr. D.L. 
Westbroek). Hij is van 1972 tot heden aldaar werkzaam, eerst als 
laboratorium assistent en vanaf mei 1979 als wetenschappelijk 
medewerker. Zijn kennis van, en belangstelling voor de micro-
chirurgie is de basis geweest voor meerdere publicaties op dit 
gebied van hem en anderen. Sinds oktober 1981 is hij actief als 
cursusleider van cursussen microchirugie, in het kader van het 
post ac~d.emisch onderwij s geneeskunde. Zijn research activi tei ten 
zijn na de zeventiger jaren geleidelijk omgebogen van het trans-
plantatie immunologisch-, naar het kanker immunologisch onder-
zoek, en met name de rol die prostaglandines daarin spelen. De 
publicaties opgenomen in dit proefschrift getuigen van deze 
laatste belangstelling. 
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10. GLOSSERY OF TERMS AND L!ST OF ABBREVIATIONS 
ADP = adenosime diphosphate 
AA = arachidonic acid = C20:4 n-6 = a polyunsaturated ~atty acid, 
precursor o~ prostaglandins o~ the 2-types 
BN = Brown Norway (inbred rat strain) 
BN175 = transplantable rat tumor, orginated spontaneously in a BN 
rat; histopatological ~eatures o~ a malignant ~ibrosarcoma 
BN472 = transplantable rat tumor, orginated spontaneously in a BN 
rat; histopatological ~eatures o~ a malignant mammary 
adenocarcinoma 
cancer = any carcinoma or sarcoma or other malignant neoplasm 
carcinogenesis = development o~ a cancer (in which we want to 
include "cancer growth" = the process between cancer initiation 
and reaching a certain cancer mass). Note also that, so~ar, the 
process o~ generation o~ a malignant cancer cannot be 
distinguished ~rom the process o~ a benign tumor; as such, in 
this study the word "carcinogenesis" has been used ~or the 
generation o~ a benign tumor as well. 
circadian relating to biologic variations or rhythms with a 
cycle o~ about 24 hours. 
Con A stimulation = Concanavalin stimulation to lymphocytes 
DBA C20:6 n-3 = docosahexaenoic acid 
EFA essential ~atty acid(s) 
en~ percentage o~ digestible energy consumed 
EPA C20:5 n-3 eicosapentaenoic acid, precursor, o~ 
prostaglandins o~ the 3-types~ 
L-D shi~t light-dark shi~t = a change in night-day rhythm, 
induced by alternating the 12 h light/12 h dark cycle ~or 
hal~ a cycle 
linoleic acid = C18:2 n-6 = essential (omega-6) polyunsaturated 
~atty acid (octadecadienoic ~atty acid) 
menhaden oil type o~ ~ish oil, rich in (omega-3) polyunsa-
turated ~atty acids (average o~ 17~ eicosapentaenoic acid, 7~ 
docosahexaenoic acid) 
NK cell = natural killer cell 
NSAIA = non steroidal anti-in~lammatory agent(s) 
PLNA = Popliteal Lymph Node Assay 
PG('s) prostaglandin(s) synthesis products o~ arachidonic 
acid 
PGE2 = prostaglandin-E2 
6-keto-PGF1a = 6-keto-prostaglandin-F1a, a bioconversion product 
o~ PGI 2 = prostacyclin 
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PHA stimulation = phytohemagglutinin stimulation of lymphocytes 
PUFA = polyunsaturated fatty acids 
RIA = radioimmunoassay(s) 
stress = the reactions of the body to forces of a deleterious 
nature, infections and various abnormal states that tend to 
disturb its normal physiological equilibrium (homeostasis). But 
also a physical or psychological stimulus which when impinging 
upon an individual produces strain or desequilibrium. 
tumor = neoplasm; an abnormal mass of tissue, that grows more 
rapidly than normal and continues to grow after the stimuli, 
which initiated the new growth cease. 
tumor dissemination = scattering of tumor cells throughout the 
body via blood- or lymph vessels = tumor metastasis. 
tumorigenesis = the development of a new growth or growths, see 
also underlined remark carcinogenesis. 
tumor metastasis = the appearance of neoplasms in parts of the 
body remote from the seat of the primary tumor. 
tumor spread = spread of tumor cells in other parts of the body 
then the primary tumor. 
tumor take = successful growth of a tumor after inoculation 
TXA2 thromboxane-A2 
TXB2 = thromboxane-B2 
Definitions from: Stedman's Medical Dictionary, 23~d edition. The 
Williams & Wilkins Company, Baltimore. 
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Appendix: Publications I-XI 
The Beaver brought paper, portfolio, pens, 
And ink in unfailing supplies: 
While strange creepy creatures came out of their 
dens, 
And watched them with wondering eyes. 
From -The Hunting of the snark-, by Lewis Carroll 
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Publication I 
EFFECT OF CHRONIC LIGHT-DARK SHIFT STRESS ON THE IMMUNE RESPONSE 
OF THE RAT 
,This article is 
Behavior, vol 
1982. 
reproduced with permission from Physiology & 
29, pp 1083-1087, Pergamon Press, Oxford, U.K. 
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Effect of Chronic Light-Dark Shift Stress 
on the Immune Response of the Rat 
WILL J. KORT AND INEKE M. WEIJMA 
Laboratory for Experimental Surgery, Medical Faculty, Erasmus University, Rotterdam, The Netherlands 
Received 10 June 1982 
KORT, W. J. AND J. M. WEIJMA. Effect of chronic light-dark shift stress on the immune response of the rat. PHYSIOL. 
BEHA V. 29(6) I 083-1087, 1982.-During a period of 35 weeks the night -day pattern of inbred Brown Norway female rats was 
changed weekly by alternating the light-dark (L-D) rhythm. After a period of 2 months, in a number of the animals, the 
cellular immune response was measured by means of Concanavalin A stimulation of peripheral blood (Con A) and a 
Popliteal Lymph Node Assay (PLNA). Serum corticosterone, plasma free fatty acids and peripheral leucocytes were 
determined as well. Seven months thereafter the remaining animals were sacrificed after which adrenal gland weight and 
spleen weight were established. Additionally, blood glucose and corticosterone were measured (corticosterone in vitro 
activity as well as the serum level). Both Con A and PLNA showed a significantly decreased immune response in the L-D 
shift stress group. Adrenal cortical activity measured in vitro as well as in vivo did not show any significant changes, 
neither at 2 months nor at 9 months. Therefore, the observed immunosuppressive effect of chronic light-dark shift stress 
can not be explained by an increased adrenal cortical activity. Other possible explanations for the effect of the light-dark 
shift stress on the immune response are discussed. 
Stress Light-dark shift Immune response 
IN experimental animals it is difficult to obtain situations in 
which chronic stress can actually be considered as effective 
chronic stress. In many situations in which chronic stress 
was the experiment's objective, adaptation or habituation 
took place in such a way that repetition of the induction of 
stress, after some time, was not experienced as a harmful 
procedure anymore. 
Prolonged exposure of stress of a type hostile and adverse 
to the animal will irrevocably lead to "the General Adapta-
tion Syndrome" (GAS) as described by Selye [25]. Less 
hostile ways of inducing chronic stress, such as lifelong ex-
posure to noise,lead to habituation and partly loss of hearing 
as a method to overcome the harmful experience [ 4]. Other 
methods of mild chronic stress, which may potentially have 
some capacities as a method of actual chronic stress, such as 
isolation stress or prolonged sequential bleeding [5,28], will 
encounter logistic problems when used in large groups of 
animals. ' 
In the present investigation, it was our aim to obtain a 
model, in which it was possibleto study, in large groups of 
animals, mild chronic stress not leading to GAS or habitua-
tion, in order to study the evoked changes on the immune 
response and, in future studies, the changes on 
tumorigenesis. 
Reversing the light-dark cycle of man and animal inter-
feres with the individual's sleep-wakefulness pattern. The 
rat, a nocturnal animal, eats and drinks and exhibits most 
activity during night [8,31]. This means that a 12 hour L-D 
shift leads to reversal of the rat's behavior pattern. Hormone 
levels and those of other metabolites following a circadian 
rhythm have to be reset, Hence, rats undergoing chronic 
L-D shifting are exposed to changes of the homeostasis, 
which is repeated with every new cycle; as such, L-D shift-
ing can be definec! as a stressful procedure [28]. Because 
adaptation to light and dark comes about endogenously, this 
will not lead to habituation of the biological system. In exper-
iments in which L-D shifts were studied, it was found that 
reestablishment of eating and drinking pattern took place 
after 7-9 days [31]. T!:erefore, in the present study, a 7 days 
interval ofL-D shifts were chosen. Acute stress and immune 
response has been a subject to numerous studies [3, 12, 22, 
23, 26]. Diseases subject to a decreased immune capacity 
were noted to occur in high frequency [22, 23, 26]; tumor 
induction was facilitated [2, 19, 21, 23] and graft survival was 
prolonged [14,22]. In studies in man, chronic emotional 
stress led to determinable immune changes [3]. It was sup-
posed that these changes might lead to promotion of tumor 
induction [27]. Therefore, it appears to be very interesting if 
chronic L-D shifting in rats might mimic at least some of the 
phenomena as has been described for chronic stress in man. 
In the present study, L-D shift stress was given to rats, 
after which cellular immune response was measured. More-
over, some determinations were carried out to elucidate the 
underlaying mechanism of the possible immune changes. 
METHOD 
Experimental Design 
The experiment consisted of 2 groups of 50 animals each. 
One of the animals out of the L-D shift stress group died 
spontaneously at 9 weeks old due to broncho-pneumonia. 
For every determination at least 10 animals per group were 
used. Seven weeks after starting the experiment, out of both 
groups, 10 animals were randomly selected and blood sam-
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pies were drawn to determine serum corticosterone, plasma 
Polyunsaturated Fatty Acids (PUFA), the number of periph-
eral blood leucocytes and Concanavalin A stimulation of pe-
lipheral blood (Con A). Furthermore a Popliteal Lymph 
Node Assay was carried out in (BNXWR)F1 hybrids 
(PLNA). Twenty-eight weeks later the experiment was ter-
minated. Animals were killed by exsanguination, after which 
adrenal gland and spleen weight was established. Decapita-
tion was carried out between 10 AM-2 P~ on one single day, 
in such a way, that L-D shift stress rats were at the end ( + 7 
days) of their period, in which the light-dark regimen was the 
same as the controls. Corticosterone was measured in a 
number of animals in blood serum as well as the "in vitro 
synthesis capacity''; lastly, determination of blood glucose 
was carried out. During the course of the experiment body 
weight was assessed at 14 day intervals. 
Animals 
Highly inbred female Brown Norway (BN) rats, obtained 
from the University Breeding Centre, were used. At 6 weeks 
old, the animals were randomly selected into the 2 experi-
mental groups. The F1 hybrid animals, necessary for the 
PLNA were bred by mating BN male to inbred Wistar/Rot-
terdam (WR) females. When the offspring were 7 weeks old 
the males were used in the assay. 
Light-Dark (L-D) Shift Stress 
Every Friday the automatic timer, controlling the light of 
the animals undergoing L-D shift stress, was changed for 12 
hours. Control animals were housed under standard lighting 
regimen: 7 am.-7 p.m. light and 7 p.m.-7 a.m. dark. Both 
animal rooms were adjecent and were at that time exclu-
sively used for the animals in the present experiment. 
Moreover, the rooms were identical in temperature, humid-
ity, airconditioning and basic backgrout:~d noise level. Han-
dling of the animals was carried out during daytime, twice a 
week for cleaning and refreshing of drinking water. In the 
dark phase, infrared light was used to perform the necessary 
handling. 
Corticosterone 
Serum corticosterone was determined in 20 J.LI of serum, 
obtained after decapitating the animals, following a 
radioimmunoassay method described by de J ong and van der 
Molen [13]. Corticosterone in vitro, which method is a reli-
able index of in vivo cortical activity [30], was carried out 
according to the method of Saffran and Schally [24]. 
Plasma Polyunsaturated Fatty Acids (PUFA) 
PUFA were determined in 0.4 m1 plasma using a gas liq-
uid chromatography technique. The method of extracting the 
free fatty acids was described by Gneushev et al. [9]. After 
extracting the free fatty acids, the solution was esterified 
with BF3 as was described by Morrison and Smith [18]. For 
this study only PUF A (being predominantly linoleic acid and 
arachidonic acid) were taken into further consideration. 
Leucocytes 
Peripheral blood leucocytes were determined in 0.02 ml of 
heparinized blood, gathered at decapitation, using a Sysmex 
Microcellcounter (Japan). Estimation of the% lymphocytes 
(necessary for the Con A) was done by making a smear with 
a drop of heparinized blood and counting I 00 cells. 
Glucose 
Blood glucose was determined using a standard 
colorimetric method using a commercial kit (Dextrostix®, 
Ames). 
Organ Weights 
Immediately after decapitating, the spleen and adrenal 
glands were excised, kept on saline moistened filter paper, 
cleansed from surrounding adipose tissue and weighed to the 
nearest 0.1 mg. 
Concanavalin A Stimulation of Peripheral Blood (Con A) · 
Con A was carried out using 10" leucocytes in whole pe-
ripheral blood. Harvesting was performed after 4 days of 
culturing. Sixteen hours before this, 0.8 J.LCi 3H-thymidine 
was added. Each determination was carried out in quadrup-
licate. Con A stimulation was expressed as count-
s/min/culture. 
Popliteal Lymph Node Assay (PLNA) 
A local graft versus host assay, measure of specific cell 
mediated immunity, was carried out according to the method 
described by Levine [15]. After local injection of parental 
cells into F1 hybrid recipients a localized form of graft-
versus-host disease will be the result. When intradermal cells 
are injected in one of the foot pads this graft-versus-host 
reaction takes place in the popliteal node draining the inocu-
lated foot. In this study the procedure used was as follows: 
0.2 ml of whole heparinized blood was taken from the exper-
imental animals via orbital puncture and injected into the left 
foot pad of non stressed (BN xWR)FI hybrids. Seven days 
after injection of the blood into the test animals, the popliteal 
lymphnodes were excised, cleansed and weighed in tenth of 
mgs. Graft-versus-host reactivity was measured as mean 
lymphnode weight. 
Statistical Evaluation 
Statistical evaluation ofthe results was carried out using a 
Student t-test for 2 means to test the hypothesis that the 
difference between the means was negligible at a significance 
level of5%. 
RESULTS 
The results of the present study are depicted in Tables I 
and 2. After 7 weekly shifts of the light-dark cycle, Con A 
stimulation was significantly depressed in the L-D shift 
stress group, t(18)=5.12, p<O.OO!. Also peripheral leuco-
cytes were markedly decreased, t(38)=5.84, p<O.OO!. Be-
cause the values of Con A are not corrected for the 
number of leucocytes, cellular immune capacity "in toto" of 
the animals undergoing L-D shift stress will be even more 
altered. Cellular immunity as measured by PLNA fortified 
these latter results, in comparison with PLNA values of the 
controls, PLNA was decreased for 20% which difference 
was statistically significant, t(18)=3.36, p<O.OI. L-D shift 
stress resulted in a 15% elevation of the plasma PUFA level, 
t(18)=4.73, p<O.OOI. 
A difference in body weight could also be assessed: 
stressed rats were 5% less in body weight than the controls, 
t(97)=3.41, p<O.OI. 
However, serum corticosterone levels were not signifi-
cantly changed, t(18)= 1.11, p<0.75. 
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TABLE 1 
DETERMINATIONS AFTER 7 WEEKLY L-D SHIFTS 
L-D shift Controls 
Serum corticosterone Mean 65.3 60.4 
p.g/100 ml SD 12.9 5.7 
n 10 10 
Plasma PUFA Mean 0.39 0.33 
p.mol/ml SD O.Q2 0.02 
n 10 10 
Peripheral leucocytes Mean 6.0 10.3 
x 10"/ml SD 0.9 3.2 
n 20 20 
Con A stimulation Mean 13,106 43,439 
counts/min/culture SD 9,368 16,212 
n 10 10 
PLNA Mean 29.2 37.0 
weights in mg SD 4.4 5.7 
n 10 10 
Body weight Mean 148.9 156.0 
weighting SD 10.1 10.2 
n 49 50 
At termination of the experiment, after 35 weekly shifts 
also some differences between the L-D shift stress group and 
the controls could be noted. 
Blood glucose, adrenal gland weight and body weight 
were significantly decreased. Although these differences 
were not more than 5-15%, the findings were consistent and 
as such of importance: glucose t(77)=2.53, p<0.05; adrenal 
gland weight t(77)=5.89, p<O.OOI; body weight, t(77)=3.35, 
p<O.Ol. 
Although these latter two parameters are in some way 
interrelated, when adrenal gland weight is given as a ratio of 
the body weight, this difference is still statistically signifi-
cant. 
Like the determinations carried out after 7 L-D shifts, 
serum corticosterone was not significantly changed after 
another 28 L-D shifts, t(17)=0.23, p<0.20. The "in vitro 
corticosterone activity" confirmed this finding. Corticoste-
rone assayed in this manner was slightly decreased in the 
L-D shift stress group, t(38)=1.39, p<0.85. 
Spleen weight was also somewhat decreased, t(77)=0.71, 
p<0.55; however, this difference was equalized when the 
spleen weights were related to the body weights. 
Body weight from which the values after 7 and 35 shifts 
are given, differed throughout the whole observation period. 
Soon after the first L-D shifts, body weight increase in the 
two different groups started to deviate from each other, re-
sulting in an establishment of the mean body weight of the 
L-D shift stressed rats some 5-10% lower than the controls. 
DISCUSSION 
So far, L-D shift stress has not yet been given as a method 
to induce chronic stress in animals; however, in studies in 
man, it has been demonstrated that disruption of the circa-
dian rhythm may be regarded as a rather stressful procedure 
[1]. In this latter study, catecholamine, body temperature, 
alertness and mood were strongly affected and adrenaline 
secretion indicated a stress response of the organism. 
TABLE 2 
DETERMINATIONS AFI'ER 35 WEEKLY L-D SHIFTS 
L-D shift Controls 
Serum corticosterone Mean 39.0 38.0 
p.g/100 ml SD 9.8 10.6 
n 9 10 
Corticosterone in vitro Mean 17.5 19.5 
p.g/100 mg adrenal glandlhr SD 4.0 5.2 
n 21 19 
Blood glucose Mean 4.9 5.5 
mmol/1 SD 0.6 1.4 
n 39 40 
Adrenal glands L+ R Mean 45.3 51.5 
weights in mg SD 3.8 5.3 
n 39 40 
Spleen Mean 337.6 344.5 
weights in mg SD 33.4 41.7 
n 39 40 
Body weight Mean 177.3 183.7 
weighting SD 8.5 9.9 
n 39 40 
In the present study, the effect of L-D shifting is clearly to 
be seen in most parameters. Body weight, a parameter which 
reflects indirectly the effect of stress as far as it influences 
the comfort of the animals [5,28], is lower throughout the 
whole observation period. Although this may be explained 
by changes in drinking and feeding pattern due to L-D shift-
ing, even after 25 shifts there is no tendency to restore this 
lagging in weight gain. This reflects that permanent L-D 
shifting not only results in acute changes of the homeostasis, 
but that a more permanent disfunction of the metabolism 
also will be noticeable. 
The immunosuppressive effect of the L-D shifting ob-
served in this study may be another example of one of these 
more long lasting effects. The immunosuppressive effect 
after 7 weekly L-D shifts is rather extensive and may cer-
tainly result in a higher susceptibility to virus and bacterial 
infection, which has been also observed after acute stress 
[22, 23, 26]. The one animal out of the L-D shift stress group 
which died during the course of the experiment, may have 
been the result of such impaired immuno capacity. Most 
investigators explain the immuno inhibitory action of acute 
stress by its ability to stimulate adrenal cortical activity [23]. 
Serum corticosterone levels are elevated and in some 
studies, the immunosuppressive effect is abolished when 
prior adrenalectomy has been carried out [14]. 
However, in the present study the immunosuppressive 
effect on the cellular immune system is not attended by sig-
nificantly increased levels of corticosterone. Also corticoste-
rone levels after 35 L-D shifts were not elevated; on the 
contrary, the values tended to be lower than the control 
values, in serum as well as been measured in vitro. 
Moreover, adrenal gland mass was clearly diminished in the 
stress group. This finding gives us more confidence that it is 
right to conclude that corticosterone and glucose values of 
the L-D shift stressed rats are virtually decreased. We were a 
little reserved in this conclusion because corticosterone and 
glucose undergo a circadian rhythm [7 ,20], and it might have 
been possible that 7 days after shifting these values stillwere 
not synchronized with control non-shift values. However, 
adrenal gland weights can not to such an extent as has been 
measured in this study, been influenced by circadian varia-
tions. Hence, in respect to a decrease of adrenal gland 
weight, the decreased corticosterone and glucose values 
make some sense. 
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Although these latter findings seem somewhat paradoxi-
cally with the effect of stress on such parameters, this is in 
accordance with other studies on chronic mild stress, in 
which uniformly no increaSe or also a decrease in adrenal 
activity was observed [3,28]. Also secondary manifestations, 
which are attended with increased serum corticosterone 
levels were only partly observed; a relative lymphocytopenia 
was manifest, however, loss oftissue mass of the spleen was 
not present (Table 2). 
These observations make it difficult to hold the hypoth-
esis that the observed immunosuppressive effect of chronic 
stress can be explained by a direct action of adrenal gland 
activity. Also in the study of Monjan and Collector [17], 
chronic stress induced modulation of the immune response 
was not attended by an increase of cortisol levels. Moreover, 
although the immunosuppressive effect of exogenous corti-
costerone administration is well known, it is very difficult to 
explain an immunosuppressive effect because of increased 
levels of endogenous corticosterone. Since such an increase 
of plasma corticosterone from stress reaches levels many 
times lower than plasma levels necessary to induce im-
munosuppressive effects by means of corticosteroid therapy. 
Still it remains possible, that changes in corticosterone levels 
(temporarily or permanently) cause interactions in biochem-
ical systems with more direct relevance to the cellular im-
mune response. 
Interesting, for instance, is the simultaneous rise of corti-
costerone and plasma free fatty acids (FFA) after acute 
stress [10]. The rise in plasma FFA due to stress is not only 
controlled by adrenergic factors [10]. Therefore plasma FFA 
levels may reflect some other aspects of the action of stress 
on the organism than corticosteroid levels. 
The consequence of different levels of PUFA in relation 
to immunosuppression has been a subject of many research 
studies [29]. In vitro T -cell activity is depressed when the 
substrate contains increasing amounts of PUFA [29]. A 
number of explications for this phenomenon have been 
given, such as: differences in membrane fluidity, alterations 
in cyclic AMP, decreased macrophage function or decreased 
synthesis of cholesterol [29]. Moreover, linoleic acid and 
arachidonic acid, which are the major part of plasma PUFA, 
are both precursors of certain types of prostaglandins. From 
these prostaglandins several types are known to have im-
munosuppressive capacities [16]. Therefore, differences in 
the level of plasma PUF A may have some correlation with 
the amount of cellular immunity. Our results support such a 
correlation, because PUFA levels in the L-D shift group 
were significantly higher than in the controls. 
It will be clear that explaining the immunosuppressive 
effect of stress by increased PUFA amounts is still based on 
very little evidence and that much research is needed for 
further support of this statement. Stress, acute as well as 
chronic, has such a tremendous effect on the biological sys-
tem, that certainly more pathways can be thought of, leading 
to a depressed immune capacity [25]. Interferon, which pro-
duction is depressed as a result of stress [6], is also a poten-
tial good candidate for further exploration of the mechanism 
of stress induced immunosuppression. 
The consequences of stress and to be more specific, its 
effect on the immune response are numerous. One effect, 
which may be advantageous in organ transplantation, is the 
delay in rejection of allografts which has been reported in 
animal studies [ 14,22]. Other effects, certainly detrimentally in-
fluencing the individual's condition are: a higher suscepta-
bility to diseases subject to immunological control [22, 23, 
26] and enhancementoftumorinduction [2, 19, 21, 23]. Also, 
in man, epidemiological studies suggest a correlation be-
tween environmental and occupational factors and cancer 
incidence [11]. Animal studies on stress and cancer devel-
opment have exclusively been carried out utilising methods 
of acute stress [2, 21, 26]; the effects of chronic stress on 
tumorigenesis is not yet clear. A study, using L-D shift stress 
to investigate the effect of chronic stress on the growth of 
transplantable tumors as well as the influence on spontane-
ous tumor occurrence is presently under investigation (to be 
published). 
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Light-Dark-Shift Stress, With Special Reference to Spontaneous 
Tumor Incidence in Female BN Rats 1'2 
Will J. Kort, 3 Pieter E. Zondervan, 4 Lorene 0. M. Hulsman, 3 lneke M. Weijma, 3 and Dick L. Westbroek 3•5 
ABSTRACT -As a way to induce mild chronic stress, light-dark 
(L-D)-shift stress was applied to inbred BN virgin female rats dur-
ing their whole life-span (group I, 100 animals); the incidences of 
spontaneous tumor and nontumor processes were recorded. A 
group of rats (group II, 100 animals) exposed to a standard light-
ing system served as the control group. Total tumors of 128 in 
group I and of 154 in group II were found in 74 and 86 animals, 
respectively. Neither were these differences nor was the pattern of 
spontaneous tumors statistically significant. Although in earlier 
studies L-0-shift stress had proved to be effective, especially with 
regard to its capacity to induce a substantial decrease in cellular 
immune response, apparently such alterations did not unfavorably 
affect longevity of BN female rats. Although as a side issue of this 
study, a strong predisposition for tumor incidence appeared to 
exist, in particular for the incidence of Langerhans' islet tumors, in 
fat animals at weaning. JNCJ 1986; 76:439-446. 
Promotional effects of environmental conditions on 
tumor incidence have been a subject of numerous stud-
ies (I -3 ). In a report on the contribution of the envi-
ronment to cancer incidence by Wynder and Gori (4), 
they postulate that 80% of the observed cancer incidence 
can be considered "preventive potential." This preven-
tive potential mainly involves defined environmental 
factors, such as diet, tobacco, alcohol, and occupation 
but also cultural and behavioral patterns, psychological 
factors, or stress (3, 5). Prospective studies by Grossarth,· 
Maticek et al. (6) on the mechanism of psychosomatic 
factors in the process of . cancerogenesis showed that 
traumatic life events or personality traits could lead to 
stress, eventually inducing neuroendocrinologic factors, 
and to enhanced cancer. In the last decade, studies on 
the influence of stress on illness or more specifically on 
carcinogenesis originated from this hypothesis or related 
hypotheses, leading to numerous comprehensive studies 
(5-8). 
In epidemiologic studies of the influence of stress on 
tumor incidence, it is always very difficult to discrimi-
nate between stress and other factors that may cause 
increased tumor incidence. In animal studies in which 
the conditions can be controlled generally more easily 
than those in studies of humans, substantial evidence 
existed for a correlation between stress and increased 
tumor growth; furthermore, no decreased tumor inci-
dence was noted (9-11 ). The mechanism that is thought 
to be, as a rule, responsible for the observed promotion 
is the decrease of the immune response caused by stress, 
for which there is much evidence from experimental as 
well as clinical studies (12,13). However, although there 
is a strong correlation between stress and immunosup-
pression, there is not much proof that the temporarily or 
more permanently induced immunosuppression will 
result in an enhanced tumor incidence. Certainly, in 
humans, in which most tumors are nonimmunogenic, 
stress-linked immunosuppression causing tumors would 
have been surprising (14). 
When a possible effect of stress on tumor promotion is 
studied, one has to consider essential differences found 
between acute and chronic stresses. Whereas acute stress 
immediately resulted in elevated levels of serum cortico-
sterone and other endocrine functions, with prolonged 
exposure to stress the reverse effect was seen: Serum 
adrenal steroid concentrations became subnormal (15, 
16). Although certain stressful events, such as bereave-
ment and hospitalization, may be considered acute 
stress, most stressful conditions in the modern life-style 
are usually regarded as chronic stress. Therefore, in 
animal studies preferably a mild form of chronic stress 
should be given, for proper study comparisons to effects 
of human stress. 
Prolonged exposure of hostile and adverse stress to the 
animal will lead to the General Adaptation Syndrome 
(GAS) as described by Selye (17). Less hostile induce-
ment of chronic stress often led to habituation or com-
pensation by other means than the above-mentioned 
adaptation, such as partial loss of hearing as seen in an 
experiment in which lifelong exposure to noise was 
used to induce chronic stress (18). Other ways to obtain 
mild chronic stress, such as isolation stress or prolonged 
sequential bleeding (19, 20), will encounter logistic 
problems when used in large groups of animals and are 
not very workable. In earlier studies by these authors, 
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L-D-shift stress was used on rats for 35 weeks. This 
stress procedure signi~icantly decreased cellular immune 
response and body weight (16). This finding implicates 
that this procedure does not seem to lead to adaptation 
and is potentially useful in a mild chronic stress study. 
Spontaneous tumor incidence of BN female animals 
was recorded earlier by our group (21, 22) and by others 
(23); these studies proved that, by establishing spon-
taneous tumor incidence, the influence of, for instance, 
dietary factors on carcinogenesis could be investigated 
(22). Expanding on this model we investigated the 
influence of mild chronic stress on tumor incidence. 
Apart from weighing the animals every 2 weeks and 
apart from recording the data gathered by autopsies, no 
other determinations were made so as not to induce 
potentially stressful procedures other than the given 
L-D-shift stress (24). 
MATERIALS AND METHODS 
Experimental design.-This experiment was part of a 
larger study on the effect of environmental conditions 
on cancer incidence, all having the same protocol and, 
apart from specific environmental conditions studied, 
having identical conditions (21, 22). The same protocol 
for the experimental design, strain of animals, and hus-
bandry was followed as that in (22). 
We used 2 groups of 100 animals each, equally 
divided into group I, L-D-shift stress, and group II, 
untreated controls. From weaning (3 wk) until termina-
tion of the experiment (150 wk) L-D-shift stress was 
used, while body weights and the conditions of the 
animals were recorded. Furthermore, at least twice daily 
the animals were carefully checked for sickness and 
death, without handling them. Those animals suspected 
to be sick were removed and housed individually; when 
moribund they were sacrificed. Animals with substantial 
tumor growth, which impeded their eating and drinking 
habits, were also killed. 
The protocol for the sick and dead was the same as 
that described elsewhere (21 ). Body weight, which was 
determined every 2 weeks, was used as a criterium for the 
condition of the animals and for establishment of possi-
ble predispositions for survival or tumor incidence. 
Experimental animals.-The BN female rats used 
(exclusively virgins) were at the time of the experiment 
at their 17th generation of inbreeding. Immediately after 
weaning (3 wk), the animals were weighed and equally 
divided into 2 groups: an experimental group and a con-
trol group. A total number of 70 litters, from which 
exactly 50% came from a second and 50% from a third 
litter, were necessary to complete the 2 groups. The time 
difference between the first and the last animal entering 
the study was 9 weeks. The animals were housed in 
Makrolon cages (41 em longX25 em wideXI5 em high) 
in groups of 5 in air-conditioned animal rooms with a 
controlled day-night rhythm. To prevent possible effects 
of the dominating animals, for instance, in food con-
sumption or uncontrolled stress, we regrouped the 
animals every 2 weeks, keeping the numbers of rats at 5 
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per group. The location of the cage in the animal room 
was changed every 2 months. The animals received a 
commercial diet ad libitum (Hope Farms AM II, 
Woerden, The Netherlands). 
L-D-shift stress.-Mild chronic stress was given by 
alternating the light-dark rhythm of the animals under-
going the L-D-shift stress. Every Friday the automatic 
timer controlling the light for these animals was changed 
half a cycle; i.e., from the standard lighting conditions 
(7 a.rrr.y7 p.m. light and 7 p.m.-7 a.m. dark) to dark 
during' the day and to light during the night; the next 
week standard lighting conditions again were used. In 
earlier studies, this procedure had proved to be stressful, 
which could be established by decreased immune re-
sponse, by a slightly inhibited increase in body we!ght, 
and by a decreased weight of the adrenal glands (16). 
Control animals were housed under a standard lighting 
regimen: 7 a.m.-7 p.m. light and 7 p.m.-7 a.m. dark. 
Both animal rooms were adjacent and were identical in 
temperature, humidity, air-conditioning, and level of 
background noise. Handling of the animals was limited 
to cleaning (twice/week), which was done during day-
time. In the dark phase for the animals in group I, an 
infrared light was used to perform the necessary 
handling. 
Autopsy.-Autopsies were conducted according to the 
protocol described in one of our previous longevity stud-
ies (21 ). Each organ system was examined, and the 
macroscopic findings were recorded. Thymus, adrenal, 
and spleen weights, as a measure of immune capacity, 
were determined. Routine microscopic examinations 
were performed on samples of liver, spleen, mesenteric 
lymph nodes, peripheral lymph nodes, kidneys, adre-
nal glands, stomach, duodenum, ileum, cecum, colon, 
uterus-cervix-vagina, pancreas, pituitary gland, thyroid, 
thymus, heart, lungs, aorta, muscle, ovaries, mammary 
gland, and bone marrow. Other organs were only exam-
ined when suspected of neoplasms. Tissues were fixed in 
4% buffered formaldehyde and, after being processed in 
an Autotechnicon, were embedded in paraffin. Sections 
at least 5 !J.m thick were stained with hematoxylin and 
eosin. Other stains were used when required by our 
pathologist (P. Z.). All materials were screened at least 
twice by the pathologist; in numerous cases additional 
expertise was requested from other pathologists.5 Car-
diac ischemia was considered to be present when areas of 
"waviness," contraction bands, nuclear pyknosis, and 
deep eosinophilia of the cytoplasm were visible in the 
heart muscle. 
Statistical evaluation.-A chi-square analysis, adapted 
to evaluate cumulative incidence data, according to 
Peto's incidental analysis (25), was used. In the results, 
the calculated values were given as G-values with their 
corresponding P-values. The correlations between body 
weight and tumor incidence were calculated with the 
use of the Fisher's exact probability test (G-values). 
Because the experimental data consisted of rats found 
dead or killed when moribund (with animals surviving 
up to 150 wk) and rats sacrificed at 150 weeks, the 
evaluation of the differences in the ages of the animals 
had to be adjusted to this terminal sacrifice. By use of 
the Fisher's exact probability test, the number of tumor-
bearing animals (for any tumor site) killed or found 
dead before 150 weeks was compared with the number of 
animals sacrificed at 150 weeks. When no significant dif-
ference could be shown, a Mann-Whitney analysis was 
used to compare the differences for the tumor site by age 
of group I and group II animals living less than 150 
weeks. Differences were statistically significant at P<.05. 
RESULTS 
From the 200 animals in the study, 2 rats in group I 
could not be further evaluated, due to cannibalism and 
autolysis; from some other animals, limited numbers of 
organs were missing for the same reasons. However, the 
Peto analysis (25) used in determining the differences in 
incidence was adapted for these missing organs. In the 
results given in text-figures 1 and 2 and in tables 1-6, 
the above-mentioned 2 animals from group I were 
excluded. 
All the animals (n=l98), independent of the experi-
mental treatment, litter size, age of the mother at litter, 
week of birth, mortality in the litter, and parity (second 
or third litter), all of which might influence life-span, 
were analyzed for possible relation to survival and 
tumor incidence. However, no relation between one of 
these husbandry variables and survival or tumor inci-
dence was present. However, correlations between body 
weight of all animals at a certain age to survival in 
general or to occurrence of tumors at some specific 
tumor sites were positively present (table 1); e.g., a 
strong correlation could be determined between the body 
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weight at weaning (3 wk of age) and tumor incidence 
and also between body weight at weaning and the inci-
dence of Langerhans' islet tumors. When the animals 
were 10 weeks of age, no such correlation between body 
weight and tumor incidence could be detected anymore. 
However, at 80 weeks the same predisposition for fat 
animals for eventually developing a tumor, as was 
detected earlier, was found again. Because, at weaning, 
fat and thin animals were equally divided in both experi-
mental groups, the observed predisposition of the body 
weight at this age to forthcoming tumor processes could 
not have led to a possible misconception of the results of 
the tumor incidence in any of the· experimental groups. 
Very soon after the start of the experiment, the mean 
body weight of the experimental group began to diverge 
from that of the control group. In the first part of the 
experiment, the mean body weight (text-fig. 1) in group 
I was slightly less to that in group II; although this dif-
ference was significant (P<.Ol ), most of the time the dif-
ference did not exceed 1(' g. A maximum of 21 gin body 
weight difference was reached in the animals at 128 
weeks; however, this relatively large difference in body 
weight between group I and group II was due to the fact 
that a selection of fat animals in group I died in this 
period. 
At autopsy the mean weights of thymus, spleen, and 
adrenal glands were not statistically significantly differ-
ent. Although small differences existed in the weights of 
the thymus and adrenal glands (mean ± SE for thymus 
wt, 62.5±3.2 and 65.9±2.7, and for adrenal wt, 73.6±1.8 
and 78.0±2.6, groups I and II, respectively), when these 
organ weights were corrected for the differences in body 
weight at termination they were almost equal. 
TABLE 1.-Body weight in relation to survival, oceurrerwe of tumors (general), occurrence of mammary tumors, and Langerhans' islet 
tumors of groups I and II together' 
No. of rats 
Body Wk Surviving Having Having Having 
wt, g/rat No. at wk: tumors mammary Langerhans' islet Total tumors tumors 
rats 
:5120 >120 Yes No Yes No Yes No 
:540 3 59 43 73 29 14 88 17 85 102 
>40 43 53 86 10 20 76 29 76 96 
[3.37] [10.15]' [1.76] [5.08]b 
:5136 10 53 49 79 23 18 84 21 18 102 
>136 49 47 80 16 16 80 25 71 96 
[0.02] [1.08] [0.03] [0.82] 
:5171 20 55 49 79 25 17 87 21 83 104 
>171 45 47 80 12 17 75 25 67 92 
[0.31] [3.85]' [0.15] [1.32] 
:5185 40 51 55 85 21 16 90 24 82 106 
>185 47 41 74 14 18 70 22 66 88 
[0.54] [0.50] [0.96] [0.15] 
:5207 80 44 50 71 23 12 82 17 77 94 
>207 48 46 84 10 20 74 29 65 94 
[0.34] [6.21]' [2.41] [4.14]b 
• Group I: L-D-shift stress; group II: untreated controls. Body wt and survival parameters are divided into two categories, with the use of the 
median as point of division. No. in brackets, G-value (Fisher's exact probability test). 
b Animals classified as fat at 3 wk (at weaning) and at 80 wk eventually developed significantly (P<.05) more often a tumor or in particularly 
a Langerhans' islet tumor than did the thin animals. 
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TEXT-FIGURE I.-Comparison of body weight increase in groups I and 
II. V eTtical bars represent the SD. Differences in body weight were 
statistically significant after 20 wk. 
From all animals entering the study, 36 and 30 in 
groups I and II, respectively, survived the 150-week 
observation period and were sacrificed at that age while 
in good condition. From these 36 and 30 animals, 
respectively, 9 and 3 animals had, apart from some 
minor nontumor processes, no pathologi«:; conditions. 
Difference in tumor incidence at 150 weeks (G-value, 
2.48; P<.lO) was probably one of the most convincing 
proofs in this experiment for the relative harmless effect 
exhibited by lifelong exposure to chronic stress. 
In the actuarial survival curve (text-fig. 2) the congru-
ent shape of both survival patterns can be seen. The 
MST of all animals was 138.5 and 140.5 weeks, a differ-
ence which was not statistically significant in the Mann-
Whitney analysis (Z-value=-0.05, P=.95). 
The animals dying in the course of the experiment 
from nontumor processes died mostly with signs of car-
diac ischemia. In group I 4 of 12 and in group II 9 of 12 
animals died from heart failure due to cardiac ischemia 
(the animals sacrificed at termination were not included 
in this comparison). All other animals, apart from the 
animals who some days before death had difficulties in 
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TEXT-FIGURE 2.-Comparison o[ the actuarial survival of groups I and 
II. Each group originally consisted of 100 animals; L-D-shift stress 
was given during the rat's whole life-span. 
breathing, died without any clinical symptoms or with-
out a detectable loss of body weight, which could have 
predicted the oncoming death of the animal. From some 
of these rats, due to cannibalism, numerous organs were 
missing. For more details of all the important non tumor 
processes, see table 2. It has to be stressed that the 
pathologies given in this table were mostly not life 
threatening. The recorded nontumor processes were 
almost equally divided for both groups; no statistical 
significant differences in incidence or in mean age were 
present. 
Totals of 128 and 154 tumors were found in 74 and 85 
animals in groups I and II, respectively. The mean 
numbers of tumors per rat were 1.7 and 1.8, respectively. 
The pattern of the spontaneous tumor incidence is seen 
in table 3. In table 4 the numbers of tumors in tumor-
bearing rats are given. 
The differences in tumor incidence were not statisti-
cally significant for tumor-bearing rats in general or for 
the number of tumor-bearing rats for a particular tumor 
site. The fact that in group I fewer tumor-bearing rats 
( 11) were present had, as a matter of course, also its 
influence on the difference in the total number of 
tumors found. Furthermore, it was striking that almost 
twice as many tumors of the cervix-uterus appeared in 
group II; this otherwise nonsignificant difference was 
caused by a high number of leiomyomas found in the 
TABLE 2.-Incidence of nontumor processes and mean ages of rats• 
Group I Group II Peto analysis (25); 
Non tumor 
No. of processes 
rats MST,wk 
No. of Nontumor incidence 
rats MST,wk G-value P-value 
Uterine infection 8 147 10 148 0.10 0.75 
Hydronephrosis 52 144 49 148 0.37 0.55 
Biliary cysts 35 150 49 148 1.48 0.22 
Pancreatic atrophy 14 150 22 145 0.00 1.00 
Mammary hyperplasia 49 144 53 148 1.26 0.27 
Cardiac ischemia 14 140 22 138 1.14 0.29 
• Group I: L-D-shift stress; group II: untreated controls. 
TABLE 3.-lncidence pattern of spontaneously occurring tumors• 
Anatomic site and tumor type , 
Pituitary gland 
Carcinoma 
Adenoma 
Adrenal gland 
Cortical carcinoma 
Cortical adenoma 
Medullary pheochromocytoma 
Pancreas. endocrine 
Islet cell carcinoma 
Islet cell adenoma 
Thyroid 
Medullary carcinoma 
Mammary gland 
Adenocarcinoma 
Adenofibroma 
Brain 
Meningioma 
.Granular cell myoblastoma 
Cervix-uterus 
Squamous cell carcinoma 
Leiomyosarcoma 
Leiomyoma 
Liver 
Hemangioendothelioma 
Gastrointestinal tract 
Leiomyosarcoma 
Leiomyoma 
Carcinosarcoma 
Fibroma 
Papilloma 
Skin and subcutaneous tissue 
Osteosarcoma 
Melanoma 
Fibrosarcoma 
Squamous cell carcinoma 
Squamous cell papilloma 
Basal cell carcinoma 
Angiosarcoma 
Salivary gland 
Adenocarcinoma 
Lungs 
Adenoma 
Kidney and bladder 
Transitional cell carcinoma 
Adenoma 
Lymphoreticular tumor 
Histiocytic sarcoma 
Myelomonocytic leukemia 
Lymphoblastoma 
Group I 
MST, 
wk n 
1 
31 
9 
2 
6 
2 
23 
2 
6 
9 
1 
3 
4 
5 
1 
3 
5 
5 
3 
124 
145 
144 
145 
147 
150 
150 
150 
147 
124 
132 
144· 
120 
140 
150 
117 
150 
141 
124 
145 
140 
137 
150 
150 
120 
140 
Group II 
MST, 
wk n 
1 
28 
9 
6 
8' 
1 
20' 
4 
4 
16' 
3 
1 
5 
11 
4 
5 
3 
2 
1 
8 
2 
150 
147 
134 
.146 
147 
150 
150 
132 
150 
118 
148 
148 
134 
148 
130 
87 
137 
150 
150 
150 
140 
143 
135 
150 
134 
79 
129 
126 
• Group I: L-D-shift stress; group II: untreated controls. n = 
number of animals with a tumor of the specified type. -=no tumor 
present. 
• Includes No. of animals in which >1 tumor was found; see also 
table 5. 
untreated control group. For the rest, the similarity in 
groups I and II for tumor incidences and age of tumor-
bearing animals was evident. In both groups a gradual 
increase in the number of tumors was noted, eventually 
resulting in greater than 2 tumors per rat in the last 10-
week period. 
Table 5 shows the difference in tumor multiplicity 
(>I tumor at the same anatomic site) between both 
80 
g•oups. Whereas in group I, no tumor multiplicity was 
to be seen, in group II tumor multiplicity was shown 
seven times, at the indicated tumor sites. 
In animals bearing mammary tumor, often certain 
endocrine tumors were found as well (table 6). Such con-
junctions were seen in the same frequency in both 
groups of animals. The incidence .of mammary tumors 
together with pituitary. gland tumors or together with 
Langerhans' islet tumors was most pronounced. 
The number of animals in which a tumor was found 
with distant metastases is given in table 7. Uniformly, in 
this rat strain only a limited number of tumors metasta-
size. In the results of this study, no exception to this find-
ing was seen. The adrenalcortical carcinoma, the only 
tumor with a high metastatic rate, was found five times 
in group I and three times in group II, with metastases 
to lungs and/or liver. Also, in this respect, no signifi-
cant difference between both groups was found. 
DISCUSSION 
In the study of the effect of chronic stress on tumor 
incidence or on longevity, numerous factors may influ-
ence the results even more than in the study of acute 
stress. In particular, the effect of uncontrolled stress due 
to handling and to housing conditions, such as back-
ground noise, pheromones, and infections preexisting or 
entering during the study, may result in unwanted vari-
ation of the results. The elimination of these unwanted 
factors will make an experiment on chronic stress often 
a cumbersome and certainly a risky venture. Although 
we cannot be completely sure that all factors leading to 
uncontrolled stress were eliminated, we are almost cer-
tain that the conditions were near optimal and, what is 
even more important, that background stress was identi-
cal in both experimental groups. 
With regard to the chosen way to induce the stress, 
one may wonder if the quality and quantity of L-D-shift 
stress can be compared with certain types of chronic 
stress in humans. Although caution must be exercised 
when rodent stress is compared to human stress, the 
comparison between L-D-shift stress and the stress that, 
for instance, shift workers undergo seems not to be too 
far-fetched. Rotation shift has been a subject in several 
studies in which the noxious effect of this social and 
physiologic stress on the organism has been investigated 
(26, 27). Without much explanation, to humans the 
social disrupture attended by rotation shift stress is an 
important part of the stress whereas to rats L-D-shift 
stress is accomplished exclusively by means of the phys-
iologic impairment of endocrine circadian rhythm (28, 
29 ). Either as a result of this disturbance of endocrine 
organ function or by other mechanisms, L-D-shift 
stress, like most other stresses, resulted in a decreased 
immune capacity (16, 27). 
In the present study, the immune capacity was not 
measured, because of the earlier mentioned possibility to 
induce unwanted stress by this procedure. However, we 
had every reason to believe that, like in earlier studies, 
which were carried out under exactly the same condi-
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TABLE 4.-Number of tumors in tumor-bearing rats• 
No. of rats dying No. oi rats with the following Total Age, wk No. of tumors No. of Meanb 
Total' With tumor 0 2 3 4 tumors 
Group I with L-D-shift stress 
0-10 0 0 
11-20 2 0 2 
21-30 0 0 
31-40 1 0 
41-50 0 0 
51-60 0 0 
61-70 0 0 
71-80 2 0 2 
81-90 2 2 2 2 1.0 
91-100 5 3 2 2 4 1.3 
101-110 7 5 2 5 5 1.0 
111-120 6 6 4 2 8 1.3 
121-130 15 13 2 10 2 1 17 1.3 
131-140 12 11 1 5 3 3 20 1.8 
141-150 46 34 12 8 17 6 3 72 2.1 
Total 98' 74 24 36 25 10 3 128 1.7 
Group II, untreated controls 
0-10 0 0 
11-20 0 0 
21-30 0 0 
31-40 1 0 
41-50 0 0 
51-60 1 1 1 1 1.0 
61-70 2 2 1 3 1.5 
71-80 2 1" 1 1 1.0 
81-90 3 3 2 4 1.3 
91-100 2 2 2 - 2 1.0 
101-110 8 7 1 6 1 8 1.3 
111-120 6 5 1 1 2 2 11 2.2 
121-130 10 6 4 6 6 1.0 
131-140 15 14 1 9 3 2 21 1.5 
141-150 50 44 6 13 16 11 2 97 2.2 
Total 100 85 15 42 24 15 2 154 1.8 
a- = no tumor present. 
b Mean = mean value calculated by dividing the No. of tumors by the No. of tumor-bearing rats. 
'Two animals (dying at 69 and 133 wk) that could not be examined histologically were excluded. 
tions, during a long period of time the immune capacity 
should be depressed (16). As others reported, for most 
tumor types this immunosuppression does not have to 
implicate that a higher incidence of neoplastic patholo-
gies has to be observed (30). Inasmuch as most spon-
taneous tumors are not immunogenic or are very weakly 
TABLE 5.-Number of rats with >1 tumor at the 
same anatomic sitea 
No. of rats in No. of rats in 
Anatomic site 
group I with group II with 
No. of tumors: No. of tumors: 
2 Total 2 Total 
Mammary glands 15 0 15 17 2 21 
Langerhans' islets 25 0 25 19 2 23 
Adrenal gland 11 0 11 13 1 15 
(cortex) 
Adrenal gland 6 0 6 6 2 10 
(medulla) 
• Group 1: 1-D-shift stress; group II: untreated controls. 
TABLE 6.-Number of rats with a mammary tumor together with a 
tumor at the folwwing anatomic Bite" 
Group I Group II 
Anatomic site No. of Percent of No. of Percent of 
rats ~~::~~Y rats ~~::~v 
Mammary gland + 6 40.0 5 23.8 
pituitary gland 
Mammary gland + 4 26.7 4 19.1 
Langer hans' islets 
Mammary gland + 2 13.3 3 14.3 
pancreatic gland + 
pituitary gland 
Mammary gland + 6.7 3 14.3 
adrenal" gland 
Mammary gland + 6.7 2 9.5 
thyroid 
• Group I: 1-D-shift stress; group II: untreated controls_ 
b Percentage is calculated by dividing the No. of rats with the 
specified combination of tumors by the total No. of mammary 
tumor-bearing rats (group I= 15; group II= 2l)X100. 
TABLE 7.-Number of tumors found with distant metastases• 
Original anatomic tumor 
site, tumor type 
Adrenal gland, cortical 
carcinoma 
Adrenal gland, medullary 
pheochromocytoma 
Pancreas, Langerhans' 
islet carcinoma 
Bone, osteosarcoma 
Total No. of tumors/ 
No. of tumors 
with metastases 
Group I 
9/5 
6/0 
2/1 
1/1 
Group II 
9/3 
8/1 
1/0 
82 
• Group I: L-D-shift stress; group II: untreated controls. Tumors 
were metastasized to lungs (from adrenal gland, cortical carci-
nomas; from adrenal gland, medullary pheochromocytoma), to liver 
(from adrenal gland, cortical carcinomas), to brains (from adrenal 
gland, cortical carcinomas), and to pleura (Langerhans' islet 
carcinoma). - = no tumor present. 
immunogenic (14), a very limited role of stress-induced 
immunosuppression on the incidence of spontaneous 
tumors would be expected. However, other mechanisms 
might be involved that are apart from a pathway via 
immunosuppression. Certainly, when one chooses L-D-
shift stress, which not only disturbs the circadian 
rhythm of a number of hormones, such as insulin and 
corticosteroids, but may decrease or increase the basal 
hormone levels, a direct interaction between this altered 
hormone function and tumor incidence may become 
possible (31 ). In this respect, mention has been made of 
the stress-increased prolactin levels on mammary tumor 
incidence for example (32). Furthermore, endogenous 
opioids have been mentioned (33). 
. I~ the results _of t~e present study, the small but sig-
mhcant retardation m body weight of the animals under 
L-D-shift stress shows that a certain disturbance of the 
normal_environme~tal condit~ons of the animals is pres-
ent. Th1s decrease m body we1ght may have had a direct 
influence on tumor incidence. In the results, a strong 
correlation between thin animals and nontumor occur-
rence was found. Therefore, the L-D-shift stress may 
have had, by the e££ect observed on the body weight, a 
positive influence on survival. It will be difficult to 
assess the contribution of this difference in body weight 
to tumor incidence. Furthermore, because the tumor 
incidence from Langerhans' islet tumors, which was the 
tumor with the most obvious correlation between body 
weight and incidence, was distributed equally in both 
groups, a relation between an L-D-shift stress-linked 
dec~ease in body weight and tumor incidence seems very 
unhkely. The finding that weight at a certain age had 
consequences on survival or tumor incidence was seen 
in earlier studies by our group and by others (21, 34). 
Apart from this indirectly mentioned (via a decrease in 
body weight) effect on tumor incidence and longevity, 
other factors must have been involved. An effect from 
L-D-shift stress more directly focused on the organism 
must be assumed to be responsible for the generally 
favorable outcome of chronic stress in regard to tumor 
inc1dence and longevity. This finding seems to receive 
little support from the data obtained by others; however, 
we must realize that most evidence for a positive correla-
tion between stress and cancer came from studies on 
acute stress and cancer (8). In studies in which chronic 
or repeated acute stress was investigated, no hazardous 
effects were found; and in some other studies even a 
beneficial effect on longevity or of less chance for tumor 
incidence was found (8, 35). 
Organ weights not significantly different between 
group I and untreated controls suggest that the chosen 
way of inducing stress was not effective, for stress is 
correlated with an increased adrenal gland weight and 
decreased thymus and spleen weight. With chronic stress 
this finding is not true:· At the most no change in 
adrenal gland weight was seen; however, slightly de-
creased weights were found (15, 16). Furthermore, it is 
important to realize that all organ weights were estab-
lished at termination, which means that they represent 
an end-point situation. 
Distribution according to tumor site and tumor inci-
dence as was found in the present experiment is not 
essentially different from the results that Burek (23) 
found in his study in BN female rats under conditions 
comparable with those for untreated controls. In this 
study (23) also a relative high incidence of cervix-uterus 
tumors was noted. In 19% of the animals, such a tumor 
was found, at an incidence in agreement with the fre-
quency of the tumors as were detected in the untreated 
animals in our study (17%). Therefore, the low cervix-
uterus tumor incidence in the animals in group I reveals 
the positive contribution of chronic stress in lessening 
the potential for tumor incidence at this anatomic site. 
So far we do not have a reasonable explanation for this 
phenomenon . 
We conclude that chronic L-D-shift stress certainly 
does not contribute to increase of tumor incidence or 
lessen the mean age of the animals. Furthermore, the 
group receiving chronic stress showed favorable results 
in regard to the total number of tumors, the number of 
tumor-bearing animals, the incidence of cardiac lesions, 
and the incidence of tumors on the cervix-uterus. As to 
how far this finding may be of some comfort to those 
persons living under a strain comparable to the investi-
gated L-D-shift stress is hard to assess; but for now there 
is not much evidence, epidemiologically as well as 
experimentally, that such stres~. is a high risk for cancer 
or decreased longevity. 
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Publication III 
THE EFFECT OF CHRONIC STRESS ON TUMOR GROWTH: AN EXPERIMENTAL 
STUDY IN THE RAT 
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The effect of chronic stress on tumor growth: 
an experimental study in the rat 
W.J. Kart*, I.M. Weijma, P.E. Zondervan **, D.L. Westbroek 
Laboratory for Experimental Surgery 
* • Department of Pathological ·Anatomy I 
Erasmus University, Medical Faculty, Rotterdam, The Netherlands 
To evaluate the effect of chronic stress on tumor growth, Light-Dark (L·D) shift 
stress was given to Brown Norway female rats prior to (for 7 weeks) and after 
syngeneic tumor inoculation. Tumor growth of a leiomyosarcoma, a squamo'!s 
cell carcinoma, a basal cell carcinoma, a fibrosarcoma, and a myeloid leukewa 
was followed. The fibrosarcoma and the myeloid leukemia showed a significant 
retardation of tumor growth in the rats on L·D shift stress, compared with ani-
mals receiving a standard lighting regimen. It seems that a specific characteri· 
stic of these 2 tumor types, most probably their hormone responsiveness, is re· 
sponsible for the observed differences in reactivity towards the type of stress 
studied. 
There is substantial evidence, sugge-
sting that personal lifestyle and environ-
mental conditions contribute to tumor 
growth or incidence (8, 26, 27). Although, 
in this respect, most certainly dietary 
components are the most important, the· 
re are several reports showing that cer-
tain events leading to stress might as well 
influence tumorigenesis (6, 9, 10, 17, 21, 
22). Persons exposed to overcrowding, iso-
lation or the conditions of certain occu-
pations, are subject to chronic stress. 
However, circumstances for individuals 
with « cancer p11one personalities» sup-
pressi:ng their emoticons, can be consider.ed 
stress as well. Although there is no com-
mon opinion on the mechanism for this 
relation between stress and tumor enhan-
cement, most investigators consider the 
observed immunosuppressive effect of cer-
tain types of stress of main importance 
(20, 21, 22, 24). Also in experimental ani-
mals the same phenomena were observed: 
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certain types of stress were immunosup-
pressive and could lead to tumor enhance-
ment, although inhibition of tumor growth 
was shown as well (22). 
In the present study it was our purpose 
to investigate a type of chronic mild stress, 
with proven immunosuppressive proper· 
ties (13), on tumor growth of different 
types of syngeneic rat tumors. The method 
of stress chosen was Light-Dark shift 
stress (L-D shift stress). L-D shift stress, 
which is more or less similar to stress, 
which shift workers are exposed to (1, 
25), leads to alterations of hormonal and 
immune function in experimental animals 
as well as humans (1, 7, 13). Moreover, 
in animal studies, not many other ways 
of inducing chronic stress are available, 
as these mostly lead to habituation or 
compensation of the subject (4, 5). 
In the present study L-D shift stress 
was investigated in a number of tran· 
splantable tumor models with different 
characteristics, this to enable a better 
judgement of possible mechanisms invol-
ved in stress induced tumor alterations. 
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In a parallel study, which results have 
been published elsewhere, the same stress 
regimen was given to rats during whole 
life span to determine spontaneous tumor 
incidence (15). 
Materials and methods 
Experimental Design: Inbred Brown Norway (BN) 
or Wistar/Rii (WR) female animals, 6 weeks of age, 
received after randomization L-D shift stress (Group 
I) or standard lighting regimen (Groug II). The 
experimental groups, consisted of 10 animals each. 
Seven weeks later into each animal one particular 
tumor was inoculated, after which stress was continued. 
Tumours: BN175, a soft tissue fibrosarcoma; 
WR1618, a skin basal cell carcinoma; BN569 a ureter 
squamous cell carcinoma; BN248 a cervix/uterus leio-
myosarcoma and BN1312 a myeloid leukemia were 
used. BN tumors originated spontaneously in Brown 
Norway rats, the WR tumor after neutron irradiation 
in a Wag/Rij rat. Tumors BN175, BN248, BN569 
and WR1618 were inoculated subcutaneously (pieces 
of approximately 5 mm3) into the right flank of the 
animal; BN1312 was inoculated intravenously, 1 x"106 
cells. Tumor characteristics are given in Table I. 
Immunogenicity · of the tumors was established 
according to the in vivo transplantation assay as de-
scribed by Prain and Main (19). Measurement of the 
dimensions of primary tumor growth was established 
weekly, using calipers. The mean of length and width 
was taken as a measure of tumor size. For tumor 
BN175 and BN1312 a different procedure was follo-
wed. Tumor growth of tumor BN1312 was determined 
by weighing the spleen 16 days after inoculation of 
the tumor. From tumor BN175 the primary tumor was 
surgically removed 8 days after inoculation. 7 days 
later the animals were sacrificed, after which the 
number of metastases in the lungs was determined 
by counting the white nodules on the surface of the 
left lung. 
Light-Dark (L-D) shift stress: Stress was given by 
weekly alterations of the night-day cycle, which was 
established by changing the automatic timer control-
ling the light of the animal room of the animals on 
stress for 12 hours.· Control animals were housed in 
an animal room adjacent to the L-D shift animal 
room and were on standard lighting regimen: 7 a.m.· 
7 p.m. light and 7 p.m.-7 a.m. dark. 
Husbandry conditions: Apart from the changes in 
night-day pattern, the animals were housed under 
identical conditions with regard to temperature (20-
220C), humidity (60-80%), airconditioning, and level 
of background noise (45-55dB). Handling of the ani-
mals was carried out during daytime, twice a week 
for cleaning and refreshing of drinking water. In the 
dark phase, infrared light was used to perform the 
necessary handling. The rats were fed a standard pel-
leted rodent diet (Hope Farms, AM II, Woerden. 
The Netherlands), ad lib. Acidified water was provi-
ded ad lib., as well. As differences in food uptake, 
due to the stress procedure could substantially in· 
fluence the results of the experiment, this was mea-
sured in a parallel study, at the time of the present 
study, in a number of non tumor bearing animals 
of the same inbred strain, following a procedure as 
described earlier (14). Mean food uptake (± S.E.) 
in Group I was 8.79 (± 0.30) gjratjday; in Group II 
8.75 (± 0.20) gjratjday. 
This difference was not statistically signi-
ficant. Body weight gain, also measured in non tumor 
bearing animals between 7-13 weeks of age (the pe-
riod, in which the experiment took place), was 59.1 
(± 0.5) and 65.3 (± 0.5), in Groups I and II, re-
spectively, a difference, which was statistically signi-
ficant (p < 0.001). 
Statistical evaluation: Tumor growth of BN248, 
BN569 and WR1618 was expressed as the mean of 
the individual regression coefficients b (tga:) obtained 
after calculating the best fitting straight line (linear 
regression: y = a + b x) from the weekly determi-
nations of the tumor size. 
For tumor BN1312 the mean spleen weight was 
given, while for tumor BN175 the tumor size at day 7 
was given. Statistical significant differences in prima-
ry tumor growth was established using a two-tailed 
Student t-test; the differences in metastases in the lungs 
of tumor BN175 bearing animals were tested using 
a Yates-analysis (28). The number of metastases in 
the lungs were scored semi-quantitatively, by dividing 
the counted nodules into one out of five categories: 
< 11 = 1. 11-25 = 2, 26-50 = 3, 51-100 = 4 and 
> 100 = 5. The differences were tested on a signi-
ficance level of 5%. 
Results 
Tumor growth of BN248, BN569 and 
WR1618 was not affected by stress (Ta-
ble II). The slopes of the tumor growth 
curves, given in Table II as tgcx. values are 
almost identical in both groups of rats. 
Tumor BN175 and BN1312, however, sho-
wed statistically significant inhibited tu-
mor growth in the group of animals re-
ceiving L-D shift stress (p < 0.05). 
By comparing the tumor characteri-
stics as given in Table I with the results 
of the effect of L-D shift stress on tumor 
growth (Table II), it appears that the po-
sitive hormone responsiveness, which was 
established for tumors BN175 and BN1312, 
might be responsible for the observed dif· 
ferences between tumors not sensitive to 
L-D shift stress and those which are. An 
alteration of tumor growth of WR1618, 
Table I • Characteristics of tumor modelsa. 
Wks before take b 
Growth rate " 
Immunogenicity 
Morphology d 
Strain 
Metastazing from site 
Original anatomical site 
BN175. 
< 
4 
mes 
BN 
+ 
soft 
tissue 
pancreas 
Hormone responsive e + 
a rats on standard lighting regimen. 
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b number of weeks before detectable tumor growth. 
BN248 
7 
mes 
BN 
cervix/ 
uterus 
BN569 
2 
14 
epi 
BN 
ureter 
BN1312 
1-2 
mes 
BN 
lympho 
ret. 
system 
+ 
WR1618 
13 
+ 
epi 
WR 
skin 
c number of days between tumor size 10 mm and 20 rnm diameter, except for tumor BN1312, for which 
was taken . the number of days between 5 x 105 and 1· x 106 tumor cells in the spleen. 
d roes = mesenchymal tumor; epi = epithelial tumor. 
e BN175 grew more rapidly in female rats; BN1312 grew more rapidly in ovariectomized and in adre· 
nalectornized rats. BN248, BN569 and WR1618 did not show any difference in tumor growth, either 
inoculated in male or in female rats. 
the one immunogenic tumor, was not 
found, implicating that the inhibiting ef-
fect of L-D shift stress on the immune 
capacity seems to be less important. 
With regard to tumor spread, establi-
shed in rats bearing tumor BN175, the 
mean score (± S.E.) of the number of 
metastases in the lungs was 2.6 ± 0.5 and 
3.6 ± 0.6, in Group I and II resp. This 
difference was not statistically significant 
(t = 1.85; p = 0.06). Involvement of the 
right axial lymph nodes was (pos/neg) 
4/6 in Group I and 6/4 in Group II, this 
difference was not statistically significant 
as well. 
Discussion 
Alth_ough the immune capacity from 
the animals used in the present study 
was not determined, there was no reason 
to presume that in the L-D shift stressed 
animals, cellular immune response and 
hormonal imbalance would be alter-ed dif-
ferently as was seen earlier. In spite of 
this decrease in cellular immune response 
and changes in hormone function (decrea-
sed adrenal cortical hormone activity), 
for most tumor types no differences in 
growth could be shown. Assessable chan-
ges in tumor growth were only determined 
in the fibrosarcoma and in leukemia. As 
these tumors both were hormone respon-
sive, it seems logical to suppose that the 
hormonal alterations accompanied by L-D 
shift stress were responsible for the ob-
served inhibition of tumor growth. An ob-
servation, which was also established in 
humans and in other experimental tumor 
models (11). 
Apart from changes in immune ca-
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Table II 
Group I Group II Group I vs Group II 
L-D shift stress Controls 
Tumor Mean (SE) Mean (SE) T-value (f) p-value 
BN248 10.80 (0.73) 11.45 (0.56) -0.69 (15) 0.50 
BN569 4.48 (0.25) 4.83 (0.57) -0.98 (13) 0.34 
WR1618 5.32 (0.52) 5.63 (0.52) -1.03 (15) 0.32 
BN175 17.7 (1.4 ) 21.4 (1.1 ) -2.27 (18) 0.04 * 
BN1312 1864.5 (75.4) 2220.7 (50.3) -4.06 (18) 0.01. 
Growth of tumors BN248, BN569, and WR1618 is given as the mean of the individual tga: values (see 
Materials and methods). BN1312 is given as the mean spleen weight at day of termination, and BN175 is 
given as mean tumor size (mean of length and width) at day 7. 
* statistically significant different. 
pacity and hormonal imbalance, due to the 
stress procedure, in the earlier mentioned 
studies a retardation in weight gain was 
noted as well (13, 15). This was confirmed 
again in a parallel study in non tumor 
bearing animals, which data is given in 
Materials and method. This lagging in bo-
dy weight was apparently not caused by 
a decreased food intake, as was also shown 
in the parallel study. In as far the obser-
ved small differences in body weight are 
partly responsible for the established dif-
ferences in tumor growth (i.e. via hormo-
nal alterations) is hard to assess. 
The finding that the type of stress as 
used in our study gave a decrease of tu-
mor growth seems to ,contradict the ap-
parent common opinion that stress leads 
to tumor enhancement. However, stress-
induced inhibiting effects on tumor growth 
were established by others as well, espe-
cially in «chronic uncontrollable» stress 
(22). As most of the data, in which tu-
mor-promoting effects were found, came 
from experiments in which acute stress 
was used, the tumor promoting effect in 
these studies might have been due to the 
specific characteristics of this type of 
stress. In a longevity study by us, in which 
during 150 weeks L-D shift stress was 
given while spontaneous tumor incidence 
was determined, differences in sponta-
neous tumor incidence (although, not sta-
tistically significant) were noted, also in 
favor of the hypothesis that mild chronic 
stress decreases tumor incidence and pro-
longs longevity (15). 
Apart from affecting tumor growth, 
stress might influence tumor metastatic 
pattern as well. In different experimental 
models, one in which tumor metastasis 
was mimicked by intravenously injection 
of tumor cells (i.e. studying tumor take) 
(18); the other one, in which the number 
of lung metastasis was established after 
spontaneous dissemination of the tumor 
from its inoculation site (24), it was shown 
that metastases were increased after 
stress. In our present study using tumor 
BN175, in a model comparable with the 
latter mentioned study of Tanemura et al. 
(24), these results could not be confirmed: 
on the contrary our data showed a de-
creased number of metastasis in the L-D 
shift stressed group. Like mentioned ear-
lier, different types of stress, depending 
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the specific characteristics of the stressor 
type, might exhibit different effects on tu-
mor growth and apparently also on tumor 
metastatic pattern. For this hypothesis 
confirmation was found in a study of Zi-
mel et al. (29), in whkh using chronic 
stress, the formation and growth of me-
tastases was inhibited. 
As far as our results concern [in the 
present experiment as well as in the ear-
lier mentioned parallel study, in which 
spontaneous tumor incidence was deter· 
mined (15)], no hazardous effect of a type 
of mild chronic stress could be detected 
on tumor growth and metastasis. Still, 
according to data from other investigators, 
acute stress may have the opposite effect. 
The question remains, of course which 
stress is most relevant to human situa· 
tions. According to a study of Lundy (16), 
surgery and anesthesia, which are typical 
examples 'of acute stress, had a direct 
effect on tumor progression particularly 
with respect to spread, by inducing im-
pairment of immune capability. Uncoped 
emotional stress, as an example of chronic 
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Effect of dietary linoleic acid on cellular immune 
response and tumor growth in rats 
W.J. Kart*, I.M. Weijma, A.M. Bijma, D.L. Westbroek 
Laboratory for Experimental Surgery, Erasmus University, Medical Faculty, 
Rotterdam, The Netherlands 
Synthetic diets high (17.7 cal.%) and low (l.l cal.%) in linoleic acid were 
fed to Brown Norway female rats. One group of animals received a com· 
mercially available standard rat chow. Seven weeks after starting the 
animals on the diet, Concanavalin A stimulation of peripheral blood lym· 
phocytes and a Popliteal Lymph Node Assay was performed. When compa-
red with the rats receiving the standard diets, those on the high and low 
linoleic acid diets showed decreased cellular immune responses. In another 
series of experiments, animals were placed on the same three diets and rats 
from each group were inoculated with tumors one of the followihg, after 
7 weeks: a syngeneic cervical "round cell sarcoma", an urothelial squamous 
cell carcinoma, a myeloid leukemia and an adrenal cortical carcinoma. Al· 
most no differences were detectable in the growth of the cervical "round 
cell sarcoma " and the urothelial squamous cell carcinoma. However, there 
were statistical significant differences in the growth of the leukemia and tlie 
adrenal cortical carcinoma, which growth was positive correlated with the 
decrease in the immune response. · 
Certain constituents of the diet, espe-
cially long chain unsaturated fatty acids 
such as linoleic aci:d, have recently been 
shown to induce immune changes (11, 12, 
16, 17, 18, 20, 24). The lymphocyte transfor-
mation induced by a variety of mitogens 
was inhibited in vitro by linoleic acid (11, 
· 17, 18, 20). In vivo skin graft survival was 
prolonged after oral and subcutaneous 
polyunsaturated fatty add (PUFA) admi-
nistration (18); although less marked, the 
same effect was seen in clinical kidney 
transplantation (16) and on experimental 
heart and kidney allograft survival (12). 
Dietary factors are also known to influen-
ce tumor growth in many experimental 
animal models. Tumor growth was enhan-
ced by diets high in PUFA (1, 3, 9, 11). 
Received january 10, 1984. 
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Although there is still no direct evi-
dence for this, .it seems logical to suppose 
that the above mentioned immunosuppres .. 
sive effects of these dietary fats are re-
sponsible for this enhanced tumor growth. 
A number of studies have been car-
ried out on this subject up to now; ho-
wever, there ·is still no conclusive eviden-
ce that fat or certain fatty acids are di-
rectly or indirectly related to carcinoge-
nesis (3, 17). 
Experimental data on the effect of 
polyunsaturated fatty acids on the im-
mune response and carcinogenesis are not 
always easy to interpret; for instance, in 
studies on linoleic acid, this dietary com-
ponent was given for only short periods 
of time, often ·in very high quantities and 
comparison was sometimes made with 
groups of animals receiving diets defi-
cient in linoleic acid (19). In the latter 
cases, the consequences of the pathologi· 
cal conditions of such diets were manife-
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sted by extremely low body weights (1). 
In the study presented here, the main 
objective was to determine the cellular 
immune response of rats receiving diets 
high and low in linoleic acid for prolon-
ged periods of time in 'Comparison with 
others receiving a standard diet. In ad-
dition, inoculations of immunogenic and 
non-immunogenic tumors were done in 
syngeneic rats on the same dietary regi-
mens as those in which the immune re-
sponse determinations were carried out 
in order to establish whether such diet 
induced immune changes could influence 
tumor growth. 
Materials and methods 
Experimental design 
Determination of the cellular immune responses 
and tumor growth was carried out in three groups 
of Brown Norway rats. Group I was placed on a diet 
high in linoleic acid (C18:2); group II received a low 
C18:2 diet and group III a commercially available 
standard rat diet. Seven weeks after the diets were star· 
ted, Concanavalin A (Con A) stimulation of periphe· 
ral blood lymphocytes and a Popliteal Lymph Node 
Assay (PLNA) were performed. In another series of 
experiments rats were inoculated with tumors, 7 weeks 
after starting the diets, of four different characteristics: 
a cervical « round cell sarcoma », a urothelial squa-
mous cell carcinoma, an adrenal cortical carcinoma 
and a myeloid leukemia. 
Each experimental group consisted of ten animals. 
Animals 
Highly inbred female Brown Norway (BN) rats, 
obtained from the University Animal Breeding Centre, 
were used. At six weeks of age, the animals were 
randomly selected and distributed into the experimen-
tal groups. F1 hybrid animals necessary for the PLNA 
were bred by mating BN males with inbred Wistar/ 
Rotterdam (WR) females. When the offspring were 7 
weeks of age the males were used in the assay. All 
animals were housed in airconditioned rooms in ma-
crolon cages in groups of 5. 
Diets 
Linoleic acid was given as a constituent of a total 
synthetic diet. The diets contained 17.7 (high) and 
3.3 (low) calories percent linoleic acid and were pre-
pared by Unilever Research Laboratories, Vlaardin-
gen, Holland. The standara diet given to the rats in 
group III was a commercially availab~e one (Hope 
Farms AM II, Woerden, Holland) containing 7.5 calo-
ries percent linoleic acid. The fatty acid analysis of the 
diets used in this experiments is given in Table 1. 
Although both the standard diet and the one high in 
C18:2 contained fat with 53% PUPA, the rats of group 
I received about twice as much PUPA as those of 
group III because of the diet differences in total fat 
content. 
Food intake of the three different diets was deter· 
mined in a number of animals. In each diet group 
intake was established in three cages containing 5 ani· 
mals each by subtracting the weight of the uneaten 
food from that of the original amount fed. This pro· 
cedure was carried out three times, each for a period 
of two days. Values were converted to consumption 
per rat per day. The values in the table express the 
mean plus or minus the standard deviation of nine 
separate determinations. 
The determinations were deliberately not carried 
out in metabolic cages, as such housing conditions 
tend to alter food consumption, at least until adapta-
tion has been achieved. Because the high and low 
C18:2 diets were completely synthetic they did not 
contain crude fiber and this might explain the small 
difference in food comsumption as compared with the 
animals· receiving the standard rat chow (Table 1). 
The C18:2 diets were freshly prepared weekly in 
three portions: one for 3 days, the other two for 2 
days. To prevent oxidation, the diets were stored at 4' 
in closed containers into which some nitrogen has been 
introduced before closure. The animals received the 
C18:2 diets every Monday, Wednesday and Friday; at 
the same time the old uneaten food was discarded. 
Because the Hope Farms food is more stable, uneaten 
portions of this diet were not discarded but only 
replenished when necessary. 
Leucocytes 
Peripheral blood leucocytes were determined in 
0.02 ml of heparinized blood, gathered by orbital ple· 
xus puncture, using a Sysmex Microcellcounter (Japan). 
Estimation of the % lymphocytes (necessary for the 
Con A) was done by making a smear with a drop of 
heparinized blood and counting 100 cells. The deter-
minations were carried out in groups of 10 animals 
each. 
Concanavalin A stimulation of peripheral blood 
Ix105 leucocytes in whole blood (heparinized with 
15 IU heparin/ml; blood collected by orbital plexus 
puncture under light aether anesthesia) were added to 
each well of Microtitre culture plates (Greiner, W. 
Germany). RPM! medium (Gibco, Scotland) containing 
10% foetal calf serum, 20 J..LM/ml L-Glutamine, 50 
IU/ml of penicillin, 50 J..Lg/ml streptomycin and 10-• 
~-mercapto-ethanol was added to a volume of 200 J..Ll. 
Each determination was carried out in quadruplicate. 
Plates were incubated with 5 J..Lg Con A (Pharmacia, 
Holland) per well at 37° in a humidified atmosphere 
Table I - Fatty acid composition of· the diets. 
Total fat 
SFA 
MUFA 
PUFA 
Kcal 
Mean food consumption 
Mean body weight incr. 
Group I 
C18:2 high 
n = 10 
15.4 
22 (14%) 
5.0 (33%) 
8.2 (53%) 
411.5 
7.0 ± 0.5 
60.8 ± 6.0 
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Group II 
C18:2 low 
n = 10 
15.4 
7.9 (51%) 
6.0 (39%) 
1.5 (10%) 
411.5 
7.0 ± 0.3 
61.0 ± 5.1 
Group III 
Hope Farms 
n = 10 
8.2 
1.0 (14%) 
2.4 (33%) 
3.8 (53%) 
465.0 
8.4 ± 0.5 
64.9 ± 6.3 
SFA = saturated fatty acids; MUFA = monounsaturated fatty acids; PUFA polyunsaturated fatty acids. 
Total fat and fatty acids in grams/100 g food. In parentheses, percentages of total fatty acids·. 
Mean food consumption, mean ± S.D. food consumption/rat/day, n = 9. 
Mean body weight incr., mean ± S.D. body weight increase over the period of 7-13 weeks of age; n 20. 
of 5% C02. Harvesting was performed on day 4 of 
culture. At 16 hours before harvesting, 0.8 1-1Ci of me-
thyl- [3H]-thimidine (with a specific activity of 2 Ci/ 
mmol; Amersham TRA 310) was added to each well. 
Con A stimulation was expressed as counts/min/cul-
ture. The values given were from 10 animals per group. 
Popliteal Lymph Node Assay 
A local graft-versus-host assay was carried out ac-
cording to the method described by Levine (14). After 
local injection of parental cells into Fl hybrid reci-
pients a localized form of graft-versus-host disease 
will be the result. When cells are injected intradermal-
ly in one of the food pads this graft-versus-host reac-
tion takes place in the popliteal lymph node draining 
the inoculated foot. 
In this study the procedure used was as follows: 
0.2 ml of whole heparinized blood was taken from 
the experimental animals (i.e. the diets groups) via or-
bital puncture and injection into the left foot pad of 
(BNxWR)Fl hybrids. The Fl hybrids were on stan-
dard rat chow. Seven days after injection of the 
blood into the test animals. the popliteal lymph nodes 
were excised, cleansed and weighed in tenths of mgs. 
Graft-versus-host reactivity was measured as mean 
lymph nodes weight in 10 animals per experimental 
group. 
Tumors 
Tumors used consisted of a cervical « round cell 
sarcoma », a urothelial squamous cell carcinoma, a 
myeloid leukemia and an adrenal cortical carcinoma. 
These tumors originated in a colony of agint: BN fe-
male rats kept at our laboratory, in which they de-
veloped spontaneously. Except for the adrenal cortical 
carcinoma, all tumors were not immunogenic as jud-
ged by immunization-challenge type of in vivo tran· 
splantation tests done according to the method descri-
bed by Prehn and Main (21). The adrenal cortical 
carcinoma proved to be immunogenic. 
Tumor size was established by weekly determina· 
tions of the dimensions of the tumor using a micro· 
meter. The mean of the lenght and the width was 
taken as a measure of the tumor size. Solid tumor 
growth was expressed as the mean of the individual 
regression coefficients (b) obtained after calculating 
the best fitting straight line (linear regression: y = :1 + 
bx) from the weekly determinations of the tumor si-,;e. 
Growth of the myeloid leukemia was established by 
weighing the spleen to-the-- nearest· milligram after 
exsanguination of the animal at 18 days after i.v. inoc~t­
lation of lxlO' tumor cells. Tumors were kept at -7G' 
until use. After one_ passage of « starting up" in syn-
geneic rats, tumors were used for inoculation experi-
ments, the solid ones by s.c. implantation of a single 
piece of approximately 5 mm3 through a small skin 
incision in the right side of the rat. The leukemia 
was injected i.v. in one of the tail veins. All experi-
mental groups consisted of 10 animals each. 
.Statistical evaluation 
Statistically significant differences between 2 groups 
were established using a Student t-test. The hypothe· 
sis that the difference between the means was negli· 
gible was rejected at a significance level of 5%. 
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Results 
The results of the cellular immune re-
sponse determinations after 7 weeks of 
diet are given in Table 2. 
In both the Con A stimulation test and 
the PLNA, the animals receiving the Hope 
Farms diet exhibited the best cellular im-
mune capacity as compared with both 
groups of rats fed on the synthetic diets. 
On comparing the values for the three 
diet groups in the Con A stimulation test, 
group II was found to be significantly lo-
wer than groups I and III (p < 0.01). 
However, stimulation by Con A in groups 
I and III was similar (p > 0.05). Although 
the PLNA values for groups I and II were 
also lower than those of group III, only 
the difference between group I and group 
III was statistically significant (p < 0.05). 
Table 2 - Effect of diet on cellular immune response. 
Con A; counts/ 
min/ culture 
mean ±S.D. 
PLNA; lymphocyte 
weights in mgs 
mean ± S.D. 
Group I 
C!8:2 high 
n = 10 
32,503 ± 9,255 
30.9 ± 4.8 
Differences in either leucocytes or lym-
phocytes were small and not statistically 
significant (Table 3). 
Table 4 presents tumor growth of the 
3 nomimmunogenic tumors and the im-
munogenic one inoculated into rats recei-
ving the diets high and low in linoleic acid 
and a standard chow. The cervical« round 
cell sarcoma » and the urothelial squa-
mous cell carcinoma showed no significant 
difference in growth in either diet group. 
However, the other nonimmunogenic tu-
mor, the myeloid leukemia, clearly mani-
fested changes in tumor growth in a se-
quence parallelling the immune response 
as determined by the Con A stimulation 
test. That is to say, group II, the group 
which gave the poorest result in Con A 
stimulation, showed the strongest inhibi-
tion of leukemia growth, followed by 
Group II 
CIS: 2 low 
n = 10 
17,519 ± 8,699 
32.6 6.4 
Group III 
Hope Farms 
n = 10 
43,439 ± 16,212 
37.0 5.7 
Con A = Concanavalin A stimulation of peripheral bloqd lymphocytes. 
PLNA = Popliteal Lymph Node Assay. 
Table 3 - Effect of diet on peripheral blood leucocytes and percentages of lymphocytes. 
Group I Group II Group III 
C18: 2 high C18: 2 low Hope Farms 
n = 10 n = 10 n = 10 
Leucocytes 
x106 9.9 ± 2.8 8.4 ± 2.9 10.3 ± 3.2 
mean ± S.D. 
% Lymphocytes 
of leucocytes 90.7 ± 3.1 92.8 ± 4.2 92.4 ± 4.3 
mean ± S.D. 
Table 4 - Effect of diet on tumor growth. 
Cervical round cell 
sarcoma 
mean growth ± S.D. 
Urothelial squamous 
cell carcinoma 
mean growth ± S.D. 
Adrenal cortical 
carcinoma 
mean growth ± S.D. 
Myeloid leukemia 
spleen weight 
mean ± S.D. 
Group I 
C18:2 high 
n = 10 
10.28. ± 1.16 
5.06 ± 1.10 
2.84 ± 0.73 
1196.8 ± 208.4 
98 
Group II 
C18:2 low 
n = 10 
10.22 ± 0.97 
5.02 ± 0.93 
3.80 ± 0.79 
946.8 ± 151.1 
Group III 
Hope Farms 
n = 10 
11.45 ± 1.59 
4.83 ± 0.57 
627 ± 1.38 
1752.5 ± 347.7 
Tumor growth is expressed as the regression coefficient of the straight line resulting from the weekly 
determinations of the tumor size. 
group I and III (Group I vs Group II, 
p < 0.01; Group I vs Group III, p < 0.001; 
Group II vs Group III, p < 0.001). The 
adrenal cortical · carcinoma, the one im-
munogenic tumor model used in this stu-
dy, also showed differences in growth pat-
tern. Again, tumor growth was most pro-
minent in group III, the group of animals 
receiving the Hope Farms diet; tumor 
growth in group I was slightly more de-
layed than that of group II (Group I vs 
Group II, p < 0.05; Group I vs Group Ill, 
p < 0.01; Group II vs Group III, p > 0.05). 
Discussion 
In an earlier study, we reported that 
a synthetic diet high in fat consisting pri-
marily of PUF A prolonged kidney allo-
graft survival in rats (12); however, a diet 
containing the same amount of fat in 
which sunflower oil was replaced by palm 
oil was only slightly less -effective. 
In this study, more or less the same 
diets were provided to investigate the im-
mune response and tumor growth. The fin-
ding that diets high in fat exerted an im-
munosuppressive effect on the cellular 
immune response was also observed in a 
number of other investigations (3, 11, 18, 
24). However, in the literature, especially 
the PUF A level of the -diet was held re-
sponsible for the immunosuppressive ef-
fect of high fat diets (1, 11, 16). Even 
immunopotentiating effects were descri-
bed when diets low or deficient in C18:2 
were given (18). In our study, no indica-
tion for such an -effect of the low C18:2 
diet was found. We think that this discre-
pancy is in some way due to the patho-
logical effects of diets very low or defi-
cient in C18:2 as used by others (8). Some 
support for this statement is the finding 
of Hillyard and Abraham (7), who in a 
study on the growth promoting effect of 
dietary PUFA on transplantable mouse 
adenocarcinoma gave increasing amounts 
of C18:2 and found that addition of as 
99 
little as 0.1% of Cl8:2 to the fat free diet 
was enough to abolish the tumor growth 
inhibiting .effect of such a diet. 
In addition to the direct consequences 
of the immuno-inhibiting effects of high 
fat diets on, for instance, virus or bacte-
rial susceptibility (17), these is substantial 
evidence that high fat diets also enhance 
tumor growth (1, 3, 17). Most investigators 
are una111imous in their opinion that high 
fat diets enhance tumor growth; however, 
the role of PUF A in this phenomenon is 
subject to much debate (1, 3, 4, 22). 
In our study on tumor growth, no 
enhanced growth was observed in either 
the syngeneic nonimmunogenic tumors or 
the immunogenic tumor model. 
Although in our leukemia study a si-
gnificantly higher spleen weight was 
found in the animals receiving a high 
PUFA diet as compared with. the low 
PUFA diet [an observation earlier shown 
in a study on dietary fat -saturation on the 
survival of mice with leukemia (2)], this 
difference in tumor growth was surpas-
sed by far by leukemia growth in the 
animals of Group III, which were on 
standard diet. Because the PUFA content 
of this diet results in plasma PUFA per-
centages somewhere in between those in 
Groups I and II (13), the PUFA content 
as such cannot be held responsible for 
the dififerences in tumor growth in the 
leukemia experiment. 
Moreover, the finding that a high PU-
F A diet enhanced tumor growth as com-
pared with a low PUFA diet co:uld not be 
confirmed in the other three tumor mo-
dels. From the results of the adrenal cor-
tical carcinoma experiment, even the op-
posite conclusion could be drawn. 
Although a (positive!) correlation was 
shown between immunosuppression and 
adrenal cortical carCinoma growth, this 
still does not necessarily imply that im-
munosuppression as such is responsible 
for the observed phenomena. 
Changes in cell membrane fluidity or 
other disturbances of the cell kinetics, as 
demonstrated after changing the fat com-
position of the media in cell culture stu-
dies (5, 6, 22, 23, 25) may be responsible 
for changes in mitotic activity in vivo si-
tuations as well as the decrease in blasto-
. . 
genesis in the Con A stimulation test. If 
this is the case, the observed depressed 
immune function would wrongly be 
considered as the cause of the chan-
ges in tumor growth, while. both tu-
mor growth and the decreased cel-
lular immune response as determined by 
the Con A stimulation test are expres-
sions of the same phenomenon. Which 
means that, in diet studies, we probably 
have to look for other criteria to measure 
immune capacity as well, preferably in 
in vivo situations, such as for instance 
by determining allograft survival or bac-
terial susceptibility. 
The results obtained strongly suggest 
that no direct correlation exists between 
immunosuppression, as been measured by 
cellular immune response assays, and tu-
mor growth. The reason for the differen-
ces in tumor growth, as been found in 
our study, remains unclear, but may be 
explained by other mechanisms. For in-
stance dietary changes in tumor prosta-
glandin synthesis capacity (10) or altera-
tions in cell membrane permeability (23) 
may have been involved. 
This study ·proved once again, that die-
tary factors can react very differently in 
different tumor systems. This leads us to 
the conclusion that, whenever dietary ef-
fects on tumor growth are judged, this 
should preferably be done on the basis 
of the results of more than one tumor 
model, as the specific characteristics of a 
given tumor model are apparently of ma-
jor importance in the results obtained. 
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Spontaneous Tumor Incidence in Female Brown Norway Rats After 
Lifelong Diets High and Low in Linoleic Acid 1'2 
Will J. Kort,3 Pleter E. Zondervan, 4 Lorette 0. M. Hulsman,3 lneke M. Weijma,3 Wim C. Hiilsmann, 5 
and Dick L. Westbroek3.6 
ABSTRACT-High linoleic acid (C18:2) (group I; 17.7 cal%) and 
low C18:2 (group II; 3.3 cal%) diets were given to groups of inbred 
Brown Norway virgin female rats (100 animals/group), during their 
whole life-span. A total of 140tumors were found in group I and 123 
tumors in group II; the median survival times of the 2 groups were 
124.2 and 118.5 weeks, respectively. Total spontaneous tumor 
incidence and median survival times were not significantly different. 
However. significant differences were found in the incidences of 
some specific tumors: The numbers of reticuloendothelial tumors 
and adrenocortical carcinomas were significantly higher in the 
group of animals receiving the low-C18:2 diet. A high incidence of 
tumor multiplicity, however, resulted in a significantly greater 
number of mammary tumors in the high-C18:2 diet group.-JNCI 
1985; 74:529-536. 
Numerous epidemiologic studies demonstrated that 
nutrition and diet are related to cancer incidence (1-3). 
Although specific direCk__acting carcinogens in the diet 
may play a role, the relationship between diet and cancer 
is probably more complex. An important role has been 
ascribed to caloric intake and the type of fat in the diet; 
especially fat and particularly the amount of PUFA have 
received much attention. 
In experimental animal studies, dietary fats high in 
PUFA are reported to be more effective in the promotion 
of chemically induced tumors than diets low in PUFA 
(4-6). In the interpretation of such studies one has to 
keep in mind that nutrient deficiencies may lead to 
biochemical alterations that promote neoplastic processes 
(7). Therefore, studies in which the effect of a high-PUFA 
diet on tumor promotion is investigated, the control 
group should receive enough PUFA to prevent disorders 
that would result from PUFA deficiency, otherwise the 
experiments may lead to false-positive results. To illus-
trate this statement, the addition of as little as 0. I% of 
Cl8:2 to a PUFA-deficient diet was sufficient to abolish 
the tumor-growth-inhibiting effect of this diet (8). 
Many studies investigating dietary factors and their 
influence on carcinogenesis were conducted with the use 
of chemically induced tumors, which are, in contrast to 
spontaneous tumors, uniformly immunogenic (9). Since 
diets that contain high amounts of Cl8:2 were often 
found to be able to suppress the immune system (10, 11 ), 
the growth of immunogenic tumors may be particularly 
influenced by dietary factors. 
Aside from these considerations, which might explain, 
at least in part, the effect of high-PUFA diets on tumor 
growth, it appeared that high-PUFA diets did not always 
enhance carcinogenesis (12, 13). For instance, in experi-
ments with rapeseed oil diet, which contains a high level 
of PUFA, mammary carcinogenesis was not enhanced 
(12). 
The present study was designed to determine whether 
diets high (17.7 cal%) and low (3.3 cal%) in Cl8:2, 
quantities of Cl8:2, which are well within the limits of 
the dietary standards for humans and animals (14, 15), 
would exhibit a difference in the occurrence of sponta-
neous tumors. The experiments involved the feeding of 
the test diets exclusively to BN rats throughout their life-
time; no carcinogens (chemical or otherwise) were given. 
The "normal" cancer incidence of the BN female rat, as 
used in the present study, has been described in a number 
of comprehensive ~udies in which this rat strain was 
subject to gerontological research (16). Aside from 
determining the body weight, handling of the animals 
was minimized; handling was also standardized to 
prevent possible interactions of v<j.riables other than the 
diet on the outcome of the results. 
NJATERIALS AND METHODS 
Experimental animals.-Two groups of 100 inbred 
female BN rats were used. These rats were the offspring of 
the BN animals used in a previous study on retired 
breeders (17). Second and third litter female rats were 
used exclusively from breeder animals whose age vari-
ation was held strictly wi.thin limits (mean age: 25.5 wk 
old). The animals were at their 17th generation of 
inbreeding at the time of the experiment. Immediately 
ABBREVIATIONS USED: Cl8:2=Linoleic acid; MST:=median survival 
time; PUFA=polyunsaturated fatty acids. 
1 Received June 19, 1984; accepted September 15, 1984. 
2 Supponed in pan by The Netherlands Cancer Foundation (Ko-
ningin Wilhelmina Fonds). 
3Laboratory for Experimental Surgery, Medical Faculty, Erasmus 
University (EUR), P. 0. Box 1738, 3000 DR Rotterdam, The Nether-
lands. 
4 Department of Pathology I, Medical Faculty, Erasmus University. 
5 Department of Biochemistry I, Medical Faculty, Erasmus University. 
6 We thank Dr. A. ]. Vergroesen (Unilever Research, Holland) for 
kindly supplying the diets used in this study; Prof. Dr. C. F. Hollander, 
Dr. M. J. van Zwieten, Institute for Experimental Gerontology, TNO, 
Rijswijk, The Netherlands, Prof. Dr. R. 0. van der Heul, and Prof. Dr. 
S. Stefanko (Pathology!, EUR) [or their help in the assessment of some 
of the diagnoses; Mr. C. van Kooten (Department for Signal Analysis, 
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up the breeding data; ar:td Mr. R. Meijer (Exp. Surg., EUR) for his 
contribution in the processing of the histology. 
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after weaning at 3 weeks, tqe animals were divided 
equally in groups and fed the test diets. All animals were 
housed in Makrolon cages on presterilized woodchips 
(Woody-Clean 3/15; Broekman Instituut, B.V., Helmond, 
The Netherlands) in groups of 5 in one air-conditioned 
animal room with controlled day-night light cycle. To 
prevent possible effects of dominating animals on e.g., 
food consumption, the rats "!'ere regrouped every 2 weeks; 
the animals were also rearranged in groups of 5, when 
necessary. The location of the cage in the animal room 
was changed every 2 months. At least twice daily, the cage 
was carefully checked for sick and dead animals without 
handling them. Animals suspected to be sick were 
removed and housed in~ividually or sacrificed when 
moribund. Animals with substantial tumor growth that 
impeded eating and drinking habits were also killed. 
The protocol of sick and dead animals was the same as 
described elsewhere (17). Body weight was determined 
fortnightly and was used as a criterion for the condition 
of the animals and for comparison of growth of animals 
on the two dietary regimens. 
Diets.-The diets contained 17.7 (high) and 3.3 (low) 
calorie% CI8:2 given as a constituent of a total synthetic 
TABLE I.-Characteristics of the study diets 
Diet compound Group r·c Group II 
Composition of the diets in caloric percentage 
Albumin 23 23 
Total fat 35 35 
C18:2 (included in total fat) 17.3 3.3 
Carbohydrates 42 42 
Distribution, g (1,000 kcal) 
Casein 64.111 64.111 
Palm oil 37.634 
Corn oil 28.000 
Sunflower oil 9.634 
Starch 120.000 120.000 
Minerals (Cas. '73)' 5.354 5.354 
Vitamins (Vit. '70)' 1.000 1.000 
Cellulose 15.000 15.000 
Total 243.099 243.099 
Composition of fatty acids,%' 
Palmitic acid 11.1 45.8 
Stearic acid 3.3 4.3 
Oleic acid 32.4 38.2 
Linoleic acid 50.7 9.5 
Linolenic acid 0.9 0.2 
Arachidonic acid 1.6 2.0 
'In mg/1,000 kcal: potassium chloride. 350; secondary mag-
nesium phosphate, 956; primary potassium phosphate, 475; po-
tassium bicarbonate, 719; calcium carbonate, 2014; trisodium 
citrate 2 H,O, 711; manganese sulfate. 67.8; ferric citrate, 43.9; 
copper citrate, 4.7; zinc citrate, 12.5; potassium iodate. 0.07. 
'In mg/1,000 kcal: choline (50%), 500; vitamin E (250 IU/g), 
80; calcium silicate, 50; myoinositol, 25; vitamin B, (1,000 
mg/kg), 5; vitamin A (325 IU/mg), 7.7; nicotinic acid, 5; (cal-
cium)-pantothenic acid, 5; riboflavin, 1.5; thiamine mononitrate, 
1.5; vitamin D (SO IU/mg), 3.125; vitamin K, (22.7%), 1; pyri-
doxine, 0.5; folic acid, 0.25; biotin, 0.05; saccharose, 314.375. 
'Established by gas chromatography. 
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TEXT-FIGURE I.-Comparison of the body wt increase in rat groups I 
and II, fed e, 17.7 cal% Cl8:2; and 0, 3.3 cal% Cl8:2. Vertical 
bars represent the standard deviations. Differences in body wt were 
statistically significant after 20 weeks. 
diet prepared by Unilever Research Laboratories, Vlaar-
dingen, The Netherlands. The diets were the same as 
those used in previous studies on diets and tumor 
inoculation (13, 18). The fatty acid composition of the 
diets, determined by gas chromatography is given in table 
I. This table shows that the diets were isocaloric and were 
identical for all constituents except the fatty acid compo-
sition. The diets were freshly prepared weekly in three 
portions: one portion for a 3-day period, the other two for 
a 2-day period. The animals received these diets ad 
libitum every Monday, Wednesday, and Friday; at the 
same time the leftover food was discarded. 
Autopsy.-Autopsies were conducted according to the 
protocol described in one of our previous longevity 
studies (17). Each organ system was examined, and 
macroscopic findings were recorded. Thymus, adrenal 
gland, and spleen weights were determined as measures 
of immune capacity. Routine microscopic examinations 
were performed on samples of liver, spleen, mesenteric 
lymph nodes, peripheral lymph nodes, kidneys, adrenal 
glands, stomach, duodenum, ileum, cecum, colon, uterus-
cervix-vagina, pancreas, pituitary gland, thyroid gland, 
thymus, heart, lungs, aorta, muscle, ovaries, mammary 
gland, and bone marrow. Other organs were only 
examined when suspected of neoplasms. Tissues were 
fixed in 4% buffered formaldehyde and after processing in 
an Autotechnicon apparatus, embedded in paraffin. 
Sections of at least 5 J.Lm-thick were stained with 
hematoxylin and eosin. Other stains were used when 
required by our pathologist (P. Z.). All materials were 
screened at least twice by the pathologist; in a number of 
cases additional expertise was requested from other 
experienced pathologists. Cardiac ischemia was scored 
when the heart muscle showed areas where "waviness," 
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TEXT-FIGURE 2.-Comparison of the actuarial survival of groups I and 
II rats, receiving e, 17.7 cal% Cl8:2; and 0, ~.3 cal% Cl8:2. Each 
group originally consisted of 100 animals; diets were given during 
the whole life·span. 
contraction bands, nuclear pyknosis, and deep eosino-
philia of the cytoplasma were present. 
Statistical evaluation.-The Peto analysis (19), which 
is a chi-square analysis adapted to evaluate cumulative 
incidence data, was used. In the results, the calculated 
values are given as G-values with their corresponding 
?-values. The correlations between body weight and 
tumor incidence were calculated with the use of Fisher's 
exact probability test. Finally, a Mann-Whitney analysis, 
a parameter-free test was used to compare the differences 
in mean age (Z-values). Differences were considered 10 be 
statistically significant when P:5.05. 
RESULTS 
Husbandry and Body Weights 
Husbandry data of all animals, i.e., litter size, weight at 
weaning, age of the mother at litter, week of birth, and 
mortality in the litter were related to survival and tumor 
incidence. None of these comparisons showed significant 
correlation. No correlation was found either in mother 
and daughter relationships for tumor and nontumor 
incidence: among the 35 animals with mammary tumors 
in the study, only 1 mother was found with the same type 
of tumor as its daughter. Thus all possible ef(ects from 
variables other than Cl8:2 content of the diets on the 
final results were excluded. 
As a direct result of the difference in the diets a 
difference occurred in the mean body weights of the 
groups. Despite the fact that the two diets were isocaloric, 
the body weight gain of the 2 groups started to diverge 
early in the experiments (text-fig. I). By 20 weeks of age, a 
statistically significant difference in body weights was 
found (mean±SE: group I, 166.0±0.9; group II, 169.3± 
0.9). From this time on, the mean body weight of animals 
in group II was higher than that in group I. The 
maximum difference in mean body weights (20 g) was 
reached at about 100 weeks, after which the weekly 
weight gain was almost equal. The differences in body 
weights in the 2 groups, however, remained statistically 
significant in the ensuing period. 
Body weights of group I and group II animals at 
termination, when killed or found dead, were not 
significantly different. There were no differences either in 
the mean weights of the thymus, spleen, and adrenal 
glands determined at autopsy. 
It is obvious that differences in body weight may have 
consequences on survival or tumor incidence. For survi-
val in general the body weight does not seem to be of 
importance. However, the incidence of mammary tumors 
is positively correlated with body weight at 40 weeks 
G=5.05; P<05). We did not find any correlations of 
body weight at other time intervals wi~h either mammary 
tumors or with other tumor or nontumor processes. 
From the 100 animals in each dietary group, 17 and 5 
animals survived the 150-week observation period in 
group I and II, respectively. MST of group I and II were 
124.2 and 118.5 weeks, respectively, a statistically not 
significant difference (Z= -1.47; P=.l4). 
The data of all animals were included in the actuarial 
survival curve (text-fig. 2). For all other evaluations, 2 
animals in group I and 4 animals in group II were 
excluded. Due to autolysis and cannibalism these animals 
could not be examined either macroscopically or micro-
scopically. 
TABLE 2.-lncidence of nontumor processes and mean ages of rats• 
N ontumor process 
Mean age, wk, and incidence± SE 
Group I II Group II 
Uterine infection 101.2±4.4 18 109.7±6.1 
Hydronephrosis 128.5±4.2 31 128.0±2.7 
Biliary cysts 130.1±2.7 44 128.3±3.0 
Stomach bezoars 127.6±2.5 70 122.3±3.5 
Pancreatic atrophy 134.3±4.0 23 125.9±5.9 
Mammary hyperplasia 128.5±5.1 19 131.6±4.9 
Cardiac ischemia 141.7±5.2 9 134.9±2.4 
Bronchopneumonia 71.3±29.9 3 83.4±13.0 
•Group 1 received 17.7 cal% C18:2 in diet; group II received 3.3 cal%. 
'Statistically significant; P<.05. 
Mann-Whitney analysis of Peto analysis of nontumor 
mean age process incidence 
II Z-value P-value G-value P-value 
17 -0.97 .33 0.05 .80 
35 -1.07 .29 2.22 .15 
30 -0.71 .47 0.40 .55 
52 -1.21 .22 0.16 .68 
13 -1.76 .08 0.73 .40 
16 -0.25 .80 0.09 .75 
25 -2.11 .03' 13.28 .01' 
9 -0.09 .93 3.57 .06 
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Mortality 
Mortality of the rats in group II was higher than that 
in group I, particularly in the first 90 weeks of the 
experiment (text-fig. 2). After this period of high mor-
tality, predominantly due to infectious diseases, mortality 
from tumor processes gradually increased in an almost 
identical pattern in both groups. The large number of 
animals dying in the first year of the experiment is the 
result of a high incidence of uterine infections, broncho-
pneumonia, and other nontumor processes (table 2). 
Animals dying from genital tract disease died mostly 
without any clinical symptoms, e.g., without loss of body 
weight. Macroscopically, the uterus appeared swollen, 
filled with a pale viscous fluid. Microscopically, neutro-
phylic exudate was visible in the oviduct lumen and 
polymorphonuclear leucocyte infiltration in the sub-
mucosa, indicating severe ·endometritis. This disease, 
described by Cassell eta!. (20), is caused by Mycoplasma 
pulmonis and has been demonstrated in 30-40% of the 
female rats in a given colony, although certainly not all 
these animals showed clinical signs of disease. The 
disease progresses much more rapidly in older animals 
and in animals with an inferior immune system (20). 
Animals dying from bronchopneumonia were some-
times ill for a few days, with obvious diHiculties in 
breathing. The course of this disease was also very rapid 
and death could not always be predicted. Culture of heart 
blood taken from a number of these animals revealed 
infections of E. coli (4 rats), Enterococcus (2 rats), 
Pseudomonas (2 rats), and Pasteurella pneumotropica 
(2 rats). 
Due to the rapid course of these illnesses, a sick or 
dying animal was not always recognized as such; it was 
then found dead at one of the daily inspections. Organs 
from such animals were often not available for examina-
tion. Since most of these organs were from rats dying in 
the first two-thirds period of the experiment when tumor 
incidence was still small, the unavailability of these 
organs for microscopic or macroscopic examination did 
not influence significantly the analyses of the tumor 
incidence data. Moreover, in the Peto analyses (19) of 
differences in incidence between groups I and II, the 
missing organs were included in the statistical analysis. 
Since a large number of thyroids were missing for 
evaluation, 16 in group I and 17 in group II, respectively, 
the results of tumor or nontumor processes for this 
specific organ may have been a££ected. 
Hydronephrosis, biliary cysts, and stomach bezoars, 
which occurred at a very high frequency, did not show 
any significant difference, either in incidence (Peto 
analyses) or in relation to mean age (Mann-Whitney 
analyses). Statistically significant differences were ob-
served only in the incidence of cardiac ischemic lesions 
and bronchopneumonia. These processes were signifi-
cantly more often encountered in group II. The mean age 
of animals with cardiac ischemic lesions in group II was 
also statistically significantly lower compared to that of 
group I animals. 
Spontaneous tumor incidence showed great variability 
TABLE 3.-lncidence pattern of spontaneously occurring tumors• 
Group I Group II 
Sites and types of tumors No. of No. of 
Pituitary gland 
Carcinoma 
Adenoma 
Adrenal gland 
Cortical carcinoma 
Cortical adenoma 
Medullary pheochromo-
cytoma 
Pancreas endocrine 
Islet cell carcinoma 
Islet cell adenoma 
Pancreas exocrine 
Adenocarcinoma 
Fibrosarcoma 
Thyroid gland 
Medullary carcinoma 
Ovaries 
Papillary cyst adenoma 
Mammary gland 
Adenocarcinoma 
Adenofibroma 
Fibroma 
Brain 
Meningioma 
Oligodendroglioma 
Schwann cell tumor 
Granular cell myoblastnma 
Cervix and vagina 
Squamous cell carcinoma 
Leiomyosarcoma 
Oviduct and uterus 
leiomyosarcoma 
Leiomyoma 
Hemangioendothelioma 
Liver 
Hepatocellular carcinoma 
Hemangioendothelioma 
Gastrointestinal tract 
Squamous cell carcinoma 
Leiomyosarcoma 
Leiomyoma 
Adenoma 
Fibroma 
Lipoma 
Papilloma 
Skin and subcutaneous tissue 
Melanoma 
Squamous cell carcinoma 
Lipoma 
Salivary gland 
Adenocarcinoma 
Lungs 
Adenoma 
Kidney 
Transitional cell carcinoma 
Lymphoreticular tumor 
Histiocytic sarcoma 
Myelomonocytic leukemia 
Lymphoblastoma 
rats with MST rats with MST 
tumors 
2 
29 
7 
4 
4 
29' 
7 
2 
19' 
1 
2 
2 
3 
3 
2 
3 
2 
1 
2 
3 
2 
144 
139 
135 
150 
142 
146 
149 
148 
134 
144 
150 
33 
107 
116 
142 
129 
84 
116 
138 
127 
139 
107 
108 
117 
135 
148 
150 
150 
124 
150 
95 
117 
tumors 
14' 
15 
5 
3 
3 
27' 
3 
1 
14 
4 
3 
2 
2 
2 
2 
1 
1 
3 
2 
4 
3 
138 
129 
136 
145 
129 
133 
81 
140 
131 
100 
132 
114 
91 
104 
131 
99 
111 
127 
150 
136 
143 
106 
133 
139 
119 
122 
114 
•Group I received 17.7 cal% C18:2 in diet: group II received 
3.~ cal%. 
This figure includes the No. of animals in which >1 tumor 
was found. See also table 6. 
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TABLE 4.-lncidence of specific tumor processes and mean age• 
Mean age, wk, and tumor incidence ± SE Mann-Whitney analysis of Peto analysis of 
mean age tumor ~ncidence Tumors 
Group I n Group II n Z-value P-value G-value P-value 
Tumor (general) 128.4±2.7 71 122.9±2.6 75 -1.86 .06 2.83 .09 
Mammary glands 139.2±3.2 20 115.6±8.2 15 -2.59 .o1• 0.00 .90 
Adrenal cortex 133.4±6.4 11 126.3±3.9 18 -1.16 .25 3.89 .o5• 
Pituitary gland 133.4±3.4 31 135.2±3.1 14 -0.42 .68 2.61 .12 
Pancreatic islets 140.2±2.3 29 132.8±2.4 30 -2.29 .o2• 1.53 .22 
Thyroid gland 144.4±2.7 7 140.3±2.6 3 -1.04 .29 0.50 .47 
Lyrnphoreticular system 117.0±21.0 2 119.2±4.8 9 -0.24 .81 4.48 .o4• 
"Group I received 17.7 cal% C18:2 in diet; group II received 3.3 cal%. 
• Statistically significant; P<.05. 
with regard to sites, as well as tumor types (table 3). In 
particular, tumors of the exocrine organs were seen with 
high frequency. For a number of important tumor sites, 
mean age and incidence are given in a separate table 
(table 4). Neither the total number of tumors nor the 
mean survival time of the whole group of animals with 
tumors was statistically significantly different when the 
2 experimental groups were compared. However, signifi-
cant differences in tumor incidences were found for 2 
tumor types: for adrenocortical carcinomas and tumors 
of the lymphoreticular system (leukemia and lympho-
blastic sarcomas). For both tumor types the incidence in 
group II (C18:2-low) was significantly higher compared 
with the rats that received the C18:2-high diet. Although 
the incidences of Langerhans islet tumors or mammary 
gland tumors were not significantly different (Peto 
analysis), the mean age at which these tumors were found 
was significantly higher in group I. The differences in 
tumor mortality from pituitary gland adenomas, thyroid 
carcinomas, and mammary tumors, which seemed to be 
substantially more numerous in group I, were caused 
only by the differences in survival in the last year of the 
experiment. When such differences were corrected for in 
the Peto analysis, they appeared to be statistically not 
significant. 
The mean numbers of tumors per rat in groups I and II 
were 2.1 and 1.6, respectively (table 5). This difference 
was not statistically significant either, because of the 
smaller number of animals surviving until the final part 
of the experiment in group II, a period in which animals 
were more often found dying with more than 1 tumor 
than earlier in the experiment. A Peto analysis done on 
tumor multiplicity(> 1 tumor/rat) confirmed this finding 
(G-value=0.74; P-value=.40). A gradual increase in the 
number of tumors was noted in both groups. In the first 
100 weeks of the study only 33% of the animals in group I 
and 37% in group II were found dead with only 1 tumor 
in most cases. In the last 50 weeks of the experiment this 
pattern changed considerably; in group I and II, 73 and 
91% of the remaining animals, respectively, were found 
with I or more tumors. 
Animals were found not only with tumors at different 
anatomic sites, but also in some cases with more than 1 
tumor at the same anatomic site (table 6). In particular, 
this was the case .with group I animals given the high-
C18:2 diet. The total number of mammary tumors in this 
group was almost twice as high as that in group II. A 
Peto analysis showed that this difference was statistiCally 
significant (G-value=4.54; P-value=.04). 
TABLE 5.-Number of tumors in tumor-beaTing rats• 
Age, wk 
Total 
No. of 
rats 
dying 
(}-10 0 
11-20 0 
21-30 1 
31-40 3 
41-50 1 
51-60 0 
61-70 2 
71-80 4 
81-90 3 
91-100 11 
101-110 13 
111-120 9 
121-130 9 
131-140 14 
141-150 30 
Totals 100 
(}-10 
11-20 
21-30 
31-40 
41-50 
51-60 
61-70 
71-80 
81-90 
91-100 
101-110 
111-120 
121-130 
131-140 
141-150 
Totals 
0 
1 
3 
7 
1 
3 
0 
4 
6 
5 
8 
14 
13 
16 
19 
100 
No. of No. of rats with 
rats the following No. of tumors 
dying No. of tumors: 
with -------- ------,-
tumor 0 2 3 4 5 6 Total Mean• 
0 
0 
Group I 
0 1 
1 2 
0 1 
0 
0 2 
1 3 0 
1 2 1 
5 6 3 2 
8 5 6 2 
5 4 3 2 
9 0 3 5 1 
13151502 
28 285932 
71 29 30 18 15 3 4 
0 
0 
0 
0 
0 
2 
0 
2 
3 
4 
7 
11 
12 
16 
18 
75 
Group II 
1 
3 
7 
1 
1 2 
2 2 
3 3 
1 4 
1 3 3 
3 7, 3 
1 6 5 
0 6 7 
1 8 4 
25 41 22 
1 
1 
1 
3 
4 2 
10 2 
1.0 
2 '2.0 
1 1.0 
7 1.4 
10 1.3 
7 1.4 
16 1.8 
32 2.5 
73 2.6 
149 2.1 
2 
2 
3 
4 
12 
16 
19 
29 
36 
123 
1.0 
1.0 
1.0 
1.0 
1.7 
1.5 
1.6 
1.8 
2.0 
1.6 
"Group I received 17.7 cal% C18:2 in diet; group II received 
3.~ cal%. . 
Calculated by dividing the No. of tumors by the No. of tumor-
bearing rats. 
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TABLE 6.-Number of rats with more than 1 tumor at the ·same anatomic site'·• 
No. of group I rats Total No. of group II rats Total 
Anatomic site with No. of tumors: No. of with No. of tumors: No. of 
2 3 tumors 2 3 tumors 
Mammary glands 14 5 1 27 15 0 0 15 
Langerhans islets 25 4 0 33 27 3 0 33 
Pituitary gland 31 0 0 31 13 1 0 15 
Adrenal gland 11 0 0 11 18 2 0 22 
:Grou~ I receive.d 17.7 cal% C18:2 in diet; group II received 3.3 cal%. 
The difference m mammary tumor multiplicity between group I and group II was statistically significant; P<.05. 
Correlations were observed between certain endocrine 
tumors and mammary tumors in groups I and II. For 
instance, correlations of mammary tumors with either 
pituitary gland or Langerhans islet tumors were seen 
with high. frequency in group I (48.2 and 40.7%, resp.), 
but not m group II (20.0 and 13.3%, resp.). This 
·observation cannot be ascribed entirely to differences in 
total tumor incidence, certainly not with respect to the 
Langerhans islet tumors, because the numbers of this 
tumor. are. not substantially different in the 2 groups. 
Combmauon of mammary tumors with adrenal gland or 
thyroid gland tumors were seen less frequently and 
seemed to be coincidental. 
The only observed correlation of some importance 
between a tumor process and a non tumor process was the 
combination of pituitary gland adenoma and mammary 
hyperplasia. Pituitary gland tumor was associated with 
mammary hyperplasia in 12 of 31 animals in group I and 
in 4 of 14 animals in group II. The diagnosis of most of 
the pituitary gland tumors, chromophobic adenoma, is 
in agreement with these findings. 
The number of animals with distant metastases is 
given in table 7. Because of their small number no 
conclusions could be drawn on the effect of the di~t on 
tumor metastatic behavior. However, the results show 
that with respect to adrenocortical carcinomas, the only 
group of tumors with a high metastatic rate, no influence 
of either diet on metastatic behavior can be established. 
TABLE 7.-Number of tumors found with distant metastases•·• 
Tumor site Type of tumor 
Cervix Squamous cell carcinoma 
Adrenal gland Cortical carcinoma 
Pancreas Langerhans islet cell 
carcinoma 
Pancreas Fibrosarcoma 
Skin Melanoma 
Total No. of tumors/ 
No. tumors 
with metastases 
Group I Group II 
2/1 
7/4 15/7 
3/2 
1/1 
1/0 3/1 
'Group I received 17.7 cal% C18:2 in diet; group II received 
3.3 cal%. . 
bThe tumors were metastasized to the pancreas (cervix. squa-
mous cell carcinoma). lungs (pancreas, fibrosarcoma; adrenal 
gland, cortical carcinomas), liver (adrenal gland, cortical car-
cinomas), brain (melanoma), and mesenterium (Langerhans islet 
cell carcinoma). 
DISCUSSION 
For the study of the influence of dietary factors on 
carcinogenesis, most investigators predominantly used 
transplantable tumors or tumors induced by carcinogens. 
Only a few reports describe mice, hamsters, or rats used in 
longevity studies (16, 20, 21 ). The most important 
advantage of longevity studies is that the influence of a 
certain dietary factor on carcinogenesis is established 
under "normal" environmental conditions. The disad-
vantage is of course the long duration o( these experi-
ments, which leaves room for a number of extrinsic or 
intrinsic factors to cause unwanted variability of the 
results. A number of such factors were carefully con· 
troll~d in the present study, such as the age of the mother, 
the litter parity, and the conditions in the animal room. 
Handling of the animals may certainly influence their 
condition or survival. Stress, the direct result of handling, 
is considered to be an important factor in immune 
response changes (22) and in carcinogenesis (23). There· 
fore, handling of the animals was restricted to weighing 
and the necessary changing of bedding and drinking 
water. Because blood sampling or anesthesia were con· 
sidered too much stress, immune changes and endocrine 
organ function were evaluated only in parallel studies in 
other rats of the same inbred strain. These studies 
intended to establish a correlation between diet-induced 
immune changes and tumor growth (13). 
The test diets used in the present study contain 
physiologic quantities of essential fatty acids; however, 
the total amount of fat (15.4 g%) has to be considered high 
when compared with a commercial rat chow (the 
stand':'-rd laboratory diet in our Institute, Hope Farms, 
contams 8.2 g% of fat). In a longevity study with the same 
BN rat strain fed the Hope Farm diet, Burek (16) observed 
the same general pattern of spontaneous tumor incidence 
seen in our study, although there were some differences 
in the number of tumors at some anatomic sites. 
In the classical studies of Tannenbaum in rats (24), as 
w.ell as in epidemiological studies in man (25), the 
dtfferences observed in tumor incidence correlated with 
body weight. Therefore, a possible effect of the body 
weight had to be considered. Whereas at 40 weeks more 
fat animals were found with tumor than thin animals 
this correlation between body weight and tumor inci: 
dence disappeared at later times in the experiment. The 
differences in tumor incidence, and more specifically in 
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mammary tumor incidence, between fat and thin animals 
at 40 weeks were not restricted to one or the other 
group; they were present in both dietary groups. The 
finding that weight at a certain age may have conse-
quences on. survival or on tumor incidence has been ob-
served in other studies as well (26). 
To judge the observed differences in tumor incidence, 
two different aspects of the results should be considered: 
the age of the animal at tumor occurrence and the 
incidence for a particular tumor type. With regard to the 
first aspect, mammary tumor-bearing rats and rats with a 
Langerhans islet tumor were found significantly earlier 
among the animals of group II. Because a direct 
relationship exists between the age and body weight of 
rats, not the age at termination but, more importantly, 
the body weight may be correlated with the occurrence of 
a certain type of cancer. With respect to mammary tumor 
incidence, the mean body weight at termination of these 
animals was significantly less in group II than that in 
group I. However, this was not the case for Langerhans 
islet tumor-bearing rats. This observation means that the 
early occurrence of mammary tumors in group II is not 
the result of the higher mean body weights of the animals 
in this group. For Langerhans islet adenomas such a cor-
relation cannot be excluded. 
The early appearance of the Langerhans islet adenomas 
in group II may have been caused by the higher activity 
of the islets established by the significantly increased 
insulin levels observed in the parallel studies (27). 
The mechanism responsible for the differences in 
adrenal gland and lymphoreticular tumor incidence is 
even more difficult to explain. The incidence of both 
tumors was significantly higher in animals on the low 
Cl8:2 diet; therefore the same reasons outlined above may 
hold for these differences as well. It is not difficult to 
make this assumption for the adrenal gland tumors; a 
correlation between certain endocrine organ functions 
and adrenal gland tumors was established by others as 
well (28). In an experiment with Syrian hamsters, the 
incidence of adrenocortical carcinomas was significantly 
higher in the high-fat diet group (21 ). 
With regard to the differences in leukemia incidence, a 
role of the endocrine system is unlikely. Cl8:2 seems to be 
protective with respect to this tumor type: The incidence 
in group II (9%) is comparable to what Burek (16) found 
in his study (7%) in animals fed standard rat chow. 
The number of tumors per rat increases according to 
the age of the animals. We saw a tendency for the number 
of tumors per rat in group I to be higher than that in 
group II. However, except for mammary tumors, this 
difference in tumor multiplicity was not statistically 
significant. The importance of the observed mammary 
tumor multiplicity is difficult to assess. In studies with 
chemical carcinogens, tumor multiplicity is used as a 
criterion for the efficacy of the treatment (5, 6); this 
seems logical because the carcinogen has a direct effect on 
certain cell types that are transformed to tumor cells. 
Tumor multipliCity is then a useful parameter to deter-
mine the efficacy of the antitumor therapy. However, it 
would seem extreme to consider Cl8:2 a chemical 
carcinogen with a direct effect on mammary tumor 
carcinogenesis, although there is some support for this 
idea. Wicha and others (29) studied the action of Cl8:2 in 
culture medium and found enhanced growth of neoplas-
tic and normal mammary tissue. The classical work of 
Prehn (9) on tumor immunogenicity also fits in this 
picture: He denies the spontaneous etiology of tumors 
and considers such tumors as the results of low levels of 
oncogens. Prostaglandins, which are metabolic end 
products of Cl8:2 were also found to play a direct role in 
mammary tumorigenesis (30). 
A high number of mammary tumors were found 
together with pituitary gland tumors and Langerhans 
islet tumors in group I but not in group II. This finding 
could imply that with increasing quantities of Cl8:2 a 
higher number of mammary tumors appear, induced via 
specific endocrine stimulation. That hormones play a 
role in the etiology of mammary tumors is widely 
accepted; evidence for this interaction was found in 
epidemiologic as well as in animal studies (31, 32). 
The results of the present study show that diets high in 
PUFA (17.7 cal%) are generally not carcinogenic. This 
finding is corroborated by the results from the parallel 
studies, in which the same diets were investigated on 
transmissible tumors (13). However, a possible effect of 
the diet high in CI8:2 on the etiology of mammary 
tumors cannot be denied. That diets high in PUFA are 
relatively protective against cardiovascular disease was 
confirmed in this presentation by a significantly lower 
incidence of ischemic heart lesions in the rats receiving 
this diet. This seems to be an important reason for the 
inclusion of high quantities of PUFA in modern human 
diet. Although no low-fat diets were given, a prudent 
comparison with data from other studies and our own 
data suggests that the quantity of fat is more important 
for enhanced tumor incidence than the distribution of 
fatty acids. 
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Abstract. Diets high (17. 7 cal%) and low (3.3 cal%) in linoleic acid were given to groups of 
Brown Norway female rats before and after inoculation of syngeneic tumor models with 
different characteristics, with regard to tumor spread, malignancy, immunogenicity, growth 
rate, rat strain, and histopathological features. Despite the differences in characteristics, in 
most tumor models, tumor growth was identical in both experimental groups. However, in 2 
tumor models, an adrenal cortical carcinoma and a myeloid leukemia, differences in growth 
were noted. In rats given the diet low in linoleic acid, growth of the cortical carcinoma was 
significantly increased, whereas the opposite effect was seen in rats with myeloid leukemia. 
Introduction 
The linoleic acid content of the diet has 
raised much interest and has been the subject 
of numerous research studies in the last 2 
decades. On the one hand linoleic acid in the 
diet is thought to be beneficial in the pre-
vention of coronary heart disease by decreas-
ing plasma cholesterol levels [I, 2], on the 
other, the incidence and growth of tumors 
seemed to be higher in man and animals 
receiving diets high in linoleic acid [2, 3]. 
Generally, the mechanism responsible for 
this higher tumor incidence is considered to 
be the immunosuppression which diets high 
in linoleic acid can exhibit [4, 5]. 
Studying dietary linoleic acid, with partic-
ular regard to immunosuppression and tu-
mor promotion, it is important to consider 
accurately the quantity of linoleic acid in the 
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control diet: a diet very low or deficient in 
linoleic acid results in pathological condi-
tions [6] and should never be used as a con-
trol. Also the tumor model used needs careful 
attention, as differences in tumor characteris-
tics, especially with regard to immunogenic-
ity and hormonal responsiveness, may easily 
lead to misinterpretation of the effects of the 
dietary components on tumor progression 
[7-9]. For these reasons a study was under-
taken in which rats were given a diet high 
(17.7 cal%) or low but adequate (3.3 cal%) in 
linoleic acid, and a wide variety of tumors 
was inoculated, in order to investigate the 
tumor characteristics in relation to the al-
leged tumor growth-promoting effect of diets 
high in linoleic acid. 
A comprehensive study on spontaneous 
tumor incidence in rats given these diets has 
been published elsewhere [I 0]. The effects of 
the same two diets on growth in transplant-
able tumor models is the subject of the 
present study. 
Materials and Methods 
Experimental Design. Groups of at least 10 ani-
mals received, after randomization, the test diets when 
they were 6 weeks of age. Group I was placed on a 35 
cal% fat diet high in linoleic acid, group II a 35 cal% 
fat diet low in linoleic acid. Seven weeks after the diets 
were started, tumors were inoculated, after which the 
dietary regimen was continued. The animals were 
housed in macrolon cages in groups of 5, water and 
food was given ad lib. The animal room was air-con-
ditioned and with a controlled 12 h light/12 h dark 
rhythm. 
Tumors. BN472, a mammary adenocarcinoma; 
BN175, a soft tissue fibrosarcoma; WR1618, a skin 
basal cell carcinoma; BN569, a ureter squamous cell 
carcinoma; BN945, an adrenal cortical carcinoma; 
BN248, a cervix/uterus leiomyosarcoma, and 
BN1312, a myeloid leukemia, were used. BN tumors 
originated spontaneously in Brown Norway rats, the 
WR tumor in a Wistar/Rij rat after neutron irradia-
tion. Apart from the myeloid leukemia, tumors were 
inoculated subcutaneously (pieces of approximately 
5 mm 3) into the right flank of the animal. Leukemia 
was inoculated intravenously, I X 106 cells. The dif-
ferences in tumor characteristics are summarized in 
table I. Immunogenicity of the tumors was established 
according to the in vivo transplantation assay as de-
scribed by Prehn and Main [II]. Measurement of the 
dimensions of primary tumor growth was established 
weekly, using a micrometer. The mean of length and 
width was taken as a measure of tumor size. For tumor 
BN175 and BN1312 a different procedure was fol-
lowed. The primary tumor of tumor BN 175 was surgi-
cally removed 12 days after inoculation, 9 days later 
the animals were sacrificed, after which the number of 
metastases in the lungs was determined by counting 
the white nodules on the surface of the left lung. The 
number of metastases in the lungs was scored semi-
quantitatively by assigning the counted nodules into 
one of five categories:...;;; 10 = 1, 11-25 = 2, 26-50 = 3, 
51-100,;, 4, and> 100 = 5. Tumor growth oftumor-
BN 1312 was determined by weighing the spleen 16 
days after i.v. inoculation of the tumor. 
Dietary Regimen. Linoleic acid was given as a con-
stituent of a semisynthetic diet. The 35 cal% fat diets 
contained either 17.7 (high) or 3.3 (low) cal% linoleic 
acid and were prepared by Unilever Research Labora-
tories, Vlaardingen, Holland. The composition of the 
diets is given in table II. Apart from the quality of 
dietary fats, both diets were identical in all important 
constituents and in caloric density. The diets were 
freshly prepared 3 times a week and were given to the 
animals every Monday, Wednesday and Friday, the 
uneaten food being discarded. 
Statistical Evaluation. If possible, comparison of 
tumor growth was carried out by taking the mean val-
ues of the individual regression coefficients b (tga) 
obtained after calculating the best fitting straight line 
(linear regression: y =a+ bx) from the weekly determi-
nations of the tumor size. For tumor BN 1312 the 
mean spleen weight at day 16 was given, while for 
tumor BN175 the tumor_ size at day 7 was given. Sta-
tistically significant differences in primary tumor 
growth were established using a two-tailed Student t 
test; the differences in number of metastases in the 
lungs of tumor BN175-bearing animals were tested 
using a Yates analysis. The differences were tested on 
a significance level of 5 %. 
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Table I. Characteristics oftumor models 1 
BN175 BN248 BN472 BN569 BN945 BNI312 WRI618 
Weeks before detectable 
tumor growth <I <I 2 4-5 1 1 
Growth rate2 4 7 6 14 10 1-2 13 
Immunogenicity + + 
Morphology mes mes epi epi epi mes epi 
Strain BN BN BN BN BN BN WR 
Metastasizing from site + + 
Original anatomical site soft tissue cervix/ mamma ureter adrenal lympho-ret. skin 
pancreas uterus cortex system 
Hormone responsive3 + n.e. n.e. n.e.4 + n.e. 
mes = Mesenchymal tumor; epi = epithelial tumor; n.e. = not established. 
Rats on standard rat chow (Hope Farms, AM II). 
2 Number of days between tumor size 10 mm and 20 mm diameter, except for tumor BN1312, for which the 
number of days between 5 X 105 and I X 106 tumor cells in the spleen was taken. 
3 BNI75 grew more rapidly in female rats; BN472 tumor growth was identical in both sexes, whereas BNI312 
grew more rapidly in ovariectomized and in adrenalectomized rats [Kart, unpublished data]. 
4 Hormonal responsiveness was ·not tested; however, the cortical carcinoma produced steroids, as was estab-
lished by atrophy of the contralateral adrenal gland [10, 23]. 
Results 
The results of tumor growth in rats on diet 
high and low in linoleic acid are given in fig-
ure 1. It will be clear that apart from tumor 
BN945, the adrenal cortical carcinoma, no 
differences were observed. With this particu-
lar tumor, growth was statistically signifi-
cantly inhibited in the high linoleic acid 
group. Furthermore, a difference was ob-
served in rats with leukemia. In group I mean 
spleen weight(± SE) at day 16 was 1,196.8 
± 69.5 mg, whereas in group II, spleen 
weight was 946.8 ± 47.8 m&; t(17) = 3.02, 
p < 0.0 I. These results imply that in this 
tumor model growth was inhibited in the diet 
group low in linoleic acid, an effect opposite 
to that seen with tumor BN945-bearing ani-
mals. Finally, growth of another hormonal 
responsive tumor, BN175, was not signifi-
cantly effected: tumor size ± SE day 7, group 
I, 16.1 ± 1.1 mm; group II, 14.3 ± 0.6 mm: 
t(l8) = 1.36, p < 0.19. 
The mean score ( ± SE) of the number of 
metastases in the lungs after inoculation of 
tumor BN175 was 3.25 (± 0.5) and 2.70 
( ± 0.3) in groups I and II, respectively. The 
difference was not statistically significant 
(Yates t score= 0.92, p < 0.65). The median 
of the number of metastases in both experi-
mental groups was identical: 39.5. 
Tumor BN472 grew substantially less rap-
idly on the semisynthetic diets as used in the 
present study in comparison with the growth 
observed in BN rats on commercial diet, in 
which invariably, using the same experimen-
tal design, metastases could be established. 
Probably as a result ofthis, at the time of sac-
rifice, no tumor spread to regional lymph 
nodes could be found in either di,etary group. 
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a 
c 
e 
: WE'E'ks after inoculation: , 
Fig. 1. Growth of transplantable tumors on diet 
high and low in linoleic acid. • --• = Group I, 1 7. 7 
cal% linoleic acid; o-- -o = group II, 3. 3 cal o/o linoleic 
acid. The vertical bars represent the SEM. 
a Tumor BN248, cervix/uterus leiomyosarcoma: tga 
(± SE) linoleic acid high diet, 10.28 ± 0.39; tga (± 
SE) linoleic acid low diet, 10.22 ± 0.29; t(l8) = 0.15, 
p < 0.88, not significant. 
b Tumor BN472, mamma adenocarcinoma: tga (± 
SE) linoleic acid high diet, 7.96 ± 0.60; tga (± SE) 
linoleic acid low diet, 8.20 ± 0.74; t(25) = 0.28, p < 
0. 78, not significant. 
c Tumor BN569, ureter squamous cell carcinoma: 
tga ( ± SE) linoleic acid high diet, 5.06 ± 0.35; tga ( ± 
SE) linoleic acid low diet, 5.02 ± 0.29; t(l8) = 0.87, 
p < 0.39, not significant. 
b 
d 
Table II. Composition of the diets 
Composition of the diets as 
a percentage of the energy 
Protein 
Fat 
Of which linoleic acid 
Carbohydrates 
Distribution {1,000 kcal) 
Casein 
Palm oil 
Com oil 
Sunflower oil 
Starch 
Minerals (Cas. '73)1 
Vitamins (Yit. '70)2 
Cellulose 
Total 
Composition of the fatty 
acids (percentagejl 
Palmitic acid 
Stearic acid 
Oleic acid 
Linoleic acid 
Linolenic acid 
Arachidonic acid 
Group I 
23 
35 
17.3 
42 
64.111 
28.0 
9.634 
120.0 
5.354 
1.0 
15.0 
243.099 
11.1 
3.3 
32.4 
50.7 
0.9 
1.6 
116 
Group II 
23 
35 
3.3 
42 
64.111 
37.634 
120.0 
5.354 
1.0 
15.0 
243.099 
45.8 
4.3 
38.2 
9.5 
0.2 
2.0 
1 Cas. '73: In mg/1,000 kcal, potassium chloride, 
350; sec. magnesium phosphate, 956; prim. potassium 
phosphate, 475; potassium bicarbonate, 719; calcium 
carbonate, 2,0 14; trisodium citrate 2 aq., 711; manga-
nese sulfate, 67.8; ferric (III) citrate, 43.9; copper 
citrate, 4. 7; zinc citrate, 12.5; potassium iodate, 
0.07. 
2 Yit. '70: In mg/1,000 kcal, choline (50%), 500; 
vitamin E (250 IU!g), 80; calcium silicate, 50; myo-
inositol, 25; vitamin B12 (1,000 mg!kg), 5; vitamin A 
(325 IU/mg), 7.7; nicotinic acid, 5; (calcium)-panto-
thenic acid, 5; riboflavin, 1.5; thiamin monocitrate, 
1.5; vitamin D (80 IU/mg), 3.125; vitamin K3 
(22.7%), I; pyridoxine, 0.5; folic acid, 0.25; biotin, 
0.05; sucrose, 314.375. 
3 Established by means of gas chromatography. 
Discussion 
In an earlier study, we reported that a 
semisynthetic diet with 35 cal% fat, consist-
ing predominantly of polyunsaturated fatty 
acids (PUF A), prolonged kidney allograft 
survival in rats [12]; however, a diet contain-
ing the same amount of fat in which sun-
flower oil was replaced by palm oil was 
almost as effective. The finding that diets 
high in fat exerted an immunosuppressive 
effect was observed in a number of other 
studies as well [4, 5, 13, 14]. However, the 
PUF A level of the diet was claimed to be 
responsible for the immunosuppressive effect 
ofhigh fat diets [13, 15]. Conversely, immu-
no-potentiating effects were described when 
diets low or deficient in linoleic acid were 
given [14]. However, in parallel studies by us, 
using the same amounts of linoleic acid as 
were given in the present study, no such dif-
ference between high and low PUF A diets on 
cellular immune response could be estab-
lished [16]. But when the immune capacity 
was related to that of rats on standard rat 
chow, which is relatively low in fat but also 
differs with regard to other dietary constitu-
ents, a decrease in immune response was 
observed [16]. This discrepancy between our 
results and those of others referred to above 
might be traced back to the chosen levels of 
PUFA in the diets. Especially with regard to 
the low PUF A diet, one has to be careful to 
avoid linoleic acid deficiency, as this cer-
tainly will give pathological conditions, such 
as a suppression of blastogenesis [6]. Our 
postulation is supported by the finding of 
Hillyard and Abraham [17], who in a study 
on the growth-promoting effect of dietary 
PUF A on transplantable mouse adenocarci-
noma gave increasing amounts of linoleic 
acid and found that addition of as little as 
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0.1% of linoleic acid to the fat-free diet was 
enough to abolish the tumor growth-inhib-
iting effect of such a diet. 
In addition to the direct consequences of 
the immuno-inhibiting effects of high fat diets 
on, for instance, virus or bacterial susceptibil-
ity [5], there is sub~tantial evidence that high 
fat diets also enhance tumor grov,7h [5, 18], 
although, recently it has been sh~ that the 
overall energy intake is of primary importance 
to the observed increase of tumor incidence, 
independent of the fat content or distribution 
of the fatty acids in the diets [19]. Also the role 
oflinoleic acid, which initially was considered 
as the most important constituent of dietary 
fat promoting tumorigenesis, is still subject to 
much debate [20, 21]. 
In our study on transplantable tumor 
growth, enhanced tumor growth in a high 
PUFA diet was observed only in the 
BN1312, myeloid leukemia, tumor growth. 
As for all other tumor models, a high amount 
of PUF A in the diet did not contribute to 
enhancement of tumor growth. On the con-
trary, in tumor BN945, the adrenal cortical 
carcinoma, a substantial increase in tumor 
growth is observed in the rats given the diet 
low in linoleic acid. Furthermore, the results 
gathered from a longevity study, in which 
rats were given the experimental diets, did 
not show important differences in total tu-
mor incidence nor in tumor incidence of any 
particular tumor site [10]. In the group fed a 
d Tumor BN945, adrenal gland cortical carcinoma: 
tga ( ± SE) linoleic acid high diet, 2.84 ± 0.25; tga ( ± 
SE) linoleic acid low diet, 3.80 ± 0.25; t(17) = 2.73, 
p < 0.0 I, significant. 
e Tumor WR 1618, skin basal cell carcinoma: tga ( ± 
SE) linoleic acid high diet, 4.78 ± 0.37; tga (± SE) 
linoleic acid low diet, 5.01 ± 0.39; t(I6) = 0.42, p < 
0.68, not significant. 
diet high on linoleic acid, 149 tumors were 
found in 71 tumor-bearing animals (out of 
100 animals); and in the group fed a diet low 
in linoleic acid, 123 in 75 animals (out of 100 
animals). This difference was not statistically 
significant in a Peto analysis, which is chi-
square analysis adapted for evaluation of cu-
mulative incidence data. It was interesting, 
however, that in this study differences in ad:. 
renal gland tumors and lymphoreticular tu-
mors were observed. Both tumor incidences 
were significantly lower in the groups with the 
high intake of linoleic acid. As both tumors 
are known to be responsive to the hormonal 
environment, certainly with regard to cortico-
steroids (table I) [22, 23], it is possible that 
this specific characteristic contributed to the 
observed phenomenon. Support for such a 
possible involvement of hormones is found in 
other studies from our group in which, using 
the same diets, significantly different levels of 
insulin and corticosterone were established 
[16, 24]. Also in other tumor models, dietary-
induced changes in hormone levels were held 
responsible for the observed differences in 
tumor growth [25]. In this respect the hor-
mone prolactin has been mentioned [26], al-
though recent literature discounts a possible 
involvement of prolactin in tumor growth 
[27]. However, as we do not have any infor-
mation concerning tumor growth responsive-
ness of myeloid leukemia and cortical carci-
nomas to this hormone or to a number of 
other hormones, a contribution via such a 
mechanism cannot be excluded. 
Also in the longevity study [10], one could 
conclude from the high incidence of death 
due to infectious diseases that the immune 
capacity of all animals on the 35 cal% fat-
containing semisynthetic diet, regardless of 
its linoleic acid content, was depressed com-
pared with animals on standard Hope Farms 
118 
rat chow. However, this temporarily or more 
permanently induced immunosuppression 
did not result in a substantially higher tumor 
incidence, when compared with other studies 
[23]. For comparison, in this longevity study 
a total of 410 tumors were found ih 208 
(88 %) oftotal) tumor-bearing animals in the 
BN female rat used [23]. 
Although it seems obvious from studies 
performed by others as well as by our group 
that certain diets may exhibit immuno-mo-
dulating properties, a relation beween this 
effect and differences in growth ofnonimmu-
nogenic tumors seems farfetched [28]. Except 
for the special cases of lymphoreticular or 
viral induced tumor growth there is not a 
greatly increased tumor incidence either in 
patients immunosuppressed after transplan-
tation or in immunodeficient animals [5]. 
Although so far the immunosurveillance the-
ory [29] cannot be excluded completely, 
other explanations for differences in tumor 
growth seem to get more support. Apart from 
the earlier discussed theories with regard to 
the contribution of hormonal alterations as 
being tumor mediating, a number of other 
possibilities are open for discussion. Immu-
nosuppression as well as hormonal activity 
play a more central role by modifying host 
resistance, but increasing amounts of PUF A 
in the diet also modify the fatty acid compo-
sition of the cell membrane and, by doing so, 
change the cell kinetics, resulting in e.g. an 
alteration of cholesterol (decreased [30]) or 
prostaglandin synthesis (increased [31 ]). 
With regard to the latter, prostaglandin syn-
thesis has a number of interesting aspects: 
malignancy and even tumor spread are 
claimed to be correlated with increased tu-
mor cell prostaglandin activity [32, 33]. 
From the results obtained we conclude 
that there is no reason to presume that, with 
the amounts ofPUFA that were given in our 
studies, a high linoleic acid content of the diet 
is related to enhanced tumor growth by 
means of inducing immunosuppression. The 
reason for the differences in tumor growth, as 
found in the present study, remains unclear, 
but bearing in mind the specific tumor char-
acteristics of the 2 tumors apparently sensi-
tive to the PUFA content of the diet (the 
myeloid leukemia and the cortical carcino-
ma), it seems that hormonal responsiveness 
with regard to e.g. corticosteroids and prolac-
tin might be involved, both in a negative or a 
positive way. 
This study proved once again that dietary 
factors can react differently in different tu-
mor systems. This leads us to another conclu-
sion: that, whenever dietary effects on tumor 
· growth are judged, this should preferably be 
done on the basis of the results of more than 
I tumor model, as the specific characteristics 
of a given tumor model are apparently of 
major importance to the results obtained. 
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Abstract 
Rats fed diets containing different amounts of polyunsaturated 
fatty acids either of the omega-3 or omega-6 type, received an 
implant of a syngeneic mammary adenocarcinoma. When the diameter 
of the tumors reached 20 mms, they were surgically removed; 2 
weeks thereafter the animals were sacrificed and lung metastases 
were counted. Cellular immune response was determined before 
tumor inoculation; certain prostaglandin values in plasma, and 
platelet aggregation were measured before and after tumor 
inoculation. 
Plasma PGE2 and TXB2 values were significantly decreased in those 
rats fed a diet containing Menhaden oil. 6-keto-PGF 1 ~, cellular 
immune response and platelet function were not significantly 
different in either one of the diet groups. 
Tumor growth in the groups of rats receiving the omega-3 fatty 
acids in their diet was significantly inhibited in comparison 
with the rats receiving the omega-6 fatty acids. However, the 
number of metastases was not significantly altered. 
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Introduction 
Epidemiologically, there is "suggestive evidence" for a causal 
relationship between dietary fat intake and some cancers [1-3]. 
In animal studies a positive correlation between dietary fat 
content and mammary tumor initiation or promotion could be 
demonstrated [4-6]. In particular diets rich in linoleic acid, 
were claimed to have mammary tumor promoting capacities in 
comparison with diets which were low or deficient in linoleic 
acid [5,6]. In this respect, omega-3 type of polyunsa\urated 
fatty acids recently received a lot of interest too. These fatty 
acids, mainly present in fish oil, are consumed in relatively 
large quantities by Eskimos and to a lesser extent by groups of 
Japanese fishermen [7,8]. Epidemiological data showed that the 
low prevalence of colon and breast cancer among Greenland Eskimos 
and ]Japanese could be correlated with the quality of their low 
fat intake [9-11]. 
An other important finding in Greenland Eskimos, which has 
been associated to their dietary habits, is the very low 
incidence of ischemic heart disease [12,13]. This prevention of 
coronary heart disease is considered to be the result of changes 
in blood platelet function, induced by the fatty acids EPA and 
DHA, which are prominent polyunsaturated fatty acids present in 
some marine lipids [13,14]. The anti aggregatory activity of 
these fatty acids is either attributed to to the formation of 
Prosta~landin-I 3 [12,15] or to a competitive inhibition by EPA 
and DHA of the biosynthesis of TXA2 from arachidonic acid, 
resulting in a reduction of its pro-aggregatory activity on 
platelets [16]. The eventual effect of both theories is the 
same: they lead to decreased thrombosis tendency and prolonged 
bleeding time. 
Prostaglandins may also play an important role in tumor 
initiation, promotion and spread [17-19]; one might therefore 
presume that the observed low incidence of mammary cancers amoung 
the Japanese is related to changes in PG metabolism induced by 
the specific dietary lipid composition of their diet. However, 
one should not forget that the incidence of e.g. stomach cancer 
amoung Japanese is very high, which is the reason that the 
overall cancer frequency is similar to that of Caucasians. 
In the present study the effect of 4 different diets was 
investigated. Two of the diets contained, next to 3 en~ linoleic 
acid, different amounts of fish oil, the others did not contain 
EPA or DHA, but 3 and 10 en~ of linoleic acid, respectively. The 
diets were given to rats, before and after inoculation of a 
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transplantable mammary adenocarcinoma, to study the influence of 
the diets on tumor growth and the formation of metastases. Some 
stable plasma-PG metabolites and platelet aggregation were 
measured in order to correlate possible alterations in PG 
synthesis with differences in tumor growth. Cellular immune 
capacity was tested as well, as the diets under study may exhibit 
changes in immune response and by this affect tumor growth. 
Materials and methods 
Experimental design.-A total number of 100 BN/Bi inbred female 
rats (Zentral Institut fur Versuchstierzucht, Hannover, Germany) 
entered the study at the age of 3 weeks (immediately after 
weening). At arrival the animals were randomly selected, divided 
into 4 groups and put on one of 4 experimental diets. The rats 
were housed 5 per Makrolon cage on wood chips bedding, receiving 
food and water ad libitum. The animal room was air-conditioned 
and had.a controlled night-dark rhythm. 
Every week the animals were weighed, and twice a week the 
average food consumption was measured. At the age of 6, 9, 12, 
15 and 17 weeks of age, in each experimental group, 2 animals 
were sacrificed for plasma PGE2 , 6-keto-PGF 1 ~ and TXB2 
determinations and ADP-induced platelet aggregation. Twice, at 
the age of 9 and 12 weeks, 2 rats in each group were killed for 
testing cellular immune response, by determining Con A-, and 
PHA-induced mitogen stimulation, and NK cell activity. Tumor 
inoculation of tumor BN472, a mammary adenocarcinoma, was 
performed when the animals were 12 weeks of age, i.e. 9 weeks on 
diet. Of the remaining 21 animals in each group, 15 rats 
received viable tumor tissue, whereas, 6 rats received 
Y-irradiation-killed tumor tissue. Tumor size was established by 
palpation every other day in the period between tumor inoculation 
and removal of the primary tumor, which was carried out when the 
tumor reached a diameter of 20 mm. The experiment was terminated 
exactly 2 weeks after primary tumor removal, at which time the 
remaining animals (11 rats with tumors, and 2 control animals, 
which had received Y-irradiated tumor tissue) were sacrificed in 
order to determine the number of metastases in lungs and regional 
lymph nodes. In 2 of the tumor bearing rats and in the 2 control 
rats out of each dietary group, plasma PG metabolites and 
ADP-induced platelet aggregation were measured as well. 
Diets.-The 
containing 30 
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four 
en~ 
experimental diets were identical, each 
of fat, but were differently composed with 
Table I 
CHARACTERISTICS OF THE STUDY DIETS 
Composition of the experimental diets (g/1 ,000 Kcal) 
Diet Compound 
Casein 
Minerals (Cas. '85)• 
Vitamins (Vit. '70)b 
Cellulose 
Starch 
Fatty acids 
diet groups A-D 
62.000 
8.458 
1.000 
15.000 
134.286 
32.3 
Sources of fatty acids (g/1 ,000 Kcal) 
cacao butter 
sunflower oil 
olive oil 
linseed oil 
Menhaden oil 
total 
A 
24.946 
2.581 
4.839 
32.366 
diet group 
e ·c 
13.656 
14.194 
4.409 
32.259 
3.441 
0.108 
3.226 
25.376 
32.151 
Composition of the fatty acids (en %)C 
diet group 
A B c 
saturated fatty acids 15 10 10 
monoenoic fatty acids 12 10 10 
linoleic acid 3 10 3 
EPA and DHA 0 0 7 
total 30 30 30 
P/S ratiod 0.2 1.0 1.0 
D 
7.204 
1.613 
13.118 
10.323 
32.258 
D 
10 
15 
3 
2 
30 
0.5 
a) In mg/1 ,000 Kcal: potassium chloride, 350; secondary magnesium phosphate, 956; 
primary potassium phosphate, 475; potassium bicarbonate, 71 9; calcium carbonate, 
201 4; trisodium citrate 2H20, 71 1; manganese sulphate, 51 .4; ferric citrate, 43.9; copper 
citrate, 4.7; zinc citrate, 1 2.5; potassium iodate, 0.07; tri-sodium dicitrate, 1 630; 
magnesium acetate, 1490. 
b) In mg/1 ,000 Kcal: choline (50%), 500; vitamin E (500 IU/g), 40; calcium silicate, 50; myo-
inositol, 25; vitamin B12 (1 ,000 mg/kg), 5; vitamin A (325 IU/mg), 7.7; nicotinic acid, 5; (calcium)-panthothenic acid, 5; riboflavin, 1 .5; thiamine mononitrate, 1 .5; vitamin D (80 
IU/mg); 3.1 25; vitamin K3 , (22.7%), 1; pyridoxine, 0.5; folic acid, 0.25; biotin, 0.05; sucrose, 
354.375. 
c) Established by gas chromatography. 
d) P/S ratio = ratio between polyunsaturated fatty acids and saturated fatty acids. 
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regard to their fatty acid content (Table 1). Diets A and B 
containe~3. respectively 10 en% of linoleic acid; diets C and D 
contained 3 en% of linoleic acid (like diet A), but also 7 and 2 
en% of EPA and DHA, respectively. The diets were prepared at 
Unilever Research Laboratories, Vlaardingen, The Netherlands. 
The diets were freshly prepared weekly. To prevent peroxide 
formation, the diets vere stored in vacuo in sealed plastic bags. 
The animals received fresh food every Monday, Wednesday and 
Friday; at the same time the uneaten food was discarded. 
Measurement oF Food consumption.-Every Monday and Wednesday a 
measured quantity of fresh food was given to the animals. Two 
days later food remnants were collected and weighed to determine 
food consumption per cage. By dividing this number by 10 (number 
of days x number of rats per cage) the approximated food 
consumption per rat per day was obtained. 
Tumor inoculation.-The tumor used in this study, originally 
classified as a malignant mammary adenocarcinoma (BN472), is one 
of the transplantable tumors routinely used in our studies on 
tumor growth and metastases [20]. The tumor metastatises from 
site to regional lymph nodes and lungs. Under light ether 
anesthesia a small incision was made in the skin of the right 
flank, and a small piece of tumor tissue (5-10 mm3 ), obtained 
from a syngeneic rat, was implanted s.c. The wound was closed 
with an autoclip. From day 7 onwards, at which day the clip was 
removed, the tumor dimensions were measured every other day using 
calipers, taking (length+ width)/2 as the "tumor diameter". 
When the tumor diameter reached 20 mm, the tumor was surgically 
removed, again under ether anesthesia. The operation was 
performed under clean but non sterile conditions. The tumor mass 
was removed as much as possible, and in an attempt to kill the 
remaining tumor cells, the wound was moistened with a 4% 
formaldehyde solution. Bleeding was controlled by bipolar 
coagulation. The wound was closed with autoclips. The procedure 
for those rats receiving Y-irradiated tumor tissue instead of 
viable tumor, was identical to the procedure described above, 
with the exception that the pieces of tumor tissue were 
Y-irradiated with 15,000 Rads in 2 hours. 
Two weeks after removal of the primary tumor the animals were 
sacrificed and autopsied. Regional lymph nodes (axial, inguinal 
and para-aortal) were examined (macroscopically) for signs of 
tumor metastasis and the lungs were fixated in Bouin's fixative 
for microscopical examination of metastasis. This latter was 
performed by counting, at a magnification of 400x, the number of 
metastases in a 3~m thick section of the left lung 
(longitidunally). Lung metastases were scored semiquantitatively 
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by the score: 0=0; 1-5=1; 6-10=2; 11-20=3; 21-30=4; >30=5. 
Determination of cellular immune response.-According to the 
schema as been given in experimental design animals were 
sacrificed for immune response measurements. To prepare the 
spleen cells necessary for the assays, spleens were chopped and 
passed through a 100 ~m gauze sieve. For mitogen stimulation, 
cells were washed three times and the cell concentration adjusted 
to 7.5 x 106 /ml in RPM!, 10~ foetal calf serum. For the NK cell 
assay lymphocytes were prepared by gradient centrifugation [21]. 
Lymphocytes were collected and depleted of adherent cells by 1 
hour incubation at 37°C in a tissue culture flask. Non adherent 
cells were resuspended at a concentration of 20.106 /ml in RPM! 
(Gibco, UK) to which also 10~ foetal calf serum was added. 
For mitogen stimulation 20 ~1 of a 50 ~g/ml Con A solution 
(Pharmacia, Holland) or 20 ~1 of a 25 ~g/ml PHA solution 
(Wellcome, UK) was added to 1 .5x1o5 lymphocytes, which were 
cultured in Microtitre culture plates {Greiner, W. Germany), at 
37°C in a humidified atmosphere of 5~ co2 . Harvesting was 
performed on day ~ of culture. At 6 hours beJore harvesting, 0.8 
~Ci of methyl-[ H)-thymidine {specific a~tivity, 2 Ci/mmol; 
Amersham TRA 310) was added to each well. Con A and PHA 
stimula~ion was expressed as counts/min/culture (containing 
0.15x10 lymphocytes). 
The NK cell assay was performed as described before [22], with 
a few small modifications, using YAC-1 lymphoma cells as a 
target. Shortly: effector cells were incubated for 4 hours with 
[ 51 cr] labelled YAC cells with an effector to target cell ratio 
of 200:1. Specific lysis was calculated according to the 
formula: 
% specific lysis = 
mean maximum release- mean spontaneous release 
mean experimental lysis- mean spontaneous lysis 
X 100 
In vitro platelet aggregation assay.-Under ether anesthesia 
the animals received a intravenous dose of 50 IU heparin, after 
which the abdomen was opened, the abdominal aorta was dissected 
at its bifurcation, and blood was collected by aortic puncture. 
The rats were then sacrifi~ed. 5 ml blood samples were equally 
divided into two plastic test tubes, one containing an extra 
amount of 10 ~1 of Heparin (5000 IU/ml), which was for the 
platelet aggregation determination. Into the other test tube the 
blood was put for the measurement of PG-endproducts. After a 
rest period of 30 minutes (to eliminate possible effects of 
endogenous TXA2 and PGI 2 ), the blood platelets were counted in a 
TOA Platelet Counter PL100. Platelet function was measured by 
using a Chronolog-Whole Blood Aggrometer (Chronolog Corp., UK). 
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In siliconized glass cuvettes, which were kept at 37°C, under 
constant stirring 0.5 ml of saline was added to 0.5 ml of whole 
blood. To induce platelet aggregation 10 ~M ADP was added to the 
sample. The changes in electrical resistance induced by the 
platelet aggregation were recorded during 10 minutes on an 
Olivetti M24 PC, which calculated the degree of maximum 
aggregation, which was taken as a measure of platelet function. 
Determination oF prostaglandins.-6-keto-PGF 1 ~, TXB2 (the 
stable degradation products of PGI 2 and TXA2 , respectively), and 
PGE2 , were determined, in the same blood sample as used for 
platelet aggregation, by means of a RIA, with the use of rabbit 
antisera (anti-6-keto-PGF 1 ~, Seragen, Boston, USA; anti-TXB2 and 
-PGE2 , Institut Pasteur, Paris, France; cross reactivity of 
these anti-sera with each other was <.1~ at 50~ B/Bo). To the 
2.5 ml heparinized blood sample, 250 ~1 2.8~ of EDTA and 10 ~1 of 
a 0.3~ Indomethacin solution (in ethanol abs.) was added 
immediately after bleeding the animals. Within the next half 
hour, the samples were centrifuged and plasma was stored at -70°C 
until they were assayed. 
Statistics.-A two way variance analysis was used to test the 
differences in cellular immune response, platelet aggregation and 
PG determinations. A one way variance analysis was used to 
compare differences in tumor size and metatases. In case of 
significant differences (i.e., an F value indicating a probablity 
<.05), the Newman Keuls test was used to find which pair(s) of 
means were statistically significantly different [23]. A Yates 
analysis [24] was used to test the differences in the score of 
metastasis. 
Results 
Animals and diets 
The animals accepted the experimental diets well, and no 
significant differences in food consumption were observed (Table 
2). There were also no statistical significant differences in 
growth rate (Figure 1 ). Peroxidation was measured in food 
samples, which were left at room temperature for 3 days, which 
was the maximum of exposure to air and room temperature. Values 
found were: 4.2, 12.1, 32.2, 15.2 milli equivalent 02 /kg fat, 
for diet groups A, B, C, and D, respectively. These low values 
indicate that peroxidation was minimal. 
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Table 2. - Food consumption/rat/day (grams)ab 
wks wks diet group 
of after 
age inocu- A B c D 
lation 
4 -8 6.3 6.2 6.1 6.2 
(.15) (.18) (.20) (.07) 
6 -6 6.2 6.2 6.3 6.3 
(.16) (.12) (.10) (.12) 
9 -3 7.0 6.8 6.8 6.8 
(.10) (.20) (.21) (.13) 
12 0 7.6 7.0 6.7 6.7 
(.17) (.12) (.25) (.20) 
14 2 7.6 7.2 7.1 7.1 
(.23) (.11) (.17) (.18) 
a) See for composition experimental diets, Table 1. Values given 
in parenthesis, SE. 
b) No statistical significant differences in food consumption in any of 
the dietary groups. 
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Figure 1. - Body weight gain of rats between week 3 and week 14 of age. 
No significant differences between diet groups A-D. 
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Cellular immune response 
In Table 3; Con A, PHA and NK cell activities are given. 
Especially the results o~ the PHA test determinations at wk 12 o~ 
age, coinciding with the inoculation procedure, showed in all 
dietary groups signi~icantly decreased values when compared with 
the values obtained 3 wks previously. The similarity o~ this 
decrease in PHA activity was striking: the percentile decrease 
{100~ -(12 wks values:9 wks values)x100} was 29.9, 31 .6, 30.5, 
29.1~ in groups A-D, respectively. 
Especially at wk 9, but also, to a somewhat lesser degree, at 
wk 12, total white blood cell counts in the spleens o~ the rats 
in group C were strikingly higher compared with the rats in other 
groups. However, also due to the limited number o~ observations, 
this di~~erence was not statistically signi~icant. 
In the NK cell activity assay (Table 3) no 
signi~icant di~~erences were observed, neither 
dietary groups nor between wk 9 and wk 12 values. 
Table 3. - Cellular Immune response" 
wks 
of 
age 
diet group 
A B c 
Con A (counts/min X 1 ()3 in .15 X 1 os spleen cells) 
9 175,363 156,998 185,880 
23,330 8,956 7,653 
12 185,579 157,115 152,654 
11,223 18,540 26,845 
PHA (count/min X 1 03 in 1.5 X 1 os spleen cells) 
9 90,886 
2,620 
63,748 
1,824 
97,372 
6,104 
66,628 
2,440 
NK cell activity (% specific lysis) 
9 18.6 17.8 
(8.5) (3.6) 
12 16.7 19.6 
(4.0) (9.6) 
91,668 
470 
63,747 
10,075 
17.4 
(4.8) 
13.6 
(3.1) 
Total white blood cell count/spleen (X 1 07) 
9 34.6 32.2 47.0 
(4.6) (4.0) (2.0) 
12 34.5 30.9 37.2 
(4.9) (13.2) (1.4) 
D 
175,433 
34,883 
112,262 
44,301 
93,637 
5,918 
66,410 
5,461 
22.4 
(1.3) 
13.2 
( .2) 
35.2 
(5.6) 
32.0 
(5.6) 
a) See for composition experimental diets, Table 1. Values. given in 
parenthesis, SEM 
o) Values statistically significant decreased, compared with values 
weekS. 
statistically 
in any o~ the 
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Tumor growth and metastasis 
From the total number of 52 animals receiving a piece of 
viable tumor tissue, 2 tumor inoculae did not grow: 1 in group 
C, the other in group D, these animals were not included in any 
further evaluation. The 24 animals receiving pieces of 
irradiated tumor did not show any signs of tumor growth, nor of 
any inflammatory reaction. In Table 4 values of -tumor growth 
rate- (mean number of days to reach a tumor diameter of 20 mm), 
and the metastatic score are given. Rats in group C as well as 
in group D showed statistically significantly inhibited growth of 
their tumors (p<.05), as it took these rats 5-6 days more to 
reach a tumor diameter of 20 mm. 
Neither the number of tumor metastases in the lungs were 
statistically significantly different, nor was tumor spread to 
regional lymph nodes (Table 4). 
Table 4. - Mean tumor growth rate and score of metastasis• 
Mean tumor 
growth rateb 
Tumor metastasis scored 
0 
1·5 
6·10 
11·20 
21·30 
<30 
No. of rats with pos. ly. 
nodes/total No. of rats 
A 
19.2 
( .9) 
11 
1/13 
diet group 
B C 
20.5 
(1.5) 
2 
6 
1 
1 
1 
2 
2/13 
26.8° 
(2.9) 
2 
7 
1 
0/12 
D 
25.0° 
(1.7) 
3 
5 
3 
0/12 
a) See for composition experimental diets, Table 1. Values given in 
parenthesis, SEM. 
b) Mean tumor growth rate= Mean number of days before the tumor 
reached a diameter of 20 mm. 
c) Differences statistically significant vs diet groups A and B, other 
differences are not statistically significant. 
d) Differences in tumor metastasis score are not statistically significant. 
Plasma PG-determinations 
Plasma PG values are given in Table 5. In these tables, 
values of plasma PG determinations of animals before tumor 
inoculation (values at wk 6 and wk 9 of age), 2 days after 
inoculation of the tumor (wk 12), when tumor size was 20 mms (wk 
15), and at termination (wk 17), are given. The last 3 
determinations were carried out in animals either receiving a 
piece of viable tumor tissue, or a piece of Y-irradiated (killed) 
132 
Table 5. - Plasma Prostaglandin valuesa 
6-keto-PGF 10 (pg/ml plasma) 
wks wks diet group 
of after 
age inocu· A yA B yB c yC 0 yO 
lation 
6 -6 71 117 61 313 
(17) (30) (1) (191) 
9 -3 293 222 141 233 
(59) (14) (2) (91) 
12 0 136 331 191 171 153 145 242 248 
(20) (130) (13) (23) (4) (5) (106) (114) 
15b 3 96 94 154 113 115 104 131 97 
(14) (31) (10) (6) (16) (9) (12) (20) 
17b 5 172 162 105 111 54 33 100 42 
(9) (43) (4) (0) (14) (13) (62) (11) 
PGE2 (pg/ml plasma) 
wks wks diet group 
of after 
age inocu- A yA B yB cc yec oc y0c 
lation 
6" -6 28 34 31 13 
(7) (3) (9) (3) 
9 -3 8 7 4 3 
(6) (2) (3) (2) 
12 0 5 8 9 10 6 5 6 5 
(4) (3) (1) (2) (0) (4) (2) (1) 
15 3 9 8 3 9 2 2 5 1 
(1) (3) (2) (4) (1) (1) (1) (0) 
17 5 15 13 24 12 3 3 3 2 
(7) (3) (17) (3) (1) (2) (2) (1) 
TXB2 (pg/ml plasma) 
wks wks diet group 
of after 
age inocu· A yA B yB c yC 0 yO 
Jation 
6 -6 34 51 1 8 
(3) (19) (0) (7) 
9 -3 1 1 1 1 
(0) (0) (0) (0) 
12 0 9 3 41 33 23 1 1 1 
(8) (3) (3) (4) (10) (0) (0) (0) 
15° 3 138 43 64 62 126 28 45 7 
(91) (1) (39) (23) (25) (18) (43) (6) 
17 5 49 14 33 14 1 1 1 1 
(24) (11) (21) (6) (0) (0) (0) (0) 
a) See for composition experimental diets, Table 1. Values given in parenthesis, SEM; Groups yA· 
yO received rirradiated tumor tissue instead of viable tumor tissue. 
b) Values obtained at week 3 and 5 after tumor-, or sham- inoculation are statistically significant 
(p <.05) decreased compared with pre-inoculation values. 
c) Rats in diet groups C and D show statistically significant (p <.05) inhibited values compared 
with rats in group A and B. 
d) Values determined at week 6 of aQe are statisticallvsicnificant elevated. comoarP.c1 with v::alllP.~ 
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tumor. These latter values are thus sham control values, 
exclusively showing dietary influences, and those effects due to 
the sham tumor inoculation procedure. 
6-keto-PGF1a values were not influenced by the diets, however, 
after tumor inoculation, in all diet groups, a decrease was 
established. Determinations 3 and 5 wks after tumor inoculation 
were statistically significanly decreased compared with previous 
values. However, this decrease was not found exclusively in the 
animals in which viable tumor tissue was inoculated but was also 
seen in those animals with Y-irradiated tumor tissue. This shows 
that not the tumor as such, but the procedure of tumor 
inoculation results in the observed decrease of 6-keto-PGF1a. 
Also PGE2 values showed significant differences; these 
differences were two sided, i.e., not only differences were 
noted, which could be attributed to the experimental diets, also 
an effect independent of the diets was observed. In comparing 
"column-wise", which show differences, which are the result of 
dietary influences, in diet groups C and D, PGE2\synthesis was 
significantly inhibited, when compared with groups A and B 
{p<.05). In comparing row-wise", the first determination of 
PG's showed (when the animals were 6 weeks of age) significantly 
lower values, when compared with next determinations {p<.01). 
0 3 5 
weeks (after inoculation) 
Figure 2. - Plasma TXB2 values 2 days (week 0), 3 and 5 weeks after tumor inoculation. 
At week 3, TXB2 values are statistically significant increased (p <.05). 
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Finally, TXB2 values showed statistically significant 
differences as well, more or less comparable with the previously 
stated PGE2 determinations. In diet groups C and D, TXB2 
synthesis was also significantly inhibited compared with groups A 
and B (p<.05). Furthermore, a strong increase in TXB2 values was 
noted at wk 3 after inoculation, coinciding with the period that 
the rats bore tumors of 20 mms. This difference was especially 
prominent is rats, in which vitale tumor tissue was inoculated, 
however, in sham operated control rats an increase in TXB2 values 
was seen as well. At wk 5 after inoculation no effect of the 
tumor could be observed any more, neither in tumor bearing 
animals, nor in sham operated animals. Figure 2 specifically 
shows the aspects of tumor growth on TXB2 values in the different 
diet groups. 
Platelet aggregation 
Platelet aggregation expressed as maximum aggregation is given 
in Table 6. The values, representing the maximum aggregation 
recorded by ADP-induced aggregation in whole blood, show a 
variable pattern. The large yariation was not due to changes in 
the number of platelets, as these were not influenced by diet or 
tumor progression. Before tumor inoculation, values (x106 /ml 
blood) were, mean±SE (n=4): 684±56.0; 701±39.1; 631±55.8; 
699±86.1, and after inoculation, mean±SE (n=6): 662±53.7; 
631±35.1; 678±36.7; 607±60.3. The differences were not 
statistically significant. 
Table 6. - Maximum ADP.aggregation (values in 'n')S.b 
wks wks diet group 
of after 
age inocu- A yA B yB c yC D yD 
lation 
6 -6 22.0 30.0 16.0 21.8 
(7.1) (1.3) ( .3) (1.0) 
9 -3 17.2 17.7 29.3 18.8 
(7.2) (3.2) (2.4) ( .4) 
12 0 27.1 24.1 23.9 18.9 22.4 23.0 20.5 20.1 
(1.1) (4.5) (5.3) ( .8) ( .4) ( .6) (3.8) (3.4) 
15 3 11.6 17.3 25.4 18.6 15.2 17.8 17.3 21.1 
(3.5) (1.4) (1.5) (1.2) (2.9) ( .3) (5.2) (1.0) 
17 5 31.3 23.9 23.2 26.1 22.0 17.8 20.0 14.7 
(3.6) (2.4) (1.0) (4.2) (1.3) ( .3) (2.5) (1.9) 
a) See for composition experimental diets, Table 1. Values given in parenthesis, SEM; 
Groups yA-yD received rirradiated tumor tissue instead of vitale tumor tissue. 
b) No statistical significant differences. 
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The effect of tumor growth on platelet function could be 
demonstrated by some small differences in the ADP-aggregation. 3 
weeks after tumor inoculation, in all dietary groups exept for 
group B, a non statistically significant decrease in platelet 
function was observed. 2 wks later, at termination, this 
temporarely decrease could not be established anymore. No 
(statistically significant) differences between the 4 diet groups 
were observed. 
Discussion 
The possible association between the specific dietary habits 
of Greenland Eskimos and ischemic heart disease has been known 
for some time [12,13], but a possible association with their diet 
and carcinogenesis has been investigated only more recently 
[9,25]. Some investigators [26-28] studied in experimental rat 
tumor models, the effects of diets containing certain amounts of 
omega-3 polyunsaturated fatty acids on tumor progression. Their 
first results confirm the validity of the hypothesis that EPA and 
DHA in the diet might reduce mammary tumor growth [26-28]. 
The most important features of feeding omega-3 fatty acids are 
the change in cell membrane composition and the alterations in 
PG-synthesis these fatty acids exhibit [29,30]. These changes 
are responsible for the observed prolonged bleeding time in 
humans [13], and possibly by this effect, also for the favorable 
effect on coronary heart disease. The possible significance of 
PG synthesis with regard to tumor initiation and promotion has 
been studied for some years [31-33]. PG's may be involved in 
practically all aspects of tumorigenesis, and not only the tumor 
itself may have the capacity to synthetise PG's (in quality and 
quantity different from normal tissue), but the tumor may also 
invite certain cells of the host defense mechanism to synthetise 
PG's. 
Bennett and associates [33] could correlate mammary tumor 
malignancy to the in vitro PG-like synthesis capacity of tumor 
biopsy material. Tumor PG synthesis capacity was found to be 
higher in malignant tumor tissue than in normal- or benign tumor 
tissue. Furthermore, hemostatic changes, induced by tumor TXA2 
synthesis, were hold responsible for changes in the ability of 
certain tumors to metastatise [34]. 
The second hypothesis, a mechanism by which host PG synthesis 
capacity is altered by tumor progression, has also been given 
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more attention recently [35]. Host macrophages or other 
monocytes, attracted by the tumor are known to be able to produce 
large quantities of PG's, predominantly PGE2 [36]. High levels 
of PGE2 may suppress NK cell activity and as such suppress one of 
the tumor host defense mechanisms [36]. 
In the present study, certainly the most important finding was 
that tumor growth in the rats receiving the diets containing 2 or 
7 en~ ~-3 fatty acids (EPA and DHA) was reduced, in comparison 
with those rats receiving diets containing 3 or 10 en~ of omega-6 
fatty acids, which is identical to the range of dietary 
polyunsaturated fatty acids in most Western diets. As diets C 
and D contained also 3 en~ of linoleic acid, like diet A, the 
possibility of a protective effect by a relative essential fat 
deficiency was excluded. Since there was no difference between 
diets either containing 7~ or 2~ of omega-3 fatty acids, the 
quantity of EPA and DHA in these diets seems to be less 
important. The favorable effects of the diets containing EPA and 
DHA on tumor growth correlated with low plasma PGE2 and TXB2 
values, and it seems therefore logical to suppose that the 
inhibited synthesis of these two PG's was in some way responsible 
for the favorable effect on tumor growth. 
Despite the significant reduction in growth rate of the 
primary tumor, no favorable effect was seen on the number of 
tumor metastases developing. According to our protocol, tumors 
were removed, when a size of 20 mm was reached. The time span 
between inoculation and termination was therefore 5-6 days longer 
in rats on diets containing Menhaden oil (group C and D) than in 
rats without fish oil in their diet (groups A and B). When there 
is a positive correlation between the number of days after 
inoculation and the number of metastasis, this might as well have 
contributed to a higher number of metastases in groups C and D. 
However, we presume that the protocol as been used in this study 
has some benefits to a protocol using "time after inoculation" as 
a breaking point. It seems more reasonable to expect that the 
number of metastases is more strongly correlated with the tumor 
volume than with the number of days after inoculation. 
In the present study, in tumor bearing animals, an effect on 
plasma PGF 1a and TXB2 was observed. PGF1a values were decreased 
whereas TXB2 values were increased. However, these effects, 
although slightly less markedly, were seen in plasma of rats 
receiving Y-irradiated tumor tissue as well. This could indicate 
that not the tumor itself, but the tumor inoculation procedure 
might have been responsible for this. I.e. the effect of 
anesthesia, wound healing, and the host immunological reaction, 
etc. This was in accordance with the results of one of our 
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former studies using a malignant fibrosarcoma [37]. In that 
study also very markedly elevated plasma PG values were found in 
rats which bore Y-irradiated tumor tissue. However, Y-irradiated 
syngeneic spleen cells did nor show such an effect. Our 
conclusion was that a type of host immune response against tumor 
tissue antigens must have been the reason for the elevated plasma 
PG values, more than the tumor synthesis capacity. 
It ~as striking that after primary tumor removal plasma PG 
values returned to pre-tumor inoculation values. 
In the present study, no differences in cellular immune 
capacity could be established, therefore excluding the 
possibility that host immune capacity is altered at the time of 
initiation. Yet, later in the study, when tumor growth was more 
pronounced, differences in immune response may have occurred, but 
these will be hard to distinguish from differences in tumor size, 
metastases, etc. This was the reason for us not to determine 
cellular immune response later in the experiment. 
Like others [38], we did not find any inhibitory effect in the 
in vitro platelet aggregation assay, of platelets from rats fed a 
EPA-rich diet or diets rich in omega-6 type of unsaturated fatty 
acids. However, in the earlier referred study [37], using a 
fibrosarcoma, changes were observed in maximum ADP-induced 
platelet aggregation, but these did occur rather "late" in the 
experiment. At that time tumors were large (>30 mm) and 
correlated with highly elevated plasma PGE2 and TXB2 levels, with 
values reaching 500 pg/ml and 1500 pg/ml, respectively. In the 
present study, the used method of in vitro platelet aggregation 
might not have been sensitive enough to detect the (certainly not 
more than very small) changes in platelet function induced by 
some of the experimental diets. However, in vivo measurements of 
bl€eding time in rats, given a diet containing cod liver oil 
(rich in EPA), showed significantly prolonged bleeding times, 
when compared with rats on a diet containing sunflower seed oil 
(rich in linoleic acid) [16]. 
To conclude on the basis of this study that diets containing 
Menhaden oil might be beneficial to treat mammary tumor patients 
seems to be farfetched, but it appears that prolonged nutrition 
with diets containing EPA and DHA may have a favorable effect on 
this type of cancer incidence, such as was suggested by 
epidemiological studies in Greenland Eskimos and Japanese 
[9,11,25]. The mechanism for this favorable effect needs much 
more study, still one may conclude that host PG synthesis 
capacity -most important probably, the PGE2 synthesis capacity-
is the most valuable connective link between EPA and DHA rich 
diets on tumor reduction, although other mechanisms based on the 
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signi~icantly altered physicochemical 
membranes cannot be excluded so~ar. 
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Abstract 
Rats fed diets containing different amounts of polyunsaturated 
fatty acids either of the omega-3 or omega-6 type, received 
cultured, syngeneic mammary tumor (BN472) cells i.v. Animals 
were sacrificed 2 weeks after tumor inoculation, and in the lungs 
the number of tumor foci were counted. No significant 
differences in the number of metastatic foci were observed in 
either one of the dietary groups. 
Prostaglandin measurements in the supernatant of in vitro 
cultured tumor cells showed that the tumor cells could produce 
Thromboxane-A2 . By many investigators this tumor synthesis 
capacity was connected with tumor metastasis activity. Yet in 
our study, diets rich in Menhaden oil, with the known capacity to 
inhibit thromboxane synthesis, could not control tumor metastasis 
in this particular tumor model. 
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Introduction 
The observation that diets rich in fish oil acted favorably on 
coronary heart disease of Greenland Eskimos, initiated an 
avalanche of publications on this subject [1-4]. This beneficial 
effect on cardiac heart disease is attributed to eicosapentaenoic 
acid and docosahexaenoic acid, which are present in 
concentrations up to 20% the fish oil types consumed by Eskimos 
[5]. EPA and DHA exert anti aggregatory actions, most probably 
by inhibiting the synthesis of the PG metabolic product TXA2 [6,7]. 
As PG synthesis also seems to play an important role in tumor 
growth [8,9], it is logical that the role of fish oil-rich diets 
was investigated on tumorigenesis as well [10-12]. In these 
recent studies, favorable effects on tumor growth in animals, fed 
fish oil rich diets, were observed [10-12]. Apart from tumor 
growth, the metastatic spread of the tumor may also be influenced 
by, partially or selectively, blocking PG synthesis [13]. 
Therefore this particular aspect of carcinogenesis needs close 
attention as well. 
In the present study tumor cells were inoculated intravenously 
in rats, which were on diets rich or poor in omega-3 and omega-6 
(predominantly linoleic acid) unsaturated fatty acids. Two weeks 
after tumor inoculation the animals were sacrificed to determine 
the number of tumor foci in the lungs. 
Materials and methods 
Experimental design.: 40 BN/Bi inbred female rats (Zentral 
Institut fur Versuchstierzucht, Hannover, Germany) entered the 
study at the age of 3 weeks (immediately after weaning). At 
arrival the animals were randomly selected into either one out of 
4 diet groups, and immediately received the experimental foods. 
Every week the animals were weighed. and twice a week food 
consumption was established. Mammary adenocarcinoma was 
inoculated when the animals were 12 weeks of age, i.e. 9 weeks 
on diet. The experiment was terminated exactly 2 weeks after 
intravenous inoculation of tumor cells to establish the number of 
tumor foci in the lungs. 
The rats were housed in Makrolon cages (5 rats/cage) on wood 
chips bedding, receiving food and water ad libitum. The animal 
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room was air-conditioned and had a controlled night-dark rhythm. 
Tumor.: The tumor used in this study, originally classified as a 
malignant mammary adenocarcinoma (BN472), is a transplantable 
tumor routinely used in our studies on tumor growth and 
metastases [14]. When implanted subcutaneously, the tumor 
metastatises spontaneously from the primary site to regional 
lymph nodes and lungs. BN472 was grown as a suspension culture 
in 75 ml culture flasks containing 30 ml of RPM! 1640 (Biochrom 
K.G., Berlin, Germany) supplemented with 2% of foetal calf serum, 
at 37°C in a humidified atmosphere with 5% co2 . The doubling 
time of the tumor cells was 10 hours. 
Supernatant of tissue medium was harvested for PG 
determinations. PG values represent tumor cell synthesis of 
arachidonic acid metabolites per culture flask containing a mean 
(±SEM) of 3.0 (±0.3) x10 5 cells/ml over a period of 3 days. An 
other tumor, BN175, a malignant fibrosarcoma, routinely used in 
our laboratory as well [15], was studied as well. This tumor 
also has metastatic properties. A normal cell line (skin 
fibroblasts) was taken as an other reference. Culturing 
conditions of BN175 and fibroblasts were identical as was for 
BN472 cells, however the culture flasks with BN175 cells 
contained a mean (±SEM) of 5.3 (±0.4) x10 5 cells/ml, whereas 
fibroblast culture flasks contained 10 ml medium per flask and 
had a cell concentration (mean±SEM) of 3.6 (±0.2) x10 5 cells/ml 
(Table IV). Fibroblasts do not show any sign of malignancy, 
after intravenous injection of these cells, the animals live 
their normal lifespan. 
When the animals were 12 weeks at age, 2.5x1o 5 vitale tumor 
cells were injected via the lateral tail vein, under light ether 
anesthesia. Two weeks after inoculation the animals were 
sacrificed and autopsied. Lungs were fixated in Bouin's fixative 
for microscopical examination of metastasis, which was performed 
by counting the metastases in a 3~m section of the left lung 
(longitudinal section). Tumor foci in the lung were scored 
semiquantitatively by classifying the microscopical count into 
the score: 0=0; 1-5=1; 6-10=2; 11-20=3; 21-30=4; >30=5. 
Diets: Four experimental diets were studied, which all contained 
30 en% of fat. The composition, with regard to their fatty acid 
content differed, by mixing various quantities of sunflower oil, 
cacaobutter, olive oil, linseed oil and/or Menhaden oil (Table 
I). The diets with 3 or 10 en% linoleic acid were named diet A 
and B respectively, and the diets with 7 or 2 en% of EPA + DHA 
were named diets c and D, respectively; they were prepared at 
Unilever Research Laboratories, Vlaardingen, The Netherlands. 
The diets were freshly prepared weekly in three portions. To 
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prevent peroxide formation, the diets were stored in sealed 
plastic bags, in vacuo. The animals received the diets every 
Monday, Wednesday and Friday; at the same time the uneaten food 
was discarded. 
Table I 
CHARACTERISTICS OF THE STUDY DIETS 
Composition of the experimental diets (g/1 ,000 Kcal) 
Diet Compound 
Casein 
Minerals (Cas. '85)8 
Vitamins (Vit. '70)b 
Cellulose 
Starch 
Fatty acids 
diet groups A-D 
62.000 
8.458 
1.000 
15.000 
134.286 
32.3 
Sources of fatty acids (g/1 ,000 Kcal) 
cacao butter 
sunflower oil 
olive oil 
linseed oil 
Menhaden oil 
total 
A 
24.946 
2.581 
4.839 
32.366 
diet group 
B C 
13.656 
14.194 
4.409 
32.259 
3.441 
0.108 
3.226 
25.376 
32.151 
Composition of the fatty acids (en 'lb)c 
diet group 
A B c 
saturated fatty acids 15 10 10 
monoenoic fatty acids 12 10 10 
linoleic acid 3 10 3 
EPA and DHA 0 0 7 
total 30 30 30 
P/S ratiod 0.2 1.0 1.0 
D 
7.204 
1.613 
13.118 
10.323 
32.258 
D 
10 
15 
3 
2 
30 
0.5 
a) In mg/1,000 Kcal: potassium chloride, 350; secondary magnestum phosphate, 956; 
primary potassium phosphate, 475; potassium bicarbonate, 719; calcium carbonate, 
2014; trisodium citrate 2H20, 711; manganese sulphate, 51.4; ferric citrate, 43.9; copper 
citrate, 4.7; zinc citrate, 12.5; potassium iodate, 0.07; tri-sodium dicitrate, 1630; 
magnesium acetate, 1490. 
b) In mg/1,000 Kcal: choline (50%), 500; vitamin E (500 IU/g), 40; calcium silicate, 50; myo-
inositol, 25; vitamin 8 12 (1,000 mg/kg), 5; vitamin A (325 IU/mg), 7.7; nicotinic acid, 5; (calcium)-panthothenic acid, 5; riboflavin, 1.5; thiamine mononitrate, 1.5; vitamin D (80 
IU/mg); 3.125; vitamin K3, (22.7%), 1; pyridoxine, 0.5; folic acid, 0.25; biotin; 0.05; sucrose, 
354.375. 
c) Established by gas chromatography. 
d) P/S ratio = ratio between polyunsaturated fatty acids and saturated fatty acids. 
1 ..... , 
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Measurement oF Food consumption.: Twice a week, the quantity of 
fresh food given to the animals, was measured. Two days later 
food remnants were weighed again and the consumption per cage was 
calculated. By dividing this number by 10 (number of days x 
number of rats/cage) the average food consumption per rat per day 
was obtained. 
Determination oF prostaglandins: 6-keto-PGF 1 ~, TXB2 and PGE2 
were determined in culture supernatants, by means of a RIA, with 
the use of rabbit antisera (6-keto-PGF 1 ~, Seragen, Boston, USA; 
TXB2 and PGE2 , Institut Pasteur, Paris, France). After 3 days of 
culturing, the total content of a culture flask was centrifuged, 
after which samples of 1 ml of the supernatant were frozen at 
-70°C until they could be assayed. 
Statistical evaluation.: A one way variance analysis was used to 
test the differences in the number of tumor foci in the lungs, 
body weight and food consumption. In case of significant 
differences (i.e., an F value indicating a probablity <.05), the 
test of Welch [16], was used to find which pair(s) of means were 
statistically significant different. A Yates analysis [17] was 
used to test the differences in the score of lung tumor foci. 
Results 
The animals accepted the experimental diets well; no significant 
were measured. 
a significantly 
"percentile body 
formula 
differences in food consumption (Table II) 
Animals in group B (10 en% linoleic acid) had 
different growth rate (p<.05), however when a 
weight increase·· was calculated according to the 
body weight week (n)- body weight week (n-1) 
X 100, 
body weight week (n-1 ) 
no statistical significant differences were observed. This 
implies that the differences in body weight of the animals in 
group B were due to their initial differences (Table III). 
Peroxidation was measured in food samples, which were left at 
room temperature for 3 days (the maximum of exposure to air and 
room temperature). Values were 4.2, 12.1, 32.2, 15.2 milli 
equivalent 02 /kg fat, for diet groups A, B, C, and D, 
respectively. The low values indicate that the degree of 
peroxydation was only minimal. 
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Table Ill 
Body weight of experimental animals (grams)•0 
Table II 
wks diet group 
Food comsumption/rat/day (grams)•0 of A B c D 
age 
wks diet group 
of A B c D 3 46 48 46 45 
age (2.0) (0.7) (2.0) (1.7) 
4 5.6 5.7 5.2 5.4 4 65 69 64 65 
(.16) (.17) (.15) (.16) (2.1) (0.9) (2.2) (1.7) 
5 6.0 7.1 6.2 6.5 5 78 83 78 81 
(.18) (.21) (.18) (.19) (2.8) (1.5) (2.4) (2.0) 
6 6.3 6.5 6.2 6.3 6 88 95 90 92 
(.18) (.19) (.18) (.18) (3.3) (2.5) (2.5) (2.0) 
7 6.3 6.8 6.3 6.4 7 100 110 101 104 
(.18) (.20) (.18) (.19) (3.4) (3.5) (3;3) (2.6) 
8 6.5 6.6 6.7 6.5 8 108 118 113 114 
(.19) (.19) (.19) (.19) (4.5) (3.7) (3.1) (3.0) 
9 7.3 7.2 6.9 7.1 9 118 127 120 122 
(.21) (.21) (.20) (.20) (4.4) (4.1) (3.4) (3.0) 
10 7.4 7.4 6.5 6.5 10 126 137 127 130 
(.22) (.22) (.19) (.19) (4.2) (4.1) (3.2) (3.1) 
11 7.7 7.5 7.1 7.0 11 136 146 134 137 
(.22) (.22) (.20) (.20) (3.9) (4.2) (3.4) . (3.1) 
12 7.3 7.0 6.7 6.8 12 141 150 139 142 
(.2i) (.20) (.19) (.20) (3.9) (4.1) (3.4) (3.2) 
13 7.3 7.3 6.9 6.7 13 146 156 146 147 
(.21) (.21) (.20) (.19) (4.1) (3.6) (3.8) (3.2) 
a) See for composition experimental diets, a) See for composilion experimental diets, 
Table I. Values given in parenthesis, SEM. Table I. Values given in parenthesis, SEM. 
b) No statistical significant differences in food b) Body weight of the animals in diet group B is 
consumption in any of the dietary groups. significantly increased (p <.01) in comparison 
with diet group A, C and D. 
The results of the PG measurements in the supernatant of cell 
cultures (Table IV) showed that both tumor BN472 and BN175 had no 
detectable PGE2 and prostacyclin synthesis, however, synthesis of 
TXA2 could be demonstrated. PG synthesis of the fibroblasts in 
tissue culture was significantly different from that of the 
mentioned two tumor cells lines. Not only was synthesis of PGI 2 
and PGE2 clearly present, but also TXA2 values were significantly 
higher. 
The scores of the tumor foci in the lungs are given in Table 
V. Differences were minimal (diet D has a relative "favorable·· 
score) and were not statistically significant. 
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Table IV 
PG values in supernatant of tissue culture (pg/108 tumor cells)8 
PGE2 6·keto-PGF1a TXB2 
tumor BN472" <10 <10 641 
(104) 
tumor BN175" <10 <10 999 
(103) 
fibroblasts 1170 3965 1908 
(89) (236) (255) 
a) Number of measurements = 6; values given in parenthesis, SEM. 
b) See for tumor characteristics, Materials and Methods. 
Table V 
Number of animals having a certain score of tumor foci in the left lungab 
tumor diet group 
score A B c D 
0 0 0 0 0 
1·5 3 4 3 7 
6·10 3 1 4 2 
11·20 3 4 3 0 
21·30 0 1 0 0 
<30 1 0 0 
a) See for composition experimental diets, Table I. 
b) No statistical significant differences in the number of metastasis. 
Discussion 
EPA- and DHA-rich diets have important inhibitory e~~ects on 
hemostasis, possibly by changing PG synthesis [4,18]. The 
possible signi~icance o~ this with regard to tumor initiation and 
promotion has not been evaluated su~~iciently, but some studies 
on this subject have been completed recently [10,19]. So ~ar 
most o~. these studies were concerned with tumor growth itsel~, 
and it was surprising that the process o~ metastasis received 
only little attention. This is surprising as many investigators 
link the ability o~ a malignant tumor to metastatise to its 
capacity to synthetise "procoagulant ~actors··, most probably TXA2 [13]. By this mechanism, indomethacin or other non steroid anti 
in~lammatory agents (NSAIA) could reduce tumor growth as well as 
the number o~ metastasis [20-22]. Because EPA and DHA rich diets 
act more or less similar on hemostasis as NSAIA's do, the study 
o~ the e~~ect o~ ~ish oil rich diets on this aspect o~ the 
carcinogenesis was certainly justi~ied. 
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The results of the present study showed that the expected 
favorable effect on the "take- of tumor cells was not present. 
In an earlier study by us, using the same tumor and dietary 
regimen, in a model in which the tumor was implanted 
subcutaneously, no differences in spontaneous dissemination of 
the tumor was could be found as well, although differences in 
tumor growth were observed [Kort, W.J., et al.:to be published]. 
In this study and in those previous carried out by us and by 
others [7], the effect of fish oil rich diets on PG synthesis and 
hemostasis could be shown. Plasma PGE2 and TXA2 values were 
significantly decreased in those rats fed the diets rich in 
Menhaden oil [Kort, W.J., et al.:to be published]. In 
experiments of Hornstra et al, the in vivo bleeding time was 
significantly prolonged [7]. This implies that if the theory 
that hemostatic changes play a role in tumor metastasis, as for 
instance was postulated by Honn et al [23], is correct, the 
animals receiving the diets rich in Menhaden oil, should have a 
reduction of the number of metastatic foci in the lungs. However 
in the present study we could not support this hypothesis. 
A necessary condition for a possible favorable effect of diets 
or drugs with TXA2-blocking properties will depend of course on 
the capacity of the tumor to produce TXA2 ; this condition was 
fulfilled in this study. In the supernatant of the cell cultures 
of tumors with metastatising capacities, TXB2 , the stable 
degradation product of TXA2 , was present. An other interesting 
finding was that a non malignant fibroblast cell line was not 
very much different from our two tumor cell lines with regard to 
their capacity to synthetise TXA2 (except for quantitative 
differences), but was for its capacity to poduce PGI 2 and PGE2 . 
Therefore the metastatic ability of a certain tumor type does not 
seem to be exlusively dependent of the capacity of that cell to 
produce TXA2 , but may be more related to the ratio of all PG's 
synthetised. Which latter implies that blocking the TXA2 
synthesis alone, would not do much good with regard to prevention 
of tumor metastasis, although the first results with TXA2 
synthetase blockers and TXA2 receptor blockers in some tumor 
metastasis models showed a significant regression of the tumor 
spread [24-26]. 
The importance of the observed quantitative differences in 
tumor TXA2 synthesis is difficult to assess. Although there are 
differences in tumor malignancy between tumor BN472 and BN175 
(BN175 is the more agressive one; tumor growth rate is higher 
[14]), one may conclude that there is a correlation between tumor 
malignancy and tumor TXA2 synthesis, however the fact that also 
the fibroblast cell line could produce considerable amounts of 
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TXA2 militates against such a connection. 
The model of intravenous tumor inoculation is a model in which 
the process of tumor cell "take" can be studied. Certainly for 
processes involving changes in hemostasis. such as been studied 
here. the model of intravenous tumor inoculation seems to be the 
model of choice. However. we have to keep in mind that in this 
model only one aspect of the multistaged process of tumor 
metastasis is involved and that to study the other steps of a 
metastatising tumor cell a spontaneous metastatising tumor is 
necessary. 
So far we may conclude that despite the fact that. with fish 
oil-rich diets. conditions can be achieved which alter 
hemostasis. no inhibitory effect was seen on the number of tumor 
foci in the lungs. after intravenous tumor inoculation. 
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Abstract 
In a previous study, significant differences in the growth rate 
of a transplantable mammary adenocarcinoma were observed between 
rats, receiving a diet rich in saturated fatty acids (lard, diet 
A), and rats on a diet, in which for partly the saturated fat was 
replaced by polyunsaturated fatty acid of the w-3 type (Menhaden 
oil, diet B). 
In the present investigation, it was our aim to study tumor 
growth in rats on diet A and B, as well in rats, that had, at 
tumor inoculation, a change of diets, from diet A to diet B. 
Tumor growth of rats receiving diet A throughout the whole 
experiment was the same as in those rats that had a conversion of 
diets. The data shows that the observed inhibiting effect of 
diet B on tumor growth could not be obtained when this diet was 
given exclusively after tumor inoculation. 
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Introduction 
Marked differences in incidence of colon and mammary tumors 
are seen between Western countries and Asian or .African countries 
[1-3]. For these differences environmental conditions are 
attributed. Life style studies amoung the main ethnic groups in 
Hawaii showed a wide range in cancer incidence rates [4]. Other 
important findings in these studies were the positive correlation 
between the incidence of certain tumor types (e.g. breast 
cancer) and saturated fat consumption. Moreover, tumor incidence 
rates of second generation Hawaii inhabitants, with adopting a 
more Westernized food consumption pattern, tended to change in 
the direction of those of Hawaii born Caucasians [4]. 
Many constituents of the diet were mentioned that could either 
promote or inhibit carcinogenesis [1,5,6]. On the basis of these 
data, or from anecdotal sources, several types of "health food"" 
were marketed [7-10]. The effects of these diets on tumor 
prevention is hard to assess and remains uncertain, although some 
investigators claim to have found good correlations for, e.g. 
high vitamin C, high fiber, or low fat with a decreased tumor 
incidence [9,10]. 
A "therapeutic" effect of certain diets on cancer has been 
proposed also [11 ,12]. Food constituents such as vitamin C and 
fiber were given in excess to cancer patients, not in order to 
counteract nutritional inadequacies as a result of cancer 
cachexia, but in order to cure the cancer [12]. Also 
··macrobiotic" diets have been advocated [11]. These ideas have 
hardly any scientific foundation and were subject to much 
criticism [13]. 
Conclusive evidence from epidemiological studies in man should 
be obtained from studies in experimental animals. Many such 
studies were carried out in rats, for instance confirming the 
epidemiologically established correlation between high fat intake 
and increased mammary tumor incidence [14-17]. Although many 
dietary constituents have been studied, the quantity and quality 
of dietary fat, received most attention. In one of such studies 
by us, we could show that animals receiving diets, enriched in 
Menhaden oil, had an inhibited tumor growth when compared with 
rats rece1v1ng diets, rich in saturated fat or enriched in 
linoleic acid [Kort, et al, in preparation]. 
This finding was taken as a starting point for the present 
study. In this study we were especially interested in the 
ability of the diet rich in Menhaden oil to inhibit tumor growth 
or tumor metastasis when the diet was given exclusively after 
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tumor inoculation, that is to say as a therapy to control tumor 
progression. 
Materials and methods 
Experimental design.: 75 BN/Bi 
Institut fur Versuchstierzucht, 
study immediately after weaning (3 
inbred female rats (Zentral 
Hannover, Germany) entered the 
weeks of age). At arrival the 
animals were randomly divided into 3 groups, 2 of which first 
received diet A (Group A-A; Group A-B) while one group received 
diet B continuously (Group B-B). Every week the animals were 
weighed while at the same time food consumption was established. 
Tumor inoculation with BN472 (a transplantable mammary 
adenocarcinoma) was performed when the animals were 12 weeks of 
age, i.e. 9 weeks on experimental diet. On the day of tumor 
inoculation, the diet of the animals in Group A-B was converted 
from diet A to diet B. 18 days after tumor inoculation primary 
tumors were removed, and 13 days therafter the experiment was 
terminated by sacrificing the animals. Housing conditions were 
controlled and identical in all groups. 
Tumor inoculation.: BN472, a transplantable mammary 
adenocarcinoma, was implanted subcutaneously in the right flank 
of the rat under light ether anesthesia. 18 days therafter, the 
primary tumors were surgically removed, again under ether 
anesthesia. 13 days after primary tumor removal the animals were 
sacrificed and underwent autopsies. Inguinal, axial and 
paraaortal lymph nodes were examined macroscopically for tumor 
metastasis, and the lungs were fixated in Bouin's fixative for 
microscopical examination of metastasis. This was performed by 
counting the metastases in one 3~m section of the left lung 
(longitudinally). Lung metastases were scored semiquantitative~y 
by classifying the microscopical count into the score: 0=0; 
1-5=1; 6-10=2; 11-20=3; 21-30=4; >30=5. 
Measurement or rood consumption.: Once a week the quantity of 
fresh food given to the animals was weighed. Two days later the 
food remnants were weighed again and the consumption per cage, in 
which 5 animals were housed, was calculated. By dividing this 
number by 10 (number of days x number of rats/cage) the mean food 
consumption per rat per day could be calculated. 
Diets: The experimental diets, prepared at Unilever Research 
Laboratories, Vlaardingen, The Netherlands, contained 30 en% of 
fat but were differently composed with regard to their fatty acid 
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content (Table I). The diets were freshly prepared weekly in 
three portions: one for 3 days, the other two for 2 days. To 
prevent peroxyde formation, the diets were stored in sealed 
plastic bags, in vacuo. The animals received the diets every 
Monday, Wednesday and Friday; at the_ same time dis~arding the 
uneaten food. 
Table I 
CHARACTERISTICS OF THE STUDY DIETS 
Composition of the experimental diets (g/1 ,000 Kcal) 
Diet Compound 
Casein 
Minerals (Cas. '85)" 
Vitamins (Vit. '70)b 
Cellulose 
Starch 
Fatty acids 
Sources of fatty acids (g/1 ,000 Kcal) 
diet group 
A B 
cacao butter 24.946 
sunflower oil 2.581 3.441 
olive oil 4.839 0.108 
linseed oil 3.226 
fish oil 25.376 
total 32.366 32.151 
diet groups A and B 
62.000 
8.458 
1.000 
15.000 
134.286 
32.3 
Composition of fatty acids (en %)c 
saturated fatty acids 
monoenoic fatty acids 
linoleic acid 
EPA and DHA 
total 
P/S ratiod 
diet group 
A . B 
15 10 
12 10 
3 3 
0 7 
30 30 
0.2 1.0 
a) In mg/1,000 Kcal: potassium chloride, 350; secondary magnesium phosphate, 956; 
primary potassium phosphate, 475; potassium bicarbonate, 719; calcium carbonate, 
2014; trisodium citrate 2H 20, 711; manganese sulphate, 51.4; ferric citrate, 43.9; copper 
citrate, 4.7; zinc citrate, 12.5; potassium iodate, 0.07; tri-sodium dicitrate. 1630; 
magnesium acetate, 1490. 
b) In mg/1 ,000 Kcal: choline (50%). 500; vitamin E (500 IU/g.), 40; calcium silicate, 50; myo-
inositol, 25; vitamin 8 12 (1,000 mg/kg), 5; vitamin A (3251U/mg), 7.7; nicotinic acid, 5; (calcium)-panthothenic acid, 5; riboflavin, 1.5; thiamine mononitrate, 1.5: vitamin D (80 
IU/mg); 3.125; vitamin K3, (22.7%), 1; pyridoxine, 0.5; folic acid, 0.25; biotin. 0.05; sucrose. 
354.375. 
c) Established by gas chromatography. 
d) P/S ratio = ratio between polyunsaturated fatty acids and saturated fatty acids. 
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Statistical evaluation.: A Student t-test was used to test the 
differences in body weight, food consumption, and tumor growth 
rate. A Yates analysis [18] was used to test the differences in 
the score of metastasis. Differences were considered 
statistically significantly different, when p~.05. 
Results 
The animals accepted the experimental diets well; no significant 
differences in food consumption were observed (Figure 1). Also 
differences in body weight were not statistically significant 
(Figure 2). 
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Fig. 1. - Determination of food consumption, no statistically significant differences between 
animals fed diet A or diet B. 
See for composition of the experimental diets, Table I. 
DIET 
__ A 
-- B 
3 4 5 6 7 8 9 10 11 12 13 
age in weeks 
Fig. ·2. - Determination of body weight, no statistically significant differences between 
animals fed diet A or diet B. 
See for composition of the experimental diets, Table 1. 
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Peroxidation was measured in food samples, which were left at 
room temperature for 3 days (the maximum of exposure to air and 
room temperature). Values were 4.2 and 32.2 milli equivalent 
02 /kg fat, for diet groups A and B, respectively. The low values 
indicate that peroxydation was only minimal, which is agreement 
with the observed similar growth rates of the two dietary groups. 
A number of animals had to be excluded from further evaluation 
because the tumor -did not show any growth at day 18: 5, 3 and 7 
rats in Group A-A, Group B-B, and Group A-B, respectively. 
The differences in tumor growth rate and the scores of the 
metastatic foci in the lungs can be seen in Table II. 
Differences were only observed for tumor growth between groups 
A-A and A-B on the one hand, and Group B-B, on the other (Group 
B-B vs Group A-A and Group A-B, statistically significant, 
p<.05). In the score of tumor foci in the lungs, differences 
were minimal and were not statistically significant. 
Table II 
Mean tumor growth rate and mean score of metastasis• 
dietary group 
A-A 8-8 A-8 
mean tumor 15.4 21.5b 15.5 
growth ratec (0.6) (2.3) (0.8) 
tumor metastasis scored 
0 5 4 4 
1-5 5 6 5 
6-10 2 2 2 
11-20 3 4 4 
21-30 2 
>30 4 4 3 
No. of rats with pos. ly. nodes/ 4/20 2/22 5/18 
total No. of rats 
a) See for composition of experimental diets, Table I. Values given in parenthesis, SEM. 
b) Difference statistically significant vs diet group A-A and A-B (p <.05). 
c) Mean tumor growth rate= Mean number of days before the tumor reached a diameter of 
20mm. 
d) Differences in tumor spread to the lungs were not statistically significant. 
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Discussion 
The importance of a therapeutic use 
cope with dietary inadequacies as 
been fully recognized [19,20]. The 
improve, and a better response 
improved tolerance to their side 
[21,22]. 
of nutritional factors to 
a result cancer cachexia has 
patient's condition might 
to antineoplastic drugs or an 
effects has been observed 
On the other hand, certain dietary regimens have been also 
suggested as alternative treatment modalities to the orthodox 
therapeutic approach to cancer [11 ,13]. This means that such 
diets are advocated as a sole therapy for cancer. Many of such 
unorthodox therapies exist, and sometimes receive much attention 
in the popular press [23-25]. Generally, the composition of 
these diets lack any scientific basis: controlled trials have 
not been performed and in vitro or in vivo research in 
experimental animals is lacking. 
One of the components also receiving attention in circles of 
the practitioners of alternative cancer management, as a dietary 
component with cancer promoting properties, was animal fat 
[24-25]. Siguel [24] gives a theoretical explanation for the use 
of vegetarian diets for its ··cancerostatic" effect. Shortly, the 
vegetarian diet would deprive neoplastic cells,of higher chain 
fatty acids and of the enzym 6-desaturase. Such a depletion 
would result in altered membrane fluidity, altered membrane 
transport properties, the ability to reproduce, etc., and by 
these means decrease neoplastic cell survival. 
Fish oil enriched diets, as were used in the present study 
were given as a tumor controlling diet, with more or less the 
same theoretical background in mind. Also polyunsaturated fatty 
acids present in fish oil (eicosapentaenoic acid, EPA; 
docosahexaenoic acid, DHA) alter membrane fluidity, arachidonic 
acid metabolims, etc. [26]. Its potential use as a 
cancerostatic component in nutrition was first suggested from 
epidemiological studies in man [27] and later confirmed in 
experimental animals by Karmali et al [28], and by us [Kort, et 
al, in preparation]. The conclusion from these studies was that 
the diets rich in fish oil, when given before and after tumor 
inoculation of a transplantable mammary adenocarcinoma, could 
reduce the tumor growth. However, due to the dietary protocol 
used in these studies it was not clear whether the diets 
exhibited their beneficial effect before or after tumor 
inoculation. 
The results of the present study show that a favorable effect 
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can be obtained as a result of the dietary status of the animal 
before tumor inoculation, and that there is no -therapeutic-
effect of the diet. Since the mean period to achieve a tumor 
size of 20 mm diameter was similar in diet groups A-A and A-B and 
different from B-B. 
Apart from its inhibitory effect on mammary tumor growth, 
diets enriched with fish oil may also be able to control tumor 
cell metastasis. The theoretical background is the ability that 
EPA and DHA alter platelet function by reducing Thromboxane-A2 
synthesis and by these means may interfer with tumor. cell 
platelet interactions, a mechanism which is considered to be 
important for tumor cell metastasis [29-32]. 
However, in the present study, no statistically significant 
differences in the number of metastatic foci in the lungs were 
observed. Therefore we cannot support a possible therapeutic 
approach for reducing tumor metastasis via fish oil rich diets. 
We therefore conclude that, on the basis of the presented 
data, no therapeutic effect can be expected of fish oil rich 
diets, neither on controlling tumor growth, nor in controlling 
tumor metastasis. A possible beneficial effect on tumor growth 
can be achieved only when the diet rich in fish oil is given 
ample time before inoculation of the tumor. 
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ABSTRACT 
Growth of BN175, a malignant fibrosarcoma, was correlated with high 
plasma TXB2 and PGE2 levels. This statistically significant increase was 
first detected 17 days after inoculation of the tumor, at which time the 
tumors were 20 mms in diameter. A further increase in tumor size was 
associated with still higher PGE2 and TXB2 values. At the same time, 
progressive alterations in platelet function, as measured by ADP-induced 
platelet aggregation, were observed. 6-keto-PGF1cr levels remained normal 
throughout the whole experiment. 
It was concluded that tumor growth was associated 
synthesis and platelet function, although it remains 
changes were caused by some host immunological response 
were predominantly the result of tumor PG-synthesis. 
INTRODUCTION 
with changes in PG 
unclear whether these 
towards the tumor or 
Like normal 
quantitative 'and 
cells, cancer cells synthetize PG's 1 ); however, 
qualitative differences in PG-synthesis between malignant 
tumor cells, on the one hand, and benign tumor or normal cells, on the other, 
have been observed (1-3). For instance in several types of malignant tissue, 
both in humans and experimental animals, high synthesis of the PGE type of 
prostaglandins has been found (1-3). In other studies, PGI 2 and TXA2 
synthesis were also found to be higher in tumor tissue than in normal or 
hyperplastic tissue (3-5). 
Some tumor associated disorders have been related to altered PG 
synthesis; e.g. hypercalcemia, often to be found in breast tumor patients, 
and diarrhoea in a patient with a medullary thyroid carcinoma, were 
l)The following abbreviations were used: PG's prostaglandins, TXB2 
thromboxane B2 , TXA2 thromboxane A2 , PGE2 = prostaglandin E2 , PGI 2 = 
prostaglandin I 2 = prostacyclin, 6-keto-PGF1cr = 6-keto prostaglandin Flcr' ADP 
= adenosine diphosphate, RIA = radioimmuno assay. 
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attributed to enhanced PG synthesis ativity (6,7). Increased PG synthesis 
has also been connected with metastasis (8). In particular Honn and his 
group showed that alterations of the TXA2 /PGI 2 ratio in favor of TXA2 
correlated with an increase of the number of metastatic foci in the lungs of 
rats in which tumor cells were inoculated intravenously (9). 
Because of its importance in certain tumor associated complications and 
possibly its influence on tumor metastatic pattern, PG-synthesis or synthesis 
capacity might be a useful tool to monitore tumor status in patients. 
Consequently, Bennett et al. (10) and also Karmali et al. (3), and later 
many others (2), measured PG synthesis in specimens of tumor tissue obtained 
at surgery and found evidence that, for instance, breast carcinomas produced 
more PG's than normal tissue and that the level of PG synthesis could be 
related to staging of the disease. 
The present study was undertaken to elucidate further the relationship 
between tumor growth and PG synthesis. Most importantly, the study was 
initiated to determine whether plasma PGE2 , TXA2 or PGI 2 values as measured 
by RIA assay could be used as a parameter to follow tumor progresssion, and 
if blood platelet aggregatory changes could be established in tumor bearing 
rats, which could be associated with either tumor progression or changes in 
plasma PG-values. 
The tumor used in this study has been used in several other 
investigations; it metastases from site to regional lymph nodes and lungs 
and appears to be sensitive to aspirin therapy (11 ,12). 
MATERIALS AND METHODS 
Experimental design and animals - Inbred Brown Norway (BN) female rats 
weighing 125-175 were used. Tap water and rat chow (Hope Farms AMI!, 
Woerden, The Netherlands) were given ad lib. For every determination of 
either' PG's or platelet aggregation, 5 different rats were taken, as we 
considered frequent blood sampling in the same rat would have too much 
influence on consecutive measurements. When blood samples were taken from 
tumor bearing animals, at the same time, they were also taken from sham 
treated control rats. Control values for PG and platelet aggregation were 
measured in animals in which pieces of tumor tissue (that had been irradiated 
with 15000 Rads Y-irradiation) were inoculated. Moreover another group of 
animals, in which irradiated isogeneic spleen cells were inoculated, served 
as controls to establish the influence of the inoculation procedure itself on 
the parameters used. The environmental conditions of the rats under study 
were strictly controlled and for all animals, either experimental or sham, 
identical. 
Tumor - The tumor used in this study was BN175, a malignant 
fibrosarcoma, classified as a non immunogenic undifferentiated mesenchymal 
tumor (12). In this study the tumor was inoculated in the flank, by putting 
a small piece of vital tumor tissue (about 5mm3 ) under the skin. Tumor size 
was measured twice weekly using calipers and determining the diameter by 
calculating the mean of length and width. 
Tissue culture - Cells of tumor BN175 are kept in tissue 
RPM! 1640 medium to which 5% foetal calf serum has been added. 
the tumor, which grows very rapidly (doubling time 24 hrs), 
diluted into a next passage. At the time of the experiment the 
its 20th passage. PG synthesis by BN175 in tissue culture was 
the supernatant just before another passage. 
culture in 
Twice a week 
is further 
tumor was in 
measured in 
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In vitro platelet aggregation - Platelet aggregation was carried out 
according to the procedure as described earlier (12) using the 
Chronolog-Whole Blood Aggrometer (Chronolog Corp., England). Heparinized (10 
U/ml) whole blood samples were diluted 1:1 with 0.9~ saline, ADP (10 ~M) was 
added to induce platelet aggregation. 10 minute recordings of the induced 
changes in electrical resistance (impedance, values given in 'Q') were 
analysed by an Olivetti M24 PC, which calculated the maximum aggregation. 
Platelets were counted on a TOA Platelet Counter PL100. 
Determination of PG's - PG's were determined in blood plasma by means 
of a RIA, with the use of rabbit antisera (6-keto-PGF 1 ~, Seragen, Boston, 
USA; TxB2 and PGE2 , Institut Pasteur, Paris, France; cross reactivity of 
these antisera with each other was <.1~ at 50~ B/Bo). RIA's were carried out 
in plasma from the same blood sample in which the platelet aggregations were 
performed. To a blood sample of 2.5 ml, 250 ~1 2.8~ of EDTA and 10 ~1 0.3~ 
of indomethacin was added immediately after bleeding the animals. Within 
half an hour thereafter, the samples were centrifuged and plasma was stored 
at -70°C until they were assayed, according our routine procedure which was 
described earlier (13). 
Statistics - Statistical evaluation of the differences were tested by 
using a Student's t-test. A difference was considered statistically 
significant when the calculated P-values were <.05. 
RESULTS 
34 out 35 animals, in which tumor BN175 was inoculated showed tumor 
growth. The one animal (killed on day 9), in which tumor inoculation was not 
successful, was excluded from further evaluation. 2 animals died before the 
intended day of sacrifice (day 30), from lung metastases. 
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Fig. 1. Tumor growth after inoculation of BN175; n=5, vertical bars 
represent ±SEM. 
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Y-irradiated pieces of tumor or spleen tissue were 
not show any visible sign of tumor growth or inflammatory 
Tumor growth pattern is shown in Fig. 1. First detectable tumor growth 
could be observed 6 days after inoculation, while at 30 days, the tumor 
reached a mean diameter of 40 mm. Tumors reaching 30 mm or more impeded the 
animal's condition markedly; such tumors often ulcerated, and were partly 
necrotic, the animals being weakened by blood loss and inflammation. 
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Fig. 2. Plasma PG values after inoculation of BN175; values are given as 
percentage of values of rats, in which Y-irradiated pieces of tumor were 
inoculated; see for reference values and for SEM, Table I. 
Table I and Fig. 2 show the results of PG determinations. Because it 
is to be expected that operation trauma and immunological reactions may 
influence PG values, in Fig. 2, PGE2 , 6-keto-PGF1cx and TXB2 are depicted as 
percentage of control (=Y-irradiated tumor) values. Until day 13, values 
172 
Table II. Plasma PG values (pg/ml) after inoculation of Y-irradiated spleen 
cells. Results show mean, in parenthesis: SEM. 
day PGE2 6-keto-PGF1cx TXB2 n 
3 86.6 53.0 76.0 5 
(21 . 5) (7.9) ( 15.3) 
6 63.2 58.8 64.4 5 
(7.0) (20.4) (6.3) 
13 36.2 52.0 29.4 5 
(8. 0) (9.0) (4.8) 
------------------------------------------------
unoperated control values 
27.1 71.1 34.4 12 
(6.4) ( 12.4) ( 7. 1 ) 
At the same time that significant changes occurred in PG levels, ADP 
induced platelet aggregation altered as well (Table III, Fig. 3). The 
progressive decrease in platelet function (except for the non-significant 
rise at day 9), resulted in statistically significant (p<.05) inhibition of 
platelet aggregation from day 13 onwards. 
% 
100 
50 
20 30 
days after inoculation 
Fig. 3. Percentage of maximum aggregation achieved with 10 ~mol ADP, after 
inoculation with tumor BN175; 100~ aggregation of blood taken from 
animals, in which Y-irradiated pieces of tumor were inoculated; see for 
reference values and SEM, Table III. 
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remain around the 100% level. Thereafter plasma PGE2 and TXB2 increased and 
reached values 10-50 times the values of sham operated animals. These 
differences are statistically significant (p<.05). 6-keto-PGF1a values 
remain normal: from day 13 onwards, there was even a slight, but not 
statistically significant decrease in PGI2 activity. 
The tumor inoculation procedure itself causes changes in PG-levels as 
well (Table I). During the first 2 weeks after inoculation of a Y-irradiated 
piece of tumor tissue, values of PGE2 and TXB2 were increased, when compared 
with unoperated control values (Table II). The values reached a maximum 9 
days after inoculation. To determine what part of the PG values in the group 
of rats with Y-irradiated tumors could be ascribed to operation trauma and 
what part to some type of host anti-tumor reaction, Y-irradiated spleen cells 
were inoculated as well. PG values determined in plasma from these rats 
showed shortly after inoculation a slight increase in PGE2 and TXB2 values: 
however, this increase disappeared shortly therafter and values were normal 
again 2 weeks after inoculation. 
Table I. Plasma PG values (pg/ml) after tumor inoculation of tumor BN175 
(TUM) and BN175 Y-irradiated with 15000 Rads (YTUM, values in Italics). 
Results show mean, in parenthesis: SEM. 
day 6-keto-PGF1a n 
TUM YTUM TUM YTUM TUM YTUM 
3 90.6 147.0 45.2 32.2 81.2 94.9 5/5 
(40.5) (61.9) (6.9) (3 .5) (20.9) (17 .3) 
6 25.0 45.0 33.2 13.4 65.6 44.0 5/5 
( 12 0 2) (4.7) (4.4) (6 .5) (7.5) (2.7) 
9 356.0 374.2 61 .0 25.3 306.0 185.0 4/5 
(205.1) (206 .9) ( 17 0 4) (10.2) (163.3) (58 .2) 
13 111 .0 204.0 54.4 21.8 133.8 79.6 5/5 
( 16 0 6) (42.4) ( 6 0 3) (4 .1) (49.8) (12 .9) 
17 151 .2 16.0 30.4 48.2 141.8 20.9 5/5 
(62.6) (5.7) (7.6) (1.6) (38.3) (10 .6) 
23 476.0 38.0 39.8 56.6 1222.6 51.6 5/5 
( 117 0 3) (5.3) (13.2) (8.9) (472.7) (3.7) 
30 521 .0 8.0 21 0 3 47.0 1618.3 13.6 3/5 
(48.4) (4.1) ( 10 0 7) (8.4) (228.7) (8.3) 
PG determinations in supernatants of cell cultures of tumor BN175, 3 
days after seeding, did not show any detectable quantities of either PGE2 or 
6-keto-PGF1a• but demonstrable levels of TXB2 could be established. 
Determinations in 6 different culture flask containing 1.4x107 cells in 30 ml 
of culture medium, showed a mean (±SEM) of 529.3 (±54.4) pg TXB2 per ml 
culture medium. 
174 
Values, calculated as a percentage of those values obtained from rats, in 
which Y-irradiated tumor cells were inoculated, finally leveled off at 
approximately 60%. Other characteristics of .ADP aggregation, such as lag 
time, shape changes or reversibility of the aggregation, did not show a 
significant alteration in any of the experimental groups. The number of 
platelets was not affected by tumor growth and was as such not correlated 
with the established changes in the in vitro platelet aggregation. 
Table III. Values of maximum aggregation (values in Q) after inoculation of 
·tumor BN175 (TUM) and BN175 Y-irradiated with 15000 Rads ( YTUM), achieved 
With 1 0 JJmOl ADP, in parenthesis: SEM. 
day mean (SEM) n mean (SEM) n 
TUM YTUM 
3 17.2 (2.4) 5 18.2 ( 1 0 9) 5 
6 16.8 (3 .0) 5 20.4 ( 1 0 7) 5 
9 18.1 ( 1 0 5) 5 16.0 ( 1 0 0) 5 
13 17.0 ( 1 0 2) 5 25.1 (2.7) 5 
17 10.7 ( 1 0 1 ) 5 17.9 ( 1 0 0) 5 
23 11 .5 (4.5) 5 18.1 ( 1 0 1 ) 5 
30 9.1 ( 1 0 6) 5 17 0 3 (0.9) 5 
DISCUSSION 
While most previous studies, in both humans and experimental animals, 
reporting elevated PG synthesis, were based on measurements of PG values 
extracted from tumor biopsy material (2,14,15), this report demonstrated that 
PGE2 , 6-keto-PGF1cr and TXB2 determined in rat plasma also showed considerable 
alterations in tumor bearing rats. Mean levels of . TXB2 and PGE2 were 
markedly increased when compared with values from rats in which Y-irradiated 
tumor cells were inoculated. Recent clinical studies, in which plasma PG 
levels were measured, are in accordance with our results, although 
6-keto-PGF1cr was found to be increased as well (16,17). In our study 
6-keto-PGF1cr levels were relatively stable, and were evidently not influenced 
by tumor progress. Consequently, the TXA2 /PGI 2 ratio was disturbed, a fact 
which might have had important implications for the homeostasis of 
platelet/vessel wall interactions (9,18). 
Base line levels of TXB2 and 6-keto-PGF1cr are very low, but can easely be influenced by the methodology of blood sampling or small alterations in 
the hemostatic system (19,20). In this study, for each determination, 
another rat was taken. This excludes problems, that may arise when blood is 
taken sequentially from the same rat. However, other factors influencing PG 
levels, which cannot be controlled easily have also been described, such as 
hormonal status, dietary composition etc. (21 ,22). Such variations in PG 
values, independant of tumor growth, were shown in the present study as well. 
In the animals in which pieces of either Y-irradiated spleen- or tumor tissue 
were inoculated, shortly after the inoculation procedure enhanced PG values 
could be found. The values in the rats in which Y-irradiated spleen cells 
were inoculated, returned to unoperated control values. However, the rats 
bearing Y-irradiated tumor tissue showed another peak at 9-13 days in PGE2 
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and TXB2 . This unexpected difference between rats, in which either dead 
spleen or tumor cells were inoculated could only be attributed to some 
difference in host anti-tumor reaction or to an inflammatory reaction related 
to the inoculation procedure. This latter is hard to imagine, as there is no 
reason to presume that inflammatory processes would be different in rats in 
which either spleen- or tumor tissue was inoculated. Moreover, no visible 
signs of an inflammatory reaction were noticed. The first explanation, the 
anti-tumor reaction is also difficult to understand, as the tumor is 
classified, according to the criteria as described by Prehn and Main as a non 
immunogenic tumor (23). Still some type of cellular immune response against 
tumor cells, either dead or alive, may exist (24). 
When plasma PGE2 levels are el-evated, the direct consequence of this is 
a suppression of the production of lymphokines, resulting in a decreased host 
immune responsiveness, thus providing the tumor a possible means for escape 
from immunologic rejection (24,25). 
Apart from its effect on host immunological responsiveness, high PG 
levels may also influence metastatic spread (8,26). PGI 2 displays a strong 
anti-aggregatory action, whereas TXA2 is a very potent pro-aggregatory agent: 
the role played by PGE2 in platelet aggregation is minor and subject to much 
controversy (27). When in our study 6-keto-PGF 1 ~ and TXB2 values are used to 
calculate a ratio, as a measure of platelet aggregatory activity, it is clear 
that pro-aggregatory factors dominate. Platelet function, as determined by 
us, indeed showed changes. However, the pattern was the inverse picture of 
what might have been expected on the basis of the determined PG values, i.e. 
our results showed a decreased aggregatory action instead of an increased 
one. This makes a direct causal relationship between the observed platelet 
function and the increase in plasma PG levels not very likely. 
To conclude that a relationship exists between high plasma PG values and 
tumor growth and at the same time altered platelet aggregation, does not seem 
to be too farfetched. However, it cannot be excluded that concomitant 
inflammatory processes, more than tumor cells themselves, induce the enhanced 
PG values. Certainly high plasma PGE2 values appear to arise predominantly 
from synthesis by cells infiltrating the tumor. To counteract the increased 
PG production by administration of PG synthesis inhibitors, and as such 
possibly improve the rejection of the tumor cells, may be a valuable 
contribution to anti-tumor therapy. That such a conclusion is not without 
any foundation, has recently been demonstrated by some investigators (28,29). 
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Publication XI 
REDUCTIVE EFFECT OF ASPIRIN TREATMENT ON PRIMARY TUMOR GROWTH AND 
METASTASIS OF IMPLANTED FIBROSARCOMA IN RATS 
This article is reproduced from the Journal of the National 
Cancer Institute, vol 76, pp 711-720, 1986, by courtesy of The 
United States Department of Health & Human Services. 
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Reductive Effect of Aspirin Treatment on Primary Tumor Growth 
and Metastasis of Implanted Fibrosarcoma in Rats 1'2 
Will J. Kort, 3 Lorette 0. M. Hulsman, 3 Wlm P. van Schalkwljk, 3 lneke M. Weljma, 3 
Pleter E. Zondervan, 4 and Dick L. Westbroek 3,5 
ABSTRACT -For suppression of primary tumor growth and meta-
static spread, aspirin and theophylline, either alone or combined, 
were given daily to inbred female BN rats after sc implantation of 
a syngeneic nonimmunogenic tumor. Treatment with 200 mg aspi-
rin/kg (body wt) resulted in a statistically significant regression of 
tumor growth as well as of the number of metastases in the lungs. 
Aspirin given in a lower dose (20 mg/kg) did not show significant 
difference from the vehicle group. Theophylline (75 mg/kg) signifi-
cantly increased primary tumor growth as well as lung metastases. 
Inhibition of in vitro platelet aggregation, determined in whole 
blood taken from non-tumor-bearing animals treated with the 
same therapeutic regimen, was most pronounced in those groups 
in which tumor growth and spread were significantly retarded. 
However, this positive correlation between inhibition of tumor 
spread and platelet aggregation was not associated with a favor-
able balance of prostacyclin and thromboxane A2 in these ani-
mals.-JNCI1986; 76:711-720. 
In vivo as well as in vitro synthesis of PG in tumor 
tissue has been well established (1-5). An important 
finding was that certain PG synthesis products were 
lower in normal and benign tumor tissue than in 
malignant tumors of the same organ (1, 4). The in-
creases were predominantly in E· and F-type PG; how-
ever, in gynecological and prostatic carcinomas, the 
source appeared to be PGI2 (6, 7). Treatment with 
aspirin, indomethacin, or other NSAIA sometimes re-
sulted in significant regression of primary tumor growth 
(8) or improvement of the condition of the patients in 
those cases, when tumor-related complications such as 
diarrhea in thyroid medullary carcinoma (9) or hyper-
calcemia in malignant breast cancer (10) were present. 
Also, in experimental tumor models, in animals, NSAIA 
therapy could decrease the mass or the incidence of 
chemically induced tumors (11-12). 
Also PG may play a role in the metastatic dissemina-
tion of cancer (13, 14); therefore, it is not surprising that 
aspirin therapy proved to be useful in prevention of 
tumor spread (15). Tumor procoagulant activity, possi-
bly the result of TXA2 activity, was associated with 
metastasis (16, 17). Tumor cell metastasis was enhanced 
in tumor-bearing mice when the PGI2- TXAz balance 
was altered in favor of TXAz (18). However, PGI,, 
which acts antagonistically in the control of platelet 
aggregation, produced a dose-dependent decrease in 
pulmonary metastatic foci (19, 20). An excellent review 
on the therapeutic implications of manipulating the 
PGI2- TXA2 balance was published by Bunting et al. 
(21). 
In cardiovascular surgery much experience has been 
gathered with aspirin therapy, either alone or in combi-
nation with other drugs, concerning its ability to pre-
vent aggregation of thrombocytes (22). In these studies 
sometimes a discrepancy between the effect of low and 
high doses of aspirin was found (23). Moreover, when 
low doses of aspirin were given in combination with 
phosphodiesterase inhibitors (these drugs amplify the 
effect of the increase in cAMP induced by circulating 
PGI2), an even stronger antiaggregatory effect was ob-
tained (24). These results and the finding that aspirin 
treatment was not always beneficial in experimental and 
clinical tumor therapy led us to the present study, in 
which the hypothesis was tested that aspirin, either 
alone or in combination with theophylline, could de-
crease primary tumor growth or the number of metas-
tases in rats. 
Moreover, in blood of non-tumor-bearing animals, 
given the same therapeutic regimen for 3 consecutive 
days, stable PG end products and platelet aggregation 
were determined in order to show a possible relationship 
between these parameters and tumor growth or spread. 
Non-tumor-bearing animals were willingly chosen so as 
not to be hindered by a possible interference of tumor 
PG activity with plasma PG levels and platelet aggrega-
tion. As such, the changes in PG levels and platelet 
aggregation found will exclusively be the result of the 
therapy given. 
MATERIALS AND METHODS 
Experimental design.-We randomly divided 65 in-
bred BN female rats, 100-150 g (body wt), into-6 experi-
mental groups. Group I received aspirin, 20 mg/kg (low 
ABBREVIATIONS USED: AA=arachidonic acid; 6-keto-PGF!a=6-keto-
prostaglandin F,.; NSAIA=non-steroidal anti-inflammatory agent(s); 
PG=prostaglandin(s); PGD,=prostaglandin D,; PGE,=prostaglan-
din E,; PGI,=prostaglandin !2 (prostacyclin); RIA=radioimmuno-
assay(s); TXA,=thromboxane A2; TXB,=thromboxane B,. 
1 Received April 30, 1985: revised October 29, 1985; accepted Decem-
ber 6, 1985. 
2Supported in part by the Netherlands Cancer Foundation (Konin-
gin Wilhelmina Fonds). 
3 Laboratory for Experimental Surgery, Medical Faculty, Erasmus 
Universiteit Rotterdam (EUR), 3000 DR, Rotterdam, The Netherlands. 
4 Department of Pathological Anatomy I, Medical Faculty, EUR. 
5 We thank Dr. V. Vuzewski (Deparunent of Pathological Anatomy 
I, EUR) for carrying out the electron microscopy and Mr. M. J. P. 
Adolfs (Department of Pharmacology, EUR) for the determination of 
prostaglandin end products. 
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dose) ip; group II, 200 mg/kg of this drug (high dose); 
group III, theophylline, 75 mg/kg sc; group IV, aspirin 
at low dose combined with theophylline at 75 mg/kg; 
group V, aspirin at high dose with theophylline at 75 
mg/kg; and, last, group VI, saline, I ml (pH 5.2), ip, 
which was the volume of the vehicle as was given in all 
experimental groups and which had the same pH as 
that of the aspirin solutions. The animals received the 
drugs throughout the whole experiment, which was 15 
days, starting on the day after tumor inoculation. The 
rats were housed in Makrolon cages in groups of 5; food 
(commercial rat chow) and water were given ad libitum. 
The animal room was air-conditioned and with a con-
trolled night-dark rhythm. 
Determinations of in vitro platelet aggregation and of 
PG were performed in blood from non-tumor-bearing 
animals of the same age housed under the same condi-
tions as the animals mentioned above. These animals 
received the therapeutic regimen for 3 days and were sac-
rificed for blood sampling at day 4, exactly 24 hours 
after the last injection. 
Tumor inoculation.-The tumor used in this study 
(BN175) originated from a female animal in one of our 
longevity studies (25), in a rat receiving lifelong a low 
linoleic acid diet. It was situated in the connective tissue 
of the pancreas and had metastasized to liver, lungs, and 
lymph nodes. Slides of the original tumor, stained with 
hematoxylin and eosin, were identified as a fibrosar-
coma by the pathologist of our group (P. Z.) and on tl>e 
basis of electron microscopy (see acknowledgment foot-
note). 
The tumor was best characterized as an undifferen-
tiated mesenchymal tumor; furthermore, on the basis of 
the fibrous-appearing matrix, the tumor was diagnosed 
as a fibrosarcoma. After some passages, the tumor pro-
gressively became more primitive with most of the cells 
large with diffuse contours; the nuclei were polymor-
phic with prominent nucleoli. The cytoplasm was eo-
sil;lophilic with fairly coarse chromatin granules. Many 
mitotic figures, some of which were atypical, were pres-
ent (figs. lA, !B). 
After inoculation in syngeneic rats, the tumor grew 
uniformly within a period of 6-8 days to a diameter 
of approximately 20 mm (fig. !C). Metastases to lungs, 
regional lymph nodes, and thymus were present 1-2 
weeks after inoculation of the tumor (figs. lB, lD). The 
tumor was stored at -70°C after its 20th passage and 
was used in experiments after one passage of "start-
ing up'' in syngeneic female rates. According to the in 
vivo transplantation assay described by Prehn and Main 
(26), the tumor should be considered as nonimmuno-
genic. 
In the present study, the tumor was inoculated in 
pieces of 5-10 mm8 sc into the right flank of the rat by 
means of a small incision, which was closed by Auto-
clips. At day 8, just before surgical removal, the dimen-
sions of the tumor were measured by using a microme-
ter. Because of the characteristics of the tumor, very soft 
and not clearly demarcated, removal proved to be cum-
bersome, especially in those cases when the tumor had 
invaded the abdominal muscles. All macroscopical visi-
ble tumor tissue_ was carefully removed and bleeding, 
which was sometimes extensive, was controlled by elec-
trocoagulation. After removal of the tumor, the subcu-
taneous area was moistened with 4% Formalin in an 
attempt to prevent local recurrence. The wound was 
closed with Autoclips. 
Fifteen days after inoculation of the tumor, the ai).i-
mals were killed by exsanguination. Local recurrence of 
the tumor and tumor spread to the axial lymph nodes 
were scored macroscopically, while the lungs were fix-
ated in Bouin's fixative to enable the counting of the 
metastases. Lymph node metastases were scored posi-
tively when there was evidence of tumor invasion in the 
right axial region (fig. lD). Lung metastases were scored 
semiquantitatively by counting the white nodules on the 
surface of the left lung and by classifying this count into 
the score: <11=1, 11-25=2, 26-50=3, 51-100=4, and 
>100=5. 
In vitro platelet aggregation assay.-According to the 
earlier mentioned protocol, drug treatment was carried 
out for 3 days in non-tumor-bearing rats. Exactly 24 
hours after the last injection, the animals were sacrificed 
for the determination of platelet aggregation and PG. 
Under ether anesthesia, after systemically heparinizing 
the animal (50 IU heparin/rat), blood was drawn by 
direct aortic puncture. Next, the blood sample (5 ml) 
was put into a plastic tube containing an additional 
amount of 25 IU heparin. To eliminate possible effects 
of endogenous TXA2 or PGI2 on the. test, the blood 
samples were left at rest for 30 minutes. Platelets were 
counted on a TOA Platelet Counter PLIOO. Platelet 
function was measured by using a Chronolog-Whole 
Blood Agrometer (Chronolog Corp., England). We used 
I mM AA (PL Biochemical Inc., Milwaukee, WI) as the 
agent aggregating by virtue of its conversion by platelets 
into PG endoperoxides. This step is sensitive to nonste-
roid inhibitors of the enzyme cyclooxygenase (27). In sil-
iconized glass cuvettes, which were kept at 37°C, under 
constant stirring 0.5 ml saline was added to 0.5 ml 
whole blood. When a monolayer of platelets was formed 
on the electrodes, a constant impedance was reached; at 
that moment, the aggregating reagent was added to the 
sample. During formation of the hemostatic plug, the 
changes in electrical resistance (impedance) were re-
corded on a linear strip chart recorder (Tekman TE 200, 
100 mV full scale). Impedance recordings were termi-
nated after 10 minutes. 
Determination of PG.-6-Keto-PGFla• TXB2, the sta-
ble breakdown products of PGI2 and TXA2, and PGE2 
were determined in blood plasma by means of an RIA, 
with the use of rabbit antisera (New England Nuclear, 
Boston, MA). RIA were carried out in plasma taken 
from the r~mnant of the blood sample in which the 
platelet aggregation was studied. 
Statistical evaluation.-By use of Student's t-test, dif-
ferences between values of mean tumor size, mean score. 
of lung metastasis, and stable PG end products between 
experimental groups and the control group were com-
pared. To analyze the differences observed in the meta-
182 
static spread to the axial lymph nodes, we used a chi-
square analysis for six random samples.· A difference 
between experimental groups and the vehicle-adminis-
tered group was considered statistically significant when 
the calculated P-value was <.05. 
RESULTS 
In group V, the group of animals receiving high doses 
of aspirin and theophylline, 3 animals died in the 1st 
week of treatment, apparently due to the toxicity of this 
combination of drugs. Another rat, in group VI, the 
control group, died as a result of uncontrolled bleeding 
after removal of the primary tumor. 
From the data given in table 1, it will be clear that the 
rats in group II and V, receiving the high doses of 
aspirin either alone or together with theophylline, sur-
passed in regression of tumor growth and spread. Thera-
py with low doses of aspirin (group I) did not show any 
significant improvement in comparison to the result in 
the vehicle group (group VI). It was rather unexpected 
that in the rats given theophylline alone, tumor size was 
increased and metastases to the lungs and regional 
lymph nodes were more often found. When theophyl-
line was combined with low doses of aspirin, this tumor-
promoting effect was for the most part abrogated, indi-
cating an antagonistic effect of these drugs for this par-
ticular phenomenon. 
Local recurrence of the primary tumor was seen in 
35% of the animals; however, as this result was observed 
among all experimental groups, to the same extent and 
equally divided, this could have influenced the variation 
of the results but could not have been responsible for the 
statistically significant differences found in tumor metas-
tasis (group II vs. group VI). 
In table 2, showing the results of the PG measure-
ments, apart from the group of rats treated with theo-
phylline alone, in all experimental groups the values of 
PG end products tend to be decreased. Although a 
limited number of animals were available in each experi-
mental group, statistically significant differences could 
be shown when treatment groups were compared with 
the vehicle-administered group. Most pronounced dif-
ferences in the level of PG end products were established 
in the group of r'!tS treated with 200 mg aspirin/kg and 
theophylline. Text-figure I shows the AA-induced plate-
let aggregation pattern in blood from these rats. Rats 
from group V (showing the strongest inhibition of PG 
synthesis) also showed a marked inhibition of platelet 
aggregation. Furthermore, it was striking that in group 
Ill, in which the rats received therapy with theophylline 
alone, 6-keto-PGFia and TXB2 were slightly increased, 
whereas in the platelet aggregation a slight hyperaggre-
gation seemed to be present. 
Changes in either PG levels or platelet aggregation 
correlated with changes in tumor growth and metastasis 
as well. Whereas treatment with 200 mg aspirin/kg and 
theophylline (group V) was superior in blocking plate-
let aggregation and PG synthesis, this group was also 
the group in which the effect of tumor growth and 
spread was most prominent. In group III, the same 
correlation was found in an inverse way; a slight hyper-
aggregability and increased 6-keto-PGFia and TXB2 
values were accompanied with enhanced tumor growth 
and lung metastasis. However, no such correlation was 
found between the effect of low-dose aspirin on platelet 
aggregation and the effect of this treatment on tumor 
growth. Whereas in plat~let aggregation almost no dif-
ference could be detected between high- and low-dose 
aspirin, with regard to tumor growth and metastasis, the 
animals treated with low dose of aspirin showed no sig-
nificant difference from the vehicle group. Also, the rats 
from group II, superior in the reduction of tumor 
growth and metastasis, do not have a favorable effect on 
PG synthesis and aggregation. 
DISCUSSION 
There is mounting evidence that treatment with 
NSAIA, like aspirin, is able to reduce primary tumor 
growth (12, 28) or the number of tumor metastases (13). 
These favorable effects of aspirin-like drugs are sup-
posed to be the result of blocking the enzyme cyclooxy-
genase, which is necessary for the metabolism of numer-
ous PG. As PG play a role in cell metabolism and are 
found in large quantities in cultures of tumor cells as 
TABLE 1.-Effect of aspirin and theophylline treatment on tumor growth and spread' 
Tumor status 
Tumor size, mm, mean length plus width 
Involvement right axial lymph node, 
+!-' 
Lung metastases, mean scored 
Group I, Group II, Group III, Group IV, Group V, 
n=lO n=10 n=10 n=10 n=7 
19.8 17.1' 21.1 20.7 16.9' 
(0.6) (0. 7) (0.5) (0. 7) (1.3) 
7/3 2/8' 9/1 9/1 4/3 
2.3 
(0.4) 
1.2' 
(0.1) 
4.0 
(0.4) 
3.4 
(0.3) 
2.1 
(0.6) 
Group VI, 
n=14.-
19.7 
(0.6) 
8/6 
3.1 
(0.4) 
• Group I, 20 mg aspirin/kg (body wt) given ip; group II, 200 mg aspirin/kg ip; group III, 75 mg theophylline/kg sc; group IV, 20 mg 
aspirin/kg ip and 75 mgtheophylline/kg sc; group V, 200 mg aspirin/kg ip and 75 mg theophylline/kg sc; group VI, 1 ml vehicle ip. Treatment 
was started immediately after inoculation of the tumor. Values given in parentheses: SE 
• Statistically significant from the vehicle-administered group, P<.05. 
~ + = involvement; - = no involvement. 
"Mean score of the number of lung metastases is determined by calculating the mean of individuals' scores on the scale: <11= 1, 11-25=2, 
26-50=3, 51-100=4, and >100=5, as was established by the counting of white metastatic nodules on the surface of the left lung. 
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TABLE 2.-Ejject of aspirin and theophylline treatrMnt on PG synthesis in non-tumor-bearing rats• 
End products Group I, Group II, Group III, Group IV, Group V, Group VI, 
n=3 n=3 n=3 n=3 n=3 n=3 
6-Keto-PGF1• 75.3' 98.0' 143.3 77.7' 72.3' 136.0 (6.6) (13.6) (18.2) (21.1) (8.4) (14.0) 
TXBz 121.3 145.5 156.0 74.7' 86.0' 148.7 
(18.7) (43.3) (18.9) (31.2) (7.0) (33.4) 
PGEz 129.3' 165.3' 161.3 172.0 97.3' 220.0 
(9.6) (21.0) (38.3) (42.4) (7.4) (18.0) 
• Group I, 20 mg aspirin/kg (body wt) given ip; group II, 200 mg aspirin/kg ip; group III, 75 mg theophylline/kg sc; group IV, 20 mg 
aspirin/kg ip and 75 mg theophylline/kg sc; group V, 200 mg aspirin/kg ip and 75 mg theophylline/kg sc; group VI, vehicle 1 ml ip. 
Determinations of RIA were carried out exactly 24 hr after the last injection of the drugs (3 consecutive days). Values given in pg/ml plasma in 
parentheses, SE. 
b Statistically significant from the vehicle group, P<.05. 
metabolic degradation products (I), the observed effect 
of aspirin in in vitro studies can be the result of a direct 
action of aspirin on tumor cell metabolism (29). How-
ever, as aspirin also may play a more central role, either 
via PG or other pathways, on the immune system, other 
mechanisms may be involved as well (30, 31 ). 
i 
20,0 
15,0 
10,0 
5,0 
1' S' 10' 
·-TEXT-FIGURE I.-Effect of aspirin and theophylline treatment on AA-
induced platelet aggregation in non-tumor-bearing rats. Determina-
tion of platelet aggregation was carried out exactly 24 hr after the 
last injection of the drugs (3 consecutive days). "" , group I, 20 mg 
aspirin/kg (body wt) given ip; 0, group II, 200 mg aspirin/kg, ip; 
+,group III, 75 mg theophylline/kg, sc; .a., group IV, 20 mg aspi-
rin/kg, ip_ and 75 mg theophylline/kg, sc; e, group V, 200 mg aspi-
rin/kg, ip, and 75 mg theophylline/kg, sc; D, group VI, vehicle. On 
the x-axis, time (t) is plotted in min ('); on the y-axis, platelet 
aggregation is given as the impedance (fi); commas before zeros 
mean decimal points. Three rats were studied at each time point. 
One of the possible mechanisms by which cyclooxy-
genase inhibitors are able to act on the prevention of 
tumor spread is also thought to be a more central one. 
The antiaggregatory action of aspirin-like drugs would 
prevent tumor cells sticking to the endothelial wall of 
the circulatory or lymphatic system and, as such, reduce 
the formation of new tumors (14). In this respect, it is 
also important to consider the direct aggregatory action 
of tumor cells on platelets (by means of release of 
TXA2?) and on vasoconstriction, as such creating favor-
able conditions for subsequent evolution of tumor 
emboli (16). Considering these phenomena, it is surpris-
ing that so little attention has been paid to the dosages 
of the therapeutic regimen. Because to create favorable 
circumstances it is necessasry to obtain unaltered or, 
even better, an enhanced synthesis of PGI2 and a 
decreased TXA2 synthesis, in this respect, it seems to be 
important to give therapy with low doses of aspirin. 
In studies on the antiaggregatory activity of aspirin 
on platelets, Moncada and Vane (22) pointed out that 
high and low doses of aspirin had different effects on the 
formation of PG. They showed that aspirin in high 
doses blocked the cyclooxygenase pathway, resulting in 
an almost complete blockade of PGI2 and TXA2 synthe-
sis. However, low dose of aspirin, in humans 1 mg/kg, 
decreased TXA2 values substantially, whereas PGI2 syn-
thesis was left intact; these original findings were con-
firmed by others as well (23, 32). According to the above-
mentioned studies, therapy with low doses of aspirin 
alone or possibly combined with phosphodiesterase 
inhibitors would be the best choice to achieve those 
conditions with the best potentials to reduce or prevent 
tumor spread. 
In the present study, there is not much evidence for 
favorable antiaggregatory conditions when therapy with 
20 mg aspirin/kg either alone or combined with theo-
phylline is given to non-tumor-bearing animals. Al-
though the measurements of PG synthesis and platelet 
aggregation detected a reduced function, this effect was 
certainly not restricted to the group of animals receiving 
the therapy with low doses of aspirin in combination 
with theophylline. And in comparison with all other 
groups, the PGI2-TXA2 ratio was even most unfavorable 
in this particular group. However, we have to realize 
that the determinations were carried out 24 hours after 
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the last injection of the drugs and therefore show more 
or less the steady state level of PG synthesis and platelet 
function. It is possible that early after the injection of 
the drugs, other levels of PG synthesis or aggregation 
would have been found, more in accordance with the 
data stated in the literature. 
The method of determining platelet aggregation as 
has been used in this study needs some further comment 
as well. Measuring platelet aggregation in whole blood 
is a rather new method, .but in several studies this tech-
nique has proved to be very worthwhile in showing 
changes in platelet function (26). Although basically the 
method of measuring platelet aggregation electronically 
is different from the classical way of determining 
platelet aggregation by means of optical changes in 
platelet-rich plasma, comparison of the patterns ob-
tained by the two different methods is not so difficult. 
Apart from the simplicity of the method, measuring in 
full blood has tl1e advantage that, especially for those 
interested in the involvement of PG synthesis on platelet 
aggregation, the contribution of the erythrocytes to the 
process of aggregation is still present. 
Although Honn (20) found excellent results with 
treatment with PGI2, thromboxane synthetase inhibi-
tors, and a TXA2 receptor blocker in order to decrease 
metastasis, in numerous other studies such a therapy to 
create favorable conditions in the prevention of tumor 
metastases according to the PGI2-TXA2 balance theory 
did not give any improvement and in other studies even 
an increase in the number of metastases was noted 
(33-35). Because the less favorable results were obtained 
in models in which spontaneous dissemination of tumor 
cells were studied, it is possible that modulating the vas-
cular PGI2- TXA2 system acts beneficially only in sys-
tems in which "tumor take" is established, which is the 
case in the protocol as has been used by Honn (20) when 
tumor cells ·were injected iv· shortly after the therapeutic 
regimen was given. 
In the present study, after therapy with 200 mg aspi-
rin/kg, not only was the number of metastases most sig-
nificantly reduced but also a reduction of the primary 
tumor was obtained. To a certain extent the beneficial 
effect on metastatic spread could be thought to be 
related to the obtained reduction of the primary tumor, 
as one may expect that there is a linear correlation 
between tumor size and the number of metastases. How-
ever, a follow-up of this study, in which a different 
experimental design was used-amputation of the leg, 
in which the tumor had been inoculated and therapy 
started after the removal of the tumor-the results 
showed the same pattern: The group of animals receiv-
ing 200 mg aspirin/kg was the group with less tumor 
metastases in the lungs (35). Amputation of the leg was 
performed in this study to prevent the unfavorable effect 
of recurrence of the primary tumor, which is a possible 
weakness of the experimental model used. 
It becomes increasingly obvious that, other than the 
earlier discussed PGI2 and TXA2, other PG also may 
play an important role in tumor growth and metastases. 
In a number of tumors, high amounts of PGE2 were 
found; moreover, a relationship between the level of 
PGE2 and tumor progression was noted (1, 36). These 
findings implicate that certainly for such tumors, like in 
our study, a more complete blockade of the cyclooxygen-
ase pathway is needed to obtain an alteration of the 
tumor progression. 
Although, so far, many investigators found favorable 
effects of NSAIA treatment on tumor growth, this was 
certainly not always the case. In some other studies, no 
improvement or even a deterioration of the tumor pro-
cess was found (37). For instance Stringfellow and Fitz-
patrick (38) observed that the metastatic pattern of 2 
melanoma cell lines were dependent on PGD2 synthesis; 
i.e., the tumor with low synthesis capacity of PGD2 was 
the one with a high number of metastases, whereas the 
one with the low number of metastases could signifi-
cantly synthesize higher amounts of PGD2 (39). When 
indomethacin was given to tumor-bearing mice, the 2 
tumors acted identically; the metastatic rate was in-
creased, particularly in the tumor cell line with the least 
metastatic potentials. This illustrates once more the 
complexity of the relation between PG synthesis and 
tumor spread. Nevertheless, clinically, in many cases 
therapy with PG or their synthesis inhibitors seems to 
be potentially beneficial in the control of tumor growth 
and spread. Even manipulating PG synthesis by increas-
ing or decreasing the amount of linoleic acid in the diet 
might be beneficial in the control of tumor growth and 
metastasis (40, 41). Observed alterations in tumor 
growth or tumor incidence in experimental animals on 
high linoleic acid diets are often attributed to the 
polyunsaturated fatty acid content of the diet (25, 42, 
43). Indomethacin was capable of blocking the stimula-
tory effect of high dietary fat in mammary tumorigenesis 
(44). 
However, either one of these therapies (or a combi-
nation of one of the therapies together with Classical 
therapies) needs a background of detailed knowledge 
concerning the PG synthesis of the tumor involved. 
Furthermore, it is challenging to investigate whether the 
values obtained by measuring the platelet aggregation of 
tumor-bearing individuals can be used as a parameter 
for monitoring the tumor progression. 
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FIGURE !A.-Primary tumor growth ol the inoculated 
fibrosarcoma demonstrates large pale cells with 
polymorphic prominent nucleoli. Fibrous-appear· 
ing matrix and many mitoses can be_ seen. Hema-
toxylin and eosin. X 500 (original magnification. X 
380) 
FIGURE lB.-Tumor m<tastases In the lung show-
ing the sam< charact<ristics as tho primary tumor. 
Hematoxylin and eosin. X 80 (original magnifica-
tion, X 60) 
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FIGURE· !C.-Macroscopic appearane< of the tumor 
inoculum in the right flank at day 8. 
FIGURE !D.-Lymph node metastases in lumbal 
(I) and inguinal (II) nodes. 
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In the midst of the word he was trying to say, 
In the midst of his laughter and glee, 
He had softly and suddenly vanished away 
For the Snark was a Boojum, you see. 
THE END 
From "The Hunting of the snark", by Lewis Carroll 
